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ABSTRACT 
 
Splicing plays a major role in eukaryotic gene expression by processing pre-mRNA to 
form mature mRNA. Splicing is catalysed by the spliceosome; a ribonucleoprotein 
complex consisting of five small nuclear ribonucleoproteins (snRNPs) and over 100 
proteins. Proper assembly of spliceosomal components is critical for its function, and 
thus assembly defects can be lethal. Several diseases have been associated with 
splicing defects, such as cancer (breast cancer, leukaemia), cystic fibrosis, duchenne 
muscular dystrophy (DMD), retinitis pigmentosa (RP) and taybi-linder syndrome (TALS). 
Studying the structural dynamics and distinct functions of snRNA complexes and the 
factors that affect the stability of those complexes provides an overall idea regarding the 
structure and function of the spliceosome, which can guide us to discover novel 
therapeutics for splicing related diseases. Hence, the aim of this study is employing 
smFRET technique to monitor the structural dynamics and assembly of snRNA 
complexes and the effect of protein factors on those dynamics with single molecule 
resolution. Three specific aims have been addressed in this thesis work to achieve the 
main goal. 
The first part of this study is focused on understanding how spliceosomal 
components are recycled. This work shows that binding of Prp24; U6 snRNP specific 
protein unwinds U2 from U2/U6 complex and stabilizes U6 at a low FRET conformation, 
suggesting a novel role for Prp24 as a recycling factor. The second part of this study is 
focused on understanding the assembly of sub-spliceosomal complexes and their global 
structure. This work shows that although the binding of individual proteins slightly 
24 
changes the conformation of U4/U6 duplex; overall it maintains a rigid structure. This 
suggests that the U4/U6 adopts a preformed conformation and act as a scaffold for 
protein binding, while preventing U6 from premature activation. The third part of this 
study is focused on understanding structural and functional similarities between minor 
and major spliceosomal complexes. This work shows that minor spliceosomal 
U12/U6atac complex adopts a conformation similar to the three-helix junction structure 
of major spliceosomal U2/U6. 
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CHAPTER 1: Introduction 
 
1.1: Gene expression 
According to the central dogma of molecular biology, in living cells, genetic information 
stored in DNA first transfers to messenger RNA (mRNA) by transcription and then 
translates into functional proteins (Figure 1.1)1. However, in eukaryotes, before 
transport out of the nucleus and protein synthesis, the transcript needs to undergo at 
least three major processing steps, adding a 5’ cap structure, adding a poly A tail to the 
3’-end and splicing (Figure 1.1)1,2.  
 
1.2: Pre-mRNA splicing 
The majority of the eukaryotic protein coding genes (exons) are disrupted by some 
sequences named  introns3,4. During transcription, both introns and exons are 
transcribed into a single transcript, known as precursor mRNA (pre-mRNA)4,5.  Before 
translation, the transcript must be processed to remove these introns and join the 
protein coding sequences together (Figure1.2a)4,6. The removal of introns and ligation 
of exons is known as splicing and the processed transcript is called a mature mRNA7,8. 
This processed mature mRNA will then be transported to the cytoplasm and be 
recognized by the ribosome complex in order to translate the mRNA into an amino acid 
sequence which eventually folds into a functional protein1,8,9. 
26 
 
 
Figure 1.1: The central dogma of molecular biology. Flow of genetic materials from 
DNA to protein is explained by the central dogma of molecular biology. First the genetic 
information stored in DNA is transferred into pre-mRNA by transcription followed by the 
RNA processing which transform pre-mRNA into mature mRNA. These two processes 
occur in the nucleus. Processed mRNA is then transported into the cytoplasm where 
mRNA coded for the formation of functional proteins by a process named as translation. 
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1.2.1: Alternative splicing 
Splicing plays a major role in eukaryotic gene expression1,5,10, and it is an essential 
checkpoint for mRNA maintenance, which helps cells to regulate gene expression11. 
Most exons undergo constitutive splicing; in which all the exons are always included in 
mature mRNA1. In contrast, some eukaryotic genes carryout alternative splicing, which 
produces multiple mature mRNAs from a single transcript by shuffling different 
combinations of introns and exons (Figure 1.2b)1,8. In some cases exons can be 
skipped and sometimes those can be lengthened or shortened by altering the position 
of the splice sites12. In this way, some transcripts can contain multiple to thousands 
splicing patterns, which results in various protein isoforms from a single transcript7,8,12. It 
has been estimated that transcripts from >95% of human transcripts undergo alternative 
splicing6,13,14. Hence, the alternative splicing play an important role in protein diversity 
and gene regulation in cells12,13. This is an evolutionary advancement in higher 
eukaryotes to overcome the complexity of an organism that requires vast number of 
genes to produce the necessary proteins15.  
 
1.3: Discovery and evolution of introns 
One of the greatest findings about eukaryotic cells is that the eukaryotic genes consist 
of introns, which are derived from the term “intragenic regions”. This was discovered 
independently by Phillip A. Sharp and Richard J. Roberts in 1977, which lead them to 
receive the Nobel Prize in physiology or medicine in 1993. The number of introns 
present in organisms is highly variable; ranging from few per genome in some species 
to hundreds of thousands per genome in vertebrates and plants15,16. As an example the 
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dystrophin gene forms a >2 million nucleotides long pre-mRNA, which is then processed 
in to a 14000 nucleotides long mature mRNA, by removing 78 introns17. When and why 
introns have evolved is not clear yet but there are two main hypotheses to explain this; 
‘Introns Early (IE)’ and ‘Introns Late (IL)’ which are still on debate15,18,19. According to 
the ‘IE’ concept, introns are very old and present in all early organisms. With evolution, 
some organisms have lost their introns resulting in fewer or no introns3,15,18. In contrast 
the ‘IL’ concept suggests that introns are inserted into eukaryotic genes at a later time 
point during the evolution3,15,18.   At present no direct evidence has been found to favour 
one hypothesis over the other and therefore it can only be speculated that some introns 
have been present from a very early stage of life, where as some of them added to the 
genes after the divergence of eukaryotes20. The enormous variation of intron number 
and the position of introns among eukaryotic genes and also within different species, 
suggest that introns have either been deleted or gained or both throughout the 
evolution15,19.  
 
1.4: Different types of Introns 
There are four major classes of introns that have been discovered; group I, group II, 
tRNA and nuclear introns (or spliceosomal introns)19-22. Among these four, tRNA introns 
are short introns which are spliced through a different mechanism than the others22. 
Therefore these introns are more accurately categorized as a part of tRNA processing 
as they are less related to other groups. Group I and II introns exhibit self-splicing, 
where they catalyze their own excision23. Moreover,  group II and nuclear introns share 
a similar reaction mechanism23.  
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Figure 1.2: RNA processing and splicing. Pre-mRNA consists of protein coding 
sequences known as exons and non protein coding sequences known as introns. 
Before translation, the Pre-mRNA is needed to be processed.  (a) During RNA 
processing, pre-mRNA undergoes splicing where introns are excised and exons are 
ligated together to form the mature-mRNA, a 5’ cap structure and a poly A tail are 
added to the 5’ end and 3’ end of the mRNA respectively. (b) Alternative splicing 
increases the diversity of proteins in higher eukaryotes. In this process, the same 
mRNA is spliced differently by selecting different set of introns/exons, resulting in 
different mature-mRNA leading to the formation of multiple isoforms of proteins from a 
single gene. 
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1.4.1: Group I introns  
Group I introns can be found in various organisms, genes and genomes including fungal 
and plant mitochondrial DNAs, chloroplasts and bacteriophages24. They can also be 
found in nuclear rRNA genes of Tetrahymena and other lower eukaryotes25. Their 
presence in a wide variety of organisms and early primitive species suggest that group I 
intron could be the ancestral element of modern introns.  Group I introns adopt highly 
conserved secondary and tertiary structures which are important for their role in self 
splicing. Folding of group I introns results in the formation of an active site by bringing 
the key residues together, which are otherwise located distantly26. In general, group I 
introns share a similar core structure at their active site. Despite their sequence 
differences, all group I introns have a series of short, conserved sequence residues, 
which are base pairing in the conserved structure (Figure1.3a)26-28. The conserved 
secondary structure of group I consists of paired regions (P1-P10) separated by single 
stranded joining regions (J) or capped by loops (Figure1.3a and b)22,24,26,28. The catalytic 
core consists of two helical domains with paired (P) regions; P4-P5-P6 and P3-P7-
P922,24,27,28. Among these paired regions, P3-P9 domain has shown to be important, 
since it has the guanosine binding site22,24,26-28. Many recent crystal structures of group I 
introns provide more information about this general architecture and also revealed 
important interactions within the domains which are important for the folding and 
catalysis of group I introns28-30.  
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1.4.2: Group II introns  
Group II introns are present in bacterial and organellar genomes in many eukaryotes 
including yeast and plants but not in animal genomes20,23,31. This type of intron has very 
divergent primary sequences, but share a highly conserved secondary structure23. 
Group II intron secondary structure is composed of six domains branching out from a 
central region (Figure 1.3c and d)20,22,23,27,32. The largest among all six domains is 
domain 1 (D1), which forms inter- and intra-domain tertiary interactions and thus acts as 
a scaffold for the assembly of other domains23. As an example, interactions between D1 
and D5 are important for D5 docking and for the positioning of D5 close to the 5’ SS, 
which is essential for the catalysis.   Also this contains exon-binding sites (EBS) and 
hence recognises 5’ and 3’ SS through base pairing interactions with intron-binding 
sites (IBS)23,27,32. The next two domains, domain 2 and 3 (D2 and D3) have not shown 
any essential role in group II function23. However the presence of D2 and D3 increase 
the catalytic efficiency. Domain 4 contains the open reading frame (ORF) and domain 6 
(D6) is important since it contains the branch point adenosine residue27,32.  Among the 
six domains, domain 5 (D5) is the most conserved and vital domain, which forms the 
catalytic centre of the group II intron (Figure 1.3c)23,32.  Despite its short sequence it 
contains several regions that are highly conserved as well as essential for the catalysis, 
including the AGC triad, asymmetric bulge and the formation of tertiary interactions 
(Figure 1.3c)27,32.        
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Figure 1.3: Secondary structure and crystal structures of Group I and Group II 
introns.  (a) Secondary structure and (b) crystal structure (in ribbon and cylinder 
representation) of the group I intron of the purple bacterium Azoarcus sp. BH7228. The 
intron, exon sequences and the structural elements (P and J) are colour coded in both 
structures in a similar manner. The RNA transcript in capital letters, residues from two 
chimaeric oligonucleotides (for intron/3’ exon segment and 5’ exon segment) are in 
lower-case letters. Reprinted by permission from Macmillan Publishers Ltd: Nature (28), 
copyright (2004). (c) Secondary structure and (d) the crystal structure (in ribbon 
representation) for group II intron of Oceanobacillus iheyensis32. Six domains are 
showing as Domain I-VI and colour coded in both structures in a similar manner. 
Reprinted from (32) with permission from AAAS. 
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1.4.2: Nuclear Introns (or spliceosomal introns) 
Nuclear introns are found in almost all eukaryotic nuclear genomes. This type of introns 
are absent in prokaryotes and the number of introns among eukaryotes change 
tremendously3,19,20. Nuclear introns are spliced by an RNA-protein complex called the 
spliceosome, which will be discussed in detailed later in this chapter.  
 
1.5: Highly conserved regions in pre-mRNA 
An erroneous splicing of an intron, even by one nucleotide can entirely change the end 
product resulting in the formation of non-functional proteins or mutant proteins that can 
eventually cause cancer or other cellular defects33,34. Hence, during the splicing 
process, precise identification of intron-exon junctions is crucial.  In favour of this, 
introns contain some short, highly conserved sequences to mark the boundaries of 
introns that help in precise excision of introns1. These sequences are named as the 5’ 
splice site (SS), the 3’ splice site and the branch site (BS, Figure 1.4a)5,6.  
The 5’ SS, is a highly conserved region at the junction between the 5’ exon and 
downstream intron. In higher eukaryotes this 5’ SS composes of AG/GURAGU 
sequence (where ‘/’ denotes the exon-intron junction and ‘R’ is a purine)2,5,6. In majority 
of the organisms (~95-99%) the dinucleotide ‘GU’, marks the 5’ intron terminus, followed 
by a less conserved sequence. The 3’ SS is a highly conserved region that can be 
found at the junction of an intron and the adjacent 3’ exon and contains a YAG/G 
sequence (where Y is a pyrimidine)2,5,6. Similar to the 5’ SS, AG is the highly conserved 
dinucleotide that marks the 3’ end of the intron. The branch site (BS) is a highly 
conserved adenosine located within the intron, ~18-40 nucleotides upstream to the 3’ 
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splice site5. This adenosine is surrounded by a consensus sequence of CURACU 
(where A is the branch site adenosine) and followed by a polypyrimidine tract in higher 
eukaryotes2,5,6. These sequences in yeast (Saccharomyces cerevisiae) are highly 
conserved when compared to those in metazoans (Figure 1.4a)5. These three regions 
play a major mechanistic role in splicing. 
 
1.6: Chemistry of splicing mechanisms 
Group I introns splice via two trans-esterification reactions using an external Guanosine 
(exoG) as a cofactor (Figure 1.4b)22,25,27. Before the first step, the exoG needs to bind to 
a pocket in the catalytic core of the group I intron, which is known as the G-binding 
site22,25,27.  During the first step, the 3’ hydroxyl group (OH) of exoG carries out a 
nucleophilic attack on the 5’ SS resulting in covalent binding of exoG to the 5’ end of the 
intron and release of the upstream exon22,25,27. The free OH group at the 3’ end of the 
exon then attacks the 3’ SS, followed by the release of exoG by replacing it with the last 
nucleotide of the intron, which is always a G and known as ωG27. This results in the 
removal of intronic RNA and ligation of two adjacent exons. 
Both group II introns and nuclear introns show a similar mechanism for splicing, 
whereby intron removal occurs via two trans-esterification reactions using 2’ OH of the 
highly conserved adenosine in the BS as the nucleophile (Figure 1.4c)21,23,27,35. In the 
first reaction, the 2’ OH adenosine in the BS carries out a nucleophilic attack on the 5’ 
splice site27,31. This reaction results in a free 3’ hydroxyl on the 5’ exon and a circular 
lariat intermediate with a 2’-5’ linkage at the branch site adenosine27,31. Secondly, the 
free 3’ hydroxyl group on the 5’ exon carries out a nucleophilic attack on the 3’-splice 
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site resulting in a removal of the lariat structure, followed by religation of the two exons 
to form the mature mRNA which will eventually be transported into the cytoplasm5,31,36. 
The resulting lariat intron can be degraded or further processed into other encoded 
RNAs such as small nucleolar RNAs, microRNAs, and long non-coding RNAs37 
Other than the branching pathway described above, group II introns also exhibit an 
alternative splicing mechanism known as the hydrolytic pathway, where a water 
molecule acts as the nucleophile for the first step (Figure 1.4d)23,31. The second step in 
this pathway is identical to that in the branching pathway. 
 
1.7: Splicing of nuclear introns catalyzed by the spliceosome  
In higher eukaryotes the splicing of nuclear introns is catalyzed by the spliceosome, a 
multi-mega-Dalton ribonucleoprotein complex1,5,6. The spliceosome consists of five 
small nuclear ribonucleoproteins (snRNPs) known as U1, U2, U4, U5 and U6 and 
numerous non-snRNP protein splicing factors.5,38 Studies have shown that the yeast 
spliceosome contains ~80 proteins, whereas human spliceosome contains ~170 
different proteins, and it has homologous counterparts for almost all yeast spliceosomal 
proteins1,39,40.  
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Figure 1.4: Splicing mechanism. (a) Highly conserved regions between metazoan 
(upper) and yeast (bottom) pre-mRNA that are essential for splicing. (b) Self splicing in 
group I, using an external guanosine. (c) Splicing mechanism in group II and 
spliceosomal introns via lariat formation. (d) Hydrolytic pathway for splicing by group II 
introns. Nucleophile in each mechanism is shown in red. 
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1.7.1 Assembly of the spliceosome 
SnRNAs and related protein factors repeatedly undergo a highly ordered and stepwise 
pathway during the spliceosomal assembly and catalysis (Figure 1.5)1,5,41. First, the U1 
snRNP recognizes the 5’ splice site in the pre-mRNA and U2 binds to the branch point, 
subsequently forming the pre-spliceosome (complex A). The U4/U6 di-snRNP 
associates with U5 to form the U4/U6•U5 tri-snRNP complex. This preformed tri-snRNP 
binds to the pre-mRNA to form the pre-catalytic spliceosome (complex B). This binding 
causes major structural rearrangements within RNA-RNA and RNA-protein interactions 
which results in the release of U1 and U4 from the complex, forming the activated 
spliceosome (complex Bact). The Bact complex is further activated by ATP-dependent 
helicases to form the B* complex, which catalyzes the first step of splicing. This gives 
rise to complex C, which catalyzes the second catalytic step. After both steps of splicing 
have occurred and the mature mRNA is formed, the spliceosomal components 
dissociate and start another cycle of splicing1,5,10,36. During the splicing reaction, only 
U2, U5 and U6 remain in the spliceosome, and thus it has been suggested that they 
form the catalytic core of the splicing machinery42,43. Assembly of the spliceosomal 
components and their recycling after both splicing reactions are highly conserved5.  
 
1.7.2: Structure and assembly of U snRNPs 
Each snRNP consists of a Uridine-rich small nuclear RNA (U snRNA), several snRNP-
specific proteins, and a common set of proteins known as the core domain which is 
made up with seven Sm or Like-Sm (LSm) proteins5,36,44. 
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Figure 1.5: Assembly and catalysis of the spliceosome. Stepwise assembly of the 
five snRNPs (circles) on premRNA (exons as boxes and intron as a black line, 
respectively) and involvement of different proteins at each step are shown. Reprinted 
from (5) with the permission from CSHL press. 
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1.7.2.1 U snRNAs 
U snRNAs are Uridine-rich RNA sequences that play a major role in spliceosome 
assembly and catalysis. These snRNAs provide platforms for protein binding and give 
discrete functions for each snRNP44. These U snRNAs adopt highly conserved 
secondary structures and consist of consensus regions that are important for the 
interactions with pre-mRNA. The U1, U2, U4 and U5 snRNAs are RNA polymerase II 
transcripts and they transport into cytoplasm to obtain 2,2,7-trimethylguanosine (m3G) 
cap44. Then the seven sm proteins bind to a short single stranded region in the U1, U2, 
U4 and U5 snRNAs, which contains a consensus AU(4-6)G sequence (known as the 
Sm site) forming the core domain of the snRNPs45. The survival motor neuron protein 
(SMN) plays an essential role in the sm core assembly46. The binding site for the Sm 
proteins is located on a single stranded region within two stem-loop structures of these 
snRNAs, which stabilizes the protein binding44.  It has been suggested that the m3G 
cap and the Sm core may act as a recognition signal during the transportation of these 
snRNAs to the nucleus44. In the nucleus, the snRNAs are localized in the Cajal bodies 
(CBs), where they are assembled into the snRNPs by binding with other snRNP-specific 
proteins47.  
U6 snRNA, in contrast is not transported to the cytoplasm, but stays in the nucleus. Also 
it’s an RNA polymerase III transcript which does not contain an Sm site44. Instead it 
contains a single stranded region at the 3’ end which is recognized by a set of seven 
proteins which are similar to the Sm proteins and thus named as ‘Like-Sm’ (LSm)44,45.   
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Figure 1.6: Protein composition of spliceosomal snRNPs. A cartoon of the 
secondary structure of each snRNP is shown and the list of proteins associated with 
each snRNP or snRNP complex is shown in the boxes under the corresponding 
structure. Sm proteins and LSm proteins complexes indicated as ‘Sm’ and ‘LSm’ 
respectively, on top of each box. Reprinted from (5) with the permission from CSHL 
press.  
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1.7.2.2: U snRNP Core domain 
Core domains of U1, U2, U4 and U5 snRNPs consists of seven Sm proteins; SmB/B’, -
D1, -D2, -D3, E, F and G (in human, 8-25 kDa)44,45,48. These proteins are important for 
the assembly, transportation and stability of U snRNPs. Each of these proteins contains 
a conserved motif with two segments; Sm1 and Sm2 connected by a linker (Figure 
1.6a)44,45. In the absence of snRNAs, Sm proteins are present as two heterodimers 
(SmD1∙D2, SmD3∙B/B’, Figure 1.6b)48 and a single heterotrimer (SmF∙E∙G). Assembly 
of Sm proteins to the U snRNAs occurs in the cytoplasm. First the SmF∙E∙G 
subcomplex binds with SmD1∙D2 and are assembled onto the U snRNA to form a stable 
subcore domain followed by the binding of SmD3∙B/B’ to form a heptameric ring around 
the Sm site, resulting in the formation of the complete core structure (Figure 1.6c)44,48. 
In contrast, core domain of U6 snRNA consists of seven LSm proteins; LSm 2-8, which 
form a doughnut-shaped structure in the absence of U6 snRNA49.  
 
1.7.3: U1 snRNP 
U1 snRNP is composed of U1 snRNA, seven Sm proteins and three U1-specific 
proteins; U1-A, U1-70K and U1-C (Figure 1.7)44. In total it has a molecular weight of 
~240 kDa, and is the smallest snRNP among five. It is also known to be the most 
abundant snRNP in the cell and can be isolated in large quantities. In majority of the 
cases U1 is the first component loaded on to the pre-mRNA and hence marks the 
starting point of the spliceosomal assembly cycle (E complex). U1 plays an important 
role in 5’ SS recognition where the 5’ end of U1 snRNA base pairs with the 5’ SS of pre-
mRNA.   
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Figure 1.7: Structure of the U snRNP Sm core domain. Structure of (a) SmB and (b) 
SmD3 showing the Sm fold, which is common for all Sm proteins (PDB:1D3B). It 
consists of an N-terminal α-helix followed by a five-stranded, highly bent, antiparallel β-
sheet. (c) A complex of SmD3.B, where β4 of B interacts with β5 of D3. (PDB: ) (d) The 
heptameric ring of Sm core (PDB:1I8F ). The β4-β5 interaction between adjacent Sm 
proteins, results in the formation of the ring structure. Figures were generated from 
PyMOL.   
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U1 snRNA consists of four stem loop structures (SL1-4) and a single helix H (Figure 
1.8a)44,50. Sm proteins bind to the Sm site located in between SL3 and SL4 to form the 
core domain44,50. Early electron microscopy images revealed a globular core domain 
and two bulges represent binding of U1-A and U1-70K (Figure 1.9a)51. According to the 
recent crystal structure data, the RNA sequence 5’ to the Sm site forms a four helix 
junction structure and SL4 is on the opposite side of the Sm ring (Figure 1.9b)52,53. Both 
SL1/SL2 and SL3/Helix H structures are coaxially stacked44. The U1-A and U1-70K bind 
to SL1 and SL2 respectively and independently from each other (Figure 1.9c)44. On the 
other hand U1-C binds to U1, only in the presence of core domain and U1-70K 
suggesting that U1 snRNP assembly is a hierarchical process52. Moreover it has been 
shown that U1-70K facilitates the binding of U1-C by providing an additional binding site 
for U1-C. Mutational studies of the zinc finger domain of U1-C have shown that 5’ SS 
recognition is drastically affected, suggesting its vital role in the formation of E 
complex52,53.  
 
1.7.4: U2 snRNP 
The U2 snRNP consists of U2 snRNA, Sm core and ~15 other proteins (Figure 1.7)44,54. 
U2 snRNA is 187 nucleotides long and has four stem-loop structures (Figure 1.8b)45. 
During spliceosomal assembly, U2 snRNA first interacts with the BS region of pre-
mRNA (pre spliceosome; A complex)5 forming a short duplex between U2 and the BS 
sequence, which facilitates the bulging out of the BS adenosine55,56. Later on, U2 
snRNA is base paired with U6 snRNA to form the activated spliceosome (Bact/ B* 
complex)5. 
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Figure 1.8: Secondary structure of U snRNAs; (a) U1, (b) U2, (c) U4/U6 and (d) U5. 
The Nucleotides subject to post-transcriptional modifications (Pseudo-U or 2’-O- 
methylated) are shown in magenta. The Sm binding sites are boxed in red where as 
LSm binding site is boxed in blue. Sequences that interact with premRNA 5’ Splice site, 
exons and the branch site are highlighted with a black box. Reprinted with permission 
from (42). Copyright (2012) American Chemical Society. 
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Studies have shown that U2 undergoes intramolecular dynamics, where it adopts 
two stem structures; either stem IIa or stem IIc (Figure 1.10a)5,57,58. The stem IIa 
conformation facilitates the U2/BS interactions during the formation of pre-
spliceosome57,58. On the other hand stem IIc supports the first step of splicing, followed 
by a change back to stem IIa which is important for the second step57,58. U2 snRNP 
associated splicing factor Cus2 is playing an important role along with the Prp5, in 
switching the U2 conformations from stem IIc to stem IIa58,59.      
Out of the U2 snRNP associated proteins, the majority are part of the protein 
subcomplexes splicing factor 3a and 3b (SF3a and SF3b)54. SF3a and SF3b are known 
to play a vital role in the stabilization of the conformation of the branch site 
adenosine16,44,60. SF3a (~197 kDa) is composed of three proteins; whereas SF3b (~450 
kDa) has seven proteins (Figure 1.10b)16,44,60,61. These SF3b proteins bind around the 
branch site sequence, across 25 nucleotides upstream to 5 nucleotides 
downstream16,61,62. Chemical cross linking studies have shown a direct interaction of 
one SF3b component; p14 with a U2 sequence that is base paired with the branch site, 
after the integration of U2 snRNP to the pre-spliceosome60,63,64. Location of p14 within 
the central cavity of the SF3b indicates that pre-mRNA need to undergo some structural 
rearrangements to interact with U263. There are two other proteins named U2Aʹ and 
U2Bʺ which play an important role in integrating U2 into the pre-spliceosome. The U2Bʺ 
protein is closely related to the U1A protein and contains two RNP domains45,65. In 
contrast to U1A that binds to SL2 of U1 snRNA by itself, U2Bʺ is associated with U2A’ 
first and then binds to SL4 of U2 snRNP (Figure 1.10c)45,61,65. Also, it has been shown 
that SF3a associates with the U2Bʺ- U2A’ complex and the core domain45.  
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Figure 1.9: Structure of U1 snRNP. (a) Enlarged stereo view of the model for U1 
snRNP based on the structural and biochemical information. Reprinted by permission 
from Macmillan Publishers Ltd: Nature (47), copyright (2001). (b) Crystal structure of 
human U1 snRNA consists of four stem-loops structures; SL1-4. Sm binding site is 
shown in yellow. (c) Model of the complete U1 snRNP. Figure c and d are reprinted by 
permission from Macmillan Publishers Ltd: Nature (48), copyright (2009).                                                                                                                                                
47 
 
 
  
Figure 1.10: Structure of U2 snRNP. (a) U2 adopts two mutually exclusive stem 
structures; Stem IIa and Stem IIc, which may form during different steps of assembly. 
Reprinted from (5) with the permission from CSHL press. (b) EM structure of U2 
associated protein SF3b. Reprinted from (56), with permission from AAAS. (c) Crystal 
structure of U2B’’-U2A’ protein complex bound with a fragment of U2 snRNA. Reprinted 
by permission from Macmillan Publishers Ltd: Nature (61), copyright (1998).
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1.7.5: U5 snRNP, U4/U6 di-snRNP and U4/U6•U5 tri-snRNP 
1.7.5.1: U4/U6 di-snRNP 
The U4/U6 di-snRNP consists of two snRNAs; U4 and U6, a set of Sm proteins that 
bind to U4 and a set of LSm proteins that bind to U6 and five particle-specific 
proteins66,67. U4 and U6 base pair with each other to form a highly conserved Y shaped 
conformation consisting of two intermolecular helices; stem I and stem II and a 5’ stem 
loop structure of U4 (Figure 1.11a)66,68. This 5’ stem loop structure is an essential 
component, which provides a platform for the binding of U4/U6 specific proteins. Other 
than the Sm/LSm core, five proteins; with the molecular weight 15.5K, 20K, 60K, 61K 
and 90K, have been identified using biochemical assays which associate with the 
human U4/U6 di-snRNP69.  
Apart from the 20K protein, rest of the proteins are highly conserved over species 
and the orthologous proteins in yeast are named as Snu13 (15.5K), Prp4 (60K), Prp31 
(61K) and Prp3 (90K) (Figure 1.11a)69. Snu13 and its counterpart play an important role 
in the formation of U4/U6 di-snRNP. Structural data have shown that Snu13 directly 
binds to the kink turn motif at the 5’ stem loop structure of U4 snRNA (Figure 1.11b)70,71. 
Previous studies have suggested that Snu13 acts as a nucleating factor where it 
facilitates the binding of one or more of the U4/U6 specific proteins to complete the 
assembly of the di-snRNP69. Co-immunoprecipitation/pull-down studies coupled with 
UV-cross linking have revealed that the binding of Prp31 is greatly accelerated by the 
presence of Snu13 (Figure 1.11b)69. Similarly, this study has shown the 20/60/90K 
complex in human (similar to Prp3/Prp4 in yeast) can only bind with the U4/U6 in the 
presence of Snu13, confirming the suggested role for Snu13 as a nucleating factor69.   
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Figure 1.11: Structure of U4/U6 di-snRNP and U4/U6•U5 tri-snRNP. (a) A schematic 
representation of the secondary structure of the U4/U6 duplex and its associated 
proteins; Sm, Lsm, Snu13, Prp31 and Prp3/4. (b) A structure showing binding of hPrp31 
(blue) and 15.5K (red) to the U4 5’ stem-loop (gold). A disordered loop in hPrp31 is 
indicated with a dash line. Reprinted from (68), with permission from AAAS. (c) 3D 
constitution of U5, U4/U6 snRNPs and U4/U6•U5 tri-snRNP and fitting U5 and U4/U6 
structures into the tri-snRNP structure. Reprinted from (73), Copyright (2006), with 
permission from Elsevier. (d) EM structure of yeast U4/U6•U5 tri-snRNP with the main 
structural domains labelled (left). A schematic representation of yeast tri-snRNP (right) 
illustrates the binding sites for some of the particle specific proteins. Areas 
corresponding to U5, U4/U6 and linker region are in grey, orange and yellow 
respectively Reprinted by permission from Macmillan Publishers Ltd: NSMB (81), 
copyright (2008).   
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UV-cross linking studies and NMR studies have shown that Prp31 binds to the U4 
stem-loop only in the presence of Snu1369. A structure of a ternary complex consisting 
of the 5’ stem-loop of U4, Prp31 and Snu13 shows that the Nop domain of Prp31 acts 
as an RNP interacting motif72. Prp3 and Prp4 are known to be the only U4/U6 di-snRNP 
specific proteins and they form a dimer prior to binding to the U4/U6 duplex73-75. Prp3 
was shown to interact with a region towards the 3’ end of U6 snRNA69,75,76. Although 
these studies have shown the binding of proteins to U4/U6 duplex, little is known 
regarding the global structure of the U4/U6 snRNP.  Currently, the only global structural 
information comes from a low resolution (~30 Å) EM structure showing large and small 
domains connected by a thin bridge (Figure 1.11c) 68,77, but the relative orientation of 
the helices of the U4/U6 3-way junction remains uncertain. 
 
1.7.5.2: U5 snRNP 
U5 snRNP, which also plays an important role within the spliceosomal assembly, 
consists of U5 snRNA, Sm core and several specific proteins. The secondary structure 
of U5 is highly conserved among species confirming its essential role in splicing. In 
yeast, the structure of U5 snRNA can be divided into three main regions; a long stem-
loop structure, a single stranded region containing the Sm binding site and a short stem-
loop structure towards the 3’ end (Figure 1.8c)78. The long stem-loop structure can be 
further divided into seven subunits including the loop I78. The loop I of U5 snRNA is 
known to play an important role in 5’ and 3’ exons aligning during the second step of 
splicing79,80. EM structure for U5 snRNP has revealed that the loop I is located in the 
centre of the particle, suggesting that other catalytic centre components interact U5 via 
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this central region77. Nine U5-specific proteins have been found in human with the 
molecular weights of 220, 200, 116, 110, 102, 100, 52, 40 and 15 kDa (Figure 1.7)81. 
Only four proteins have been observed in yeast namely; Prp8p (in human 220 kDa), 
Snu246p/Brr2 (in human 200 kDa), Snu114p (in human 116 kDa) and Prp18p (Figure 
1.7)78. Prp18 only associates weakly with U5 and is involved in the second catalytic 
step78. Similarly the mammalian homologous of Prp18 also has a function in the second 
step of splicing although it is not associated with U5. Prp8 and its mammalian 
equivalent play an essential role in splicing in vitro and in vivo. Cross linking studies 
have shown that Prp8 interacts with the 5’ SS, branch site and 3’ SS39,82,83. Other than 
that, Prp8 also interacts with loop I of U5 and U6 snRNA, and facilitates the activation of 
Brr239,82. Overall Prp8 brings all important components together at the catalytic centre39. 
Brr2 is a DExD/H-box helicase, which is thought to be involved in the unwinding of 
U4/U6 snRNA, during the formation of activated spliceosomes84. However, the exact 
mechanism of the unwinding of U4/U6 by Brr2 is not known yet. Snu114 is a GTPase, 
which is similar in sequence to the eukaryotic ribosomal elongation factor EF-2 (or 
bacterial EF-G) that is shown to be involved in modulating Brr2 activity during 
spliceosomal activation by switching between GTP-bound state and GDP-bound 
state39,85.  
 
1.7.5.3: U4/U6•U5 tri-snRNP 
During spliceosomal assembly, the U4/U6 di-snRNP first interacts with the U5 snRNP to 
form the U4/U6•U5 tri-snRNP, which then binds with the pre-spliceosome to form the 
pre-catalytic complex or B complex5. This tri-snRNP is the largest spliceosomal 
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subcomplex, which consists of U4, U6, U5 snRNAs and ~29 distinct proteins (Figure 
1.7)54,61. Structural rearrangements that occur within the tri-snRNP result in the removal 
of U4 from the tri-snRNP, which is crucial for the transition from pre-catalytic complex to 
the activated complex (Bact)5. Visualisation of yeast U4/U6•U5 tri-snRNP by EM has 
revealed an elongated, triangular shaped particle with a dimension of 30-40 nm (Figure 
1.11c, d)77,86. It has been shown that the global structure of the tri-snRNP consists of a 
pointed lower end (‘foot’), a broader upper left structure (‘head’) and a smaller 
protruding domain (‘arm’), which is connected to the centre (‘body’) of the particle via a 
linker region (Figure 1.11d, left)86. Whereas the images for human tri-snRNP haven’t 
shown a clear separation of the domains as it has in yeast. U5 associated proteins; 
Prp8, Brr2 and Snu114 are found within the head and the central part of the particle 
suggesting that U5 snRNP is located in that region (Figure 11 d, right)86. On the other 
hand the U4/U6 proteins; LSm8 and Prp3 are mapped to the arm region, showing the 
position of U4/U6 di-snRNP among the tri-snRNP (Figure 11 d, right)86. Tri-snRNP 
specific bridging proteins such as Prp6 were found in the linker region of the particle 
(Figure 11 d, right)86.  
 
1.7.6: The proteome of spliceosomal complexes 
During assembly and catalysis, the spliceosomal components undergo various 
conformational changes that are crucial for its activity. Other than the snRNAs, protein 
factors also play a crucial role in spliceosomal assembly in order to have optimum 
catalytic activity5,36,39. These proteins are involved in maintaining the structures of 
individual snRNPs and complexes, by engaging in the structural rearrangements within 
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the assembly cycle, such as unwinding, annealing, or stabilizing the RNA components 
in order to form the active complex1,87. Also, binding of some proteins may prevent the 
premature formation of certain conformations of snRNAs important for the catalysis or 
proper assembly of the spliceosome1,5. Although the role of majority of the spliceosomal 
proteins has been identified, there are many to reveal. The study of the spliceosomal 
proteome is difficult as the spliceosome undergoes drastic structural changes during 
which many proteins are added and removed from the spliceosome. During the 
spliceosomal assembly and catalysis, the protein composition changes dramatically. As 
an example, B complexes contain ~60 proteins in yeast and ~110 proteins in humans 
whereas C complex consists of ~50 proteins in yeast and ~110 in metazoans5.  
The spliceosomal proteome consists of various types of proteins including SR family 
proteins, DExD/H-box-type ATPase-dependent RNA helicases and ATPase-
independent RNA chaperones. Also several proteins which are involved in the 
spliceosomal assembly cycle belong to the “Prp group” (Prp: pre-mRNA processing 
proteins), including Prp2, Prp24, Prp31, Prp43, Prp16 etc. Despite the families they 
belong to, spliceosomal proteins can broadly be categorized into two major groups as 
snRNP associated and non-snRNP associated. There are several protein factors that 
are the building blocks of snRNPs, which have a major role of maintaining the global 
structure of each of the individual snRNP or snRNP complexes. As an example Brr2, 
Prp8 and Snu114 are U5 associated proteins39 whereas Prp24 is a U6-associated 
protein1,39. Brr2 is a U5 associated DExD/H-box helicase, which is composed of two 
helicase domains88. The N-terminal helicase domain carries out the unwinding activity, 
whereas the C-terminal helicase domain is not active and may act as a platform to 
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interact with other spliceosomal components89,90. Brr2 is involved in the unwinding of 
the U4/U6 duplex before the spliceosomal activation, suggesting that the role of Brr2 
needs to be highly coordinated and tightly regulated in order to prevent the premature 
activation1. Brr2 has also been shown to be involved in the unwinding of the U2/U6 
complex after the catalysis91.  
Prp8, another U5-associated protein is the largest and most highly conserved 
protein in spliceosome. Previous studies have shown that Prp8 interacts with several 
spliceosomal proteins, snRNAs and both 5’ and 3’ splice sites39,82,83. It contains an RNA 
recognition motif (RRM) in the middle of the protein, a Jab1/MPN domain (Figure 1.12a) 
and an RNase H like domain (Figure 1.12b) at the C-terminal region of the protein92-94. 
Prp8 plays an important role in the regulation of Brr2 function. A C-terminal portion of 
Prp8, containing the RNase H and Jab1/MPN domains, interact with Brr2 and facilitates 
its helicase activity1,95. Together with Prp28, Prp8 also acts as a trans-helicase, which 
mediates the transition of 5’ SS from U1 to U6 (Figure 1.12c)96. Ubiquitinylation of Prp8 
inhibits the helicase activity of Brr2 providing another regulatory step for the Brr2 
function1,97. Snu114 is a GTPase which is highly homologous to translation elongation 
factor G (EFG)98. The GTPase domain of Snu114 is required for the loading of this 
protein to the U5 snRNP99. This protein also plays a crucial role in the regulation of 
ATPase activity and helicase activity of Brr25,85. It is also required for the aligning of 
exons during the second step of splicing. Other than these direct roles, Snu114 is 
suggested to have a role in translocation of spliceosome, similar to that in eukaryotic 
ribosome by EF-2 (or bacterial EF-G)98. Prp24 is a U6 snRNP associated protein, which 
is composed of four RRMs100. This protein has been shown to function in the assembly 
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of U4/U6 duplex and also some studies have also suggested its role in the U4/U6 
duplex unwinding101. Therefore Prp24 plays an important role as a recycling factor 
within the spliceosomal assembly pathway102. 
A large proportion of spliceosomal protein factors belong to the SR family39. Several 
snRNP associated proteins including U1-70K, Snu66 and Srm160 are part of the SR 
family39,103. On the other hand the majority of non-snRNP proteins also belong to SR 
family including ASF/SF2, SC35 and U2AF39. Proteins in this family consist of one or 
two copies of N-terminal RRM and a serine/arginine rich C terminal domain39,103. The 
general role for these proteins is to stimulate splicing by binding to exonic sequences, 
recruiting spliceosomal proteins and stabilizing RNA-RNA interactions39.  A study done 
by Akusjarvi and co workers has demonstrated that the SR proteins are also function as 
splicing repressors104.  As an example, during the first step of spliceosomal assembly,  
two SR proteins; SF1 (Figure 1.12d) and U2AF (Figure 1.12e, f) play a major role by 
recognizing he BS tract at the 3’ SS and the polypyrimidine t respectively36,105,106. 
Interaction between U2AF and RNA occur via two modes; either the RNA interacts with 
RRMs from two different proteins (Figure 1.12d) or a single protein interacts with two 
separate RNA molecules (Figure 1.12e)36,106.  
There are at least eight DExD/H-box proteins that are highly conserved from yeast to 
human, and known to be involved in the various steps of spliceosomal assembly cycle 
such as UAP56, Prp5, Prp28, Brr2, Prp2, Prp16, Prp22 and Prp4339,54,103. Some of them 
have shown a weak helicase activity in vitro. Within the spliceosomal assembly 
pathway, these helicases play an important role in the transition of spliceosomal sub 
complexes by modulating the RNA-RNA, RNA-protein and protein-protein interactions. 
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These proteins have distinct functions at specific steps of assembly and facilitate the 
disruption of interactions in one sub complex and allow them to assemble with different 
components to form another sub complex. 
UAP56 (Sub2 in yeast) and Prp5 involve in the first few steps of spliceosomal 
assembly. UAP56 is found to be interacting with U2AF (Mud2 in yeast) and supports the 
early stages of assembly in an ATP-dependent way39,95,107. UAP56 promotes the 
dissociation of U2AF and BBP (Branch point binding protein) which binds at 3’ SS and 
BS respectively to facilitate the U2 binding1,16,95. The UAP56 helicase has also been 
shown to be important later in the assembly cycle, where it is suggested to be involved 
in the unwinding of U4/U6107.  
Prp5 also has a role in association of U2 to the pre-mRNA16. Some studies have 
revealed that PRP5 genetically interacts with CUS2, suggesting a role in removal of 
Cus2 from U2 snRNP in an ATP-dependent manner16,108. Prp28 mediates the exchange 
of 5’ SS interactions from the 5’ end of U1 to the ACAGAG motif in U6 and thus 
facilitates the release of U1 during the transition from B complex to Bact/B*. Brr2 plays 
an important role in the unwinding of U4/U6 and also in the dissociation of U2/U6 at a 
later stage.  
The two helicases, Prp2 and Prp16 function in the first and the second catalytic 
steps respectively95,109. In the absence of ATP, Prp2 associates with the pre-mRNA 
prior to the first step and leaves the mRNA upon ATP hydrolysis110. Another role of Prp2 
is to remove the SF3a and SF3b after the activation of spliceosome111. Prp16 also plays 
a crucial role in spliceosomal assembly and catalysis. Mutations in Prp16 that affect its 
helicase or ATPase activity have resulted in erroneous splicing, suggesting a role in 
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proofreading during spliceosomal assembly39,95. Studies have shown that similar to 
Prp2, Prp16 also interacts with the pre-mRNA in the absence of ATP, and is released 
upon ATP hydrolysis112. Although it is not clear, which components are associated with 
Prp16, it has been suggested that Prp16 may interact with the 3’ SS region of the pre-
mRNA, and also mediates the remodelling of the spliceosome prior to the second step 
of splicing113. It is also involved in the rearrangement of one of the basepaired helices 
within the U2/U6 duplex114,115.  
Prp22 is another helicase that aids spliceosomal assembly and catalysis. This 
helicase binds to a region that is immediately downstream of the 3’ SS in the fully 
spliced mRNA116. The role of Prp22 is to unwind mRNA/U5 interactions using its 3’ to 5’ 
helicase activity at the end of the second step of splicing, leading to the release of 
spliced mRNA117. Mutated Prp22 improves the splicing of pre-mRNAs with mutations at 
3’ SS, suggesting that Prp22 is involved in the regulation of fidelity of the second step of 
splicing1,95. Prp43 is another DExD/H-box RNA helicase that plays an important role in 
the spliceosomal assembly pathway. It associates with Ntr1/Spp382 and Ntr2 to form 
the NTR complex which facilitates the disassembly of the spliceosome118. Interaction of 
Ntr2 with Brr2 and U5 suggests that it may be engaged in the loading of NTR complex 
to the spliceosome after the completion of both steps of splicing119. Once the helicase 
activity of Prp43 is activated by Ntr1, it mediates the release of the lariat intron after the 
completion of splicing, which suggested its use as a quality control check point within 
the spliceosomal assembly120.   
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Figure 1.12: The proteome of spliceosomal complexes plays an important role in 
assembly and catalysis. (a) Crystal structure of a large fragment of Prp8 containing 
reverse transcriptase, endonuclease, MPN, and RNase H domains. Reprinted by 
permission from Macmillan Publishers Ltd: Nature (87), copyright (2013). (b)Surface 
view of RNase H like domain of yeast Prp8 interacting with the 5’ SS. Other regions that 
interact with these two regions are shown with different colours. Reprinted from (89), 
copyright (2008), with permission from Wiley publishers. (c) A schematic representation 
of coordination activity of Prp8. Brr2, Prp28, 5’ SS and exons are coordinated by RNase 
H domain and Jab1/MPN domains of Prp8 at the catalytic core. Reprinted from (1), 
Copyright (2009), with permission from Elsevier. (d) NMR structure showing binding of 
SF1 (grey) to the branch site sequence of RNA (cyan). Branch site adenosine is in 
yellow. Reprinted From (100) with permission from AAAS. (e) and (f) X-ray structure of 
U2AF65 RRM1 and RRM2 (grey) bound to a seven nucleotide polyuridine RNA (cyan) 
illustrating the early recognition of the polypyrimidine tract by U2AF. Interactions 
between U2AF and RNA can occur in two ways; (e) single protein interacts with two 
separate RNA molecules or (f) RNA interacts with RRM1 and RRM2 from separate 
molecules. Reprinted from (101), Copyright (2006), with permission from Elsevier  
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Another important protein involved in the spliceosomal assembly cycle is Prp19, 
which is associated with another set of 7 proteins to form Prp19/CDC5 complex in 
human or 8-11 proteins to form the NTC complex in yeast121. NTC plays an important 
role in the stabilization of U5, U6 interactions with the 5’ SS and exonic region after 
dissociation of U1 and U439. It also facilitates the conformational changes of U6, such 
as removal of LSm ring and remodelling of U6 interactions with the 5’ SS39. Another 
member of NTC, namely Cwc21 is bound to Prp8 and Snu114 directly, suggesting that 
Cwc21 may assist the interaction of NTC with U5 snRNP122. On the other hand human 
Prp19 is associated with CDC5, which is a large complex containing ~30 proteins that 
plays an important role in the second step of splicing123.  
Other than the above mentioned protein families or groups, numerous other proteins 
are involved in the spliceosomal assembly cycle, such as, Spp2, Cwc25 and Yju2, Slu7 
and Prp1895. Spp2 is a protein factor that facilitates the loading of Prp2 onto the 
spliceosome95. The G patch region of Spp2 interacts with the C-terminal region of Prp2 
ensuring their association124. It has been shown that Spp2 binds to the spliceosome 
prior to the first step and both Prp2 and Spp2 are dissociated together with SF3a and 
3b111. Another protein factor Cwc22 has also been shown to be important at this point. 
Although Cwc22 is not important for the binding of Prp2 to the spliceosome, in the 
absence of it, Prp2 is dissociated from the spliceosome upon ATP hydrolysis without 
releasing SF3a/b125. After the release of SF3a/b, another two proteins called Yju2 and 
Cwc25 bind to the spliceosome which promote the first step in splicing. Yju2 is shown to 
be interacting with NTC complex, whereas Cwc25 binds to the spliceosome after the 
role of Prp2 but only in the presence of Yju2126,127. After the first transesterification 
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reaction, Prp16 facilitates the removal of Yju2 and Cwc25, remodelling the spliceosome 
for the second step128. This structural rearrangement allows the binding of another set 
of proteins in the following order Slu7 and Prp18 and then Prp22, which promotes the 
second catalytic reaction in an ATP-independent manner95. Studies have shown that 
these three proteins interact directly with the 3’ SS whilst Slu7 and Prp22 interact with 
the intron as well113,116. These proteins along with Prp8 and other second step factors 
stabilize the interactions between the U5 stem loop I and exons promoting the second 
catalytic reaction95.              
 
1.7.7: Spliceosomal sub complexes  
During the spliceosomal assembly cycle, U snRNP and associated proteins form 
several sub complexes called E, A, B, Bact, B* and C. Through the formation of each of 
these sub complexes, other than the snRNP proteins, numerous non-snRNP associated 
protein factors join and release from the complexes.  
The E complex is formed once the U1 snRNP is bound to the 5’ SS and other non-
snRNP proteins, SF1 and U2AF bind to the BS and polypyrimidine tract respectively1. In 
the E complex, all conserved regions of pre-mRNA are recognized by U1 and the other 
non-snRNP proteins. Upon binding of U2 snRNP to the branch site, the A complex (pre-
spliceosome) will be formed. Assembly of the A complex is ATP dependent and also 
requires the polypyrimidine tract and a functional 3’ SS in mammals and 5’ SS and BS 
in yeast1. During the transition from E complex to the A complex, the E complex-bound 
factors need to be dissociated and ATP may have to be consumed for this.  
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After the formation of the A complex, the spliceosome moves on and forms the B 
complex. There are several intermediates that have been isolated and grouped as B 
complexes, although it is not clear whether all these complexes are functionally 
active1,44. The most accepted B complexes are the initial B complex, intermediate Bact 
complex (BΔU1) and the catalytically active B* complexes44. The B complex is formed 
once the U4/U6.U5 tri-snRNP is recruited on to the pre-mRNA5. U5 associated Prp8 
protein plays a crucial role in the transition from the A complex to B complex by 
interacting with pre-mRNA and other proteins82,122. One of the major structural 
rearrangements that occurs within spliceosomal assembly is the transition of the B 
complex to the Bact complex1,5,42,129. During this transition, U1 and U4 snRNPs are 
dissociated from the spliceosome complex, leaving only U2, U6 and U5 on the pre-
mRNA5,42. This exchange causes a dissociation of 35 proteins and enrolment of 12 
other proteins in yeast, including entire U1 snRNP, all U4/U6 associated proteins and 
several U5-specific proteins (Figure 1.13)5,129.  
The B* complex is the catalytically activated form of the spliceosome. It is very 
similar to Bact in composition but several helicases needed for the structural 
rearrangements are present in Bact, but not in the B* complex44. One of the major 
structural arrangements, in B* is the positioning of U2, U6 and U5 for the catalysis. U5 
is placed in a way that it can interact with 5’ and 3’ exons through its SLI structure79,130. 
Similarly, U6 is positioned in a way that its conserved regions can interact with the 5’ 
SS, which allows U2 and U6 to extensively base pair with each other to form the 
catalytically active conformation87. Prp19/CDC5 (NTC in yeast) plays a major role in the 
transition from Bact to B* by promoting the removal of the U6 snRNP LSm ring and the 
62 
stabilization of U6 and U5 snRNAs131,132. Also during this conversion, U2 snRNP 
associated SF3a and SF3b proteins are dissociated freeing the branch site adenosine 
for the catalysis133. 
 After the first step of splicing, the spliceosome adopts the C complex, which 
consists of the 5’ exon and the lariat intermediate44. This step has fewer conformational 
rearrangements compared to the activation step, where only two proteins (Spp2/Prp2) 
are released and nine are added (Figure 13)5,129,134. Previously reported human C 
complex structures indicate that it is made up with three main domains namely; a large 
ovoid-shape body domain, an arm overhang from the body domain and a small domain 
slightly detached from the rest of the structure135. Purified human spliceosomal C 
complexes revealed the major components of this complex including Prp19/CDC5 
proteins, Prp19-related factors and the U5 proteins, including Prp8 (Figure 1.13)1,129. It 
has also been shown that during C complex formation some of the SF3a and SF3b 
proteins are removed suggesting the disruption of U2/BS interactions129.  Novel cryo-
EM structure of yeast spliceosomal C complex at 3.6 Å resolution has shed a light on 
the splicing field136. C. Yan and co-workers have been able to resolve a spliceosomal C 
complex particle containing U2 and U5snRNPs, NTC, U6 snRNA and an RNA intron 
lariat. This structure illustrates an asymmetric conformation consisting a triangular 
central domain connect to a head domain and two arms; arm I and II. The head and arm 
II domains are similar to the head-like and arm overhang in previously published EM 
structure of U5.U2/U6 complex137. Moreover, this structure indicates that the catalytic 
core is located within the central triangular-shaped domain and it is ~100 Å away from 
the head region’ either arm or the edge of the central domain which contains the 3’ end 
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of the U5 snRNA. The distances between two arms and head and far most corner of the 
central body seems to be large (~320 Å) suggesting the importance of large, extended 
arrangement of spliceosome in proper splicing of pre-mRNAs with different lengths and 
sequences. The aforementioned distinct arrangements of subcomplexes along with their 
snRNA components are vital for spliceosomal assembly and catalysis. 
 
1.8: Splicing by a minor class spliceosome 
Two types of spliceosomes have been reported to be present in organisms: the U2-
dependent major and U12-dependent minor spliceosomes38,138. The major spliceosome 
splices the highly abundant U2-type introns, whereas the minor spliceosome splices the 
less abundant U12-type introns139. As an example; in metazoans, U2-dependent major 
spliceosomes responsible for the splicing ~99.5% of all introns, whereas U12-
dependent minor spliceosomes only splice the remaining ~0.5%38,138,140. This class of 
introns is found to be present in most eukaryotes including plants, animals and some 
fungi. On the other hand, some studies have shown that U12-type introns are absent in 
common model organisms such as Saccharomyces cerevisiae38,141-144.   
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Figure 1. 13: Composition changes in the yeast spliceosomal subcomplexes 
during the assembly process. Protein compositions in complex B, Bact and C obtained 
from mass spectrometry are shown and are grouped according to their association with 
snRNP or snRNP subcomplexes. Reprinted from (124), Copyright (2009), with 
permission from Elsevier 
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Two types of spliceosomes have some characteristic differences as well as similarities. 
Two introns have different splice sites and branch site consensus sequences. Instead of 
GT and AG at the 3’ and 5’ ends in U2-type introns,38,141,145 the majority of the U12-type 
introns have AT and AC at the 3’ and 5’ ends respectively (Figure 1.14a). Therefore 
these introns are termed as “ATAC introns”23,141,145. The minor spliceosome consists of 
four unique ribonucleoproteins named as; U11, U12, U4atac and U6atac (analogous to 
U1, U2, U4 and U6 respectively), and U5; which is common for both spliceosomes 
(Figure 1.14b)38,146. Minor spliceosomal assembly cycle follows the steps as same as 
the major spliceosomal assembly pathway, except the first step of assembly cycle 
(Figure 1.14c).143 In minor spliceosome, during the formation of complex A, U11 and 
U12 form a di-snRNP before binding with mRNA whereas in major spliceosome they 
bind separately (Figure 1.14c)38,143,145,146. The rest of the steps in the assembly cycle as 
well as the intron removal mechanism are identical in both spliceosomes38.   
Previous studies have suggested that regardless of sequence differences, the 
analogous snRNAs in two spliceosomes can form very similar secondary structures with 
similar conserved regions, which suggest  similar functional roles in spliceosomal 
assembly and catalysis (Figure 1.14b)38,147-149. In addition, the sub-complexes in both 
types of spliceosomes can adopt conformations that are very similar to each other. For 
example, the U12/U6atac complex is similar to the U2/U6, and the U4atac/U6atac 
complex similar to U4/U6 (Figure 1.14c)143,146-148. These structural similarities indicate 
that the minor spliceosomal snRNA complexes can also be highly dynamic and undergo 
important conformational changes during the assembly cycle same as the major 
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spliceosomal components. Other than sharing similar snRNA components, both 
spliceosomes also share most of the snRNP-associated proteins140,150-152.  
Despite its lower abundance, U12-type introns are present in many genes required for 
essential cellular functions such as DNA replication and repair, transcription, RNA 
processing and also found in vesicular transport and voltage-gated ion channel 
activity140,141,143,146,153. Surprisingly, it has been shown that U12-type introns are almost 
absent in genes related to metabolism and biosynthetic pathways144,146,153. Recently, 
Younis and co-workers have shed new light on the significance of minor spliceosome in 
cells154. They have shown that the minor spliceosomal U6atac is highly unstable in 
human cells under normal conditions, suggesting that U6atac could be a rate limiting 
factor for the splicing by minor spliceosome. In contrast, they have found a dramatic 
increase in the level of U6atac in the presence of a protein kinase, which activates in 
response to stress. This has shown to activate the splicing by minor spliceosome, 
resulting in activation of various cellular processes. With these findings, they have 
proposed that minor spliceosome acts like a switch that helps cells to adapt to the 
stress and also helps to accelerate the translation of the transcript present in the cells, 
which increases the protein production under the stress conditions154.  
Marking its significant involvement in cellular processes, previous studies have 
shown that defects in human minor spliceosomal assembly due to mutations in U4atac 
snRNA cause the Taybi-Linder Syndrome (TALS), which is a rare autosomal recessive 
development defect155-157. All these facts point out the importance of studying the U12-
dependent spliceosome in detail.  
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Although many studies have been performed on the minor spliceosome, the 
structural rearrangements of snRNA complexes and similarities and differences 
between major and minor spliceosomal complexes have not yet been revealed. 
 
1.9: Structural rearrangement of snRNA complexes during spliceosomal 
assembly 
Five snRNAs join and release at different steps in the spliceosomal assembly cycle 
along with their associate proteins. The arrangement of RNA-RNA interactions within 
this process is highly complex and largely dynamic5,42. The snRNAs form well studied 
secondary interactions, as well as, poorly understood tertiary interactions. During 
spliceosomal activation and catalysis most of these interactions are restructured making 
it more complicated, suggesting that structural changes of snRNA complexes play an 
important role in assembly and catalysis42.  
Out of five snRNAs, U6 (U6atac in minor) is the most dynamic as it exhibits 
extensive structural rearrangements during spliceosomal assembly158. Before its 
involvement in the spliceosomal assembly, U6 snRNP can be found as a free particle 
(Figure 1.15)159. First, it base pairs with U4 and forms the U4/U6 duplex, which enters to 
the spliceosomal assembly cycle (Figure 1.15)159. Later, U4 dissociates from U6 and U6 
snRNA base pairs with U2 to form the catalytically active complex (Figure 1.15)160,161. At 
the end of two catalytic steps of splicing, U6 needs to be recycled as a free snRNP, 
which will then be involved in another cycle of splicing (Figure 1.15). Therefore, this 
dynamic nature of U6 is believed to be very crucial for the spliceosomal assembly and 
catalysis.  
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 Figure 1.14: Overview of the less abundant minor spliceosome. (a) Consensus 
sequences at 5’ SS, 3’ SS and BS of U2 type (major spliceosome) and U12 type (minor 
spliceosome) introns are showing. Y is pyrimidine, R is purine and Y(n) is 
polypyrimidine tract. (b) Sequences and secondary structures of minor spliceosomal 
snRNAs of human; U11, U12, U5 and U4atac/U6atac. These share many similarities 
with the secondary structures of major spliceosomal snRNAs. (c) Assembly and 
catalysis pathway of minor spliceosome, which is very similar to major spliceosome. 
Reprinted by permission from Macmillan Publishers Ltd: Nature reviews: Molecular cell 
biology (136), copyright (2003). 
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1.9.1: U6 snRNP 
Free U6 snRNP consists of U6 snRNA, seven LSm proteins (LSm2-8) bound at the 3’ 
end and Prp24, a U6 associated chaperone159. It has been suggested that in yeast this 
LSm ring together with Prp24 act as a chaperon complex, which is involved in the 
conformational rearrangements of the U6 complexes162. The secondary structure of 
yeast U6 snRNA within the free U6 snRNP particle is composed of 5’ stem-loop, 3’ 
stem-loop, named as intramolecular stem-loop (ISL), a stem extension named as 
telestem and a large asymmetric internal loop between 3’ stem-loop and telestem 
(Figure 1.15)101,163. Recently, a crystal structure of U6 has been revealed, which is 
showing that U6 consists of an ISL structure containing AGC triad, a telestem region 
which is perpendicular to ISL and a large asymmetric internal loop linking these two, 
similar to previous NMR structures164. U6 also contains a pyrimidine-rich sequence at 
the 3’ end, which is essential for the binding the LSm proteins49. Although the 5’ stem 
loop is shown unchanged and less important during the splicing cycle, the ISL region 
has shown to be very dynamic and contains highly conserved dynamic bulge U80. 
Highly conserved ACAGAGA region and the AGC triad fall within this asymmetric bulge 
(Figure 1.15)165 .  
 
1.9.1.1: U6 snRNA – the most structurally dynamic spliceosomal RNA 
The U6 snRNA is highly conserved over most of the organisms in both its sequence and 
its size158. There are many structural and functional similarities between the group II 
intron and the RNA-based catalysis of the spliceosome.166,167 The catalytically important 
domain (D5) in the group II intron has many similarities with the U6 snRNA. The 
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intramolecular stem loop (ISL) in U6 is similar to D5 in the group II intron (Figure 
1.16a,b)167. They both share similar conserved residues, such as the metal ion binding 
bulge and the AGC triad (Figure 1.16a,b)167,168. Sharing common structural domains in 
the active site is consistent with the proposed function of the spliceosome as a ribozyme 
and the structural similarities with group II catalytic domain have lead to suggest that U6 
is crucial for catalysis169.  
A phylogenetic study has shown that a 39 nucleotide sequence within the U6 core is 
conserved over almost all of the U6 snRNA sequences, whereas the flanking 
sequences are highly degenerated170. Strikingly, most of the point mutations within this 
region show either full or partial inhibition of splicing in vitro and full or partial lethality in 
yeast, revealing the crucial function of this core region in catalysis170. Interestingly, three 
highly conserved regions of U6; the dynamic bulge at U80, the AGC triad, and the 
ACAGAGA loop which are suggested to make a base-pairing network between U2 and 
the pre-mRNA fall within this core region, implying its importance in the formation of the 
catalytic core of the spliceosome (Figure 1.15 and 1.16b and d) 171,172. Minor 
spliceosomal analogue, U6atac also contains these three conserved regions (Figure 
1.16c)143,148,173. Some genetic screening studies have also shown that mutations in the 
ACAGAGA region and the AGC triad are lethal or temperature sensitive, suggesting 
they play major roles in the catalysis87,161,174. During the formation of the activated 
complex, U6 replaces U1 and interacts with the 5’ splice site via the ACAGAGA 
loop109,175.  The AGC triad of U6 also plays a vital role in splicing by interacting with U2 
and may also be involved in the catalysis as well176. Previous studies have shown that 
mutations at the first two nucleotides of the AGC triad are lethal and the mutations at 
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the third position result in strong growth defects, implying its significance in splicing87,176. 
The dynamic bulge within the highly conserved ISL region contains a U nucleotide 
(U80) which has been shown to be important for coordinating Mg2+ ions necessary for 
the first step of catalysis35,169,177. An NMR study has shown that this dynamic bulge and 
the adjacent C67-A79 can act as a dynamic hinge, where the stabilized C67-A79 pair by 
protonation of A79 causes flipping out of U80 into the major grove, and deprotonated 
A79 keeps U80 stacked inside the ISL177. The binding of Mg2+ ions is favoured by U80 
when it’s stacked within the ISL, suggesting this arrangement is necessary for the 
catalysis169. 
 
1.9.2: U4/U6 complex prevents U6 from premature activation 
U6 snRNA base pairing with the U4 snRNA is followed by the interaction with U5 before 
entering into the spliceosomal assembly cycle. U4/U6 duplex form a highly conserved Y 
shaped structure, which consists of two intermolecular helices namely stem I and II and 
highly conserved 5’ stem-loop structure of U4 (Figure 1.15)69. During the U4/U6 duplex 
formation, U6 snRNA undergoes drastic structural rearrangements. Mainly the ISL 
region of U6 snRNA (3’ stem loop) unwinds and base pairs with U4 to form stem II 
(Figure 1.15)170. Similarly the nucleotides within the internal loop region base pair with 
U4 to form the stem I (Figure 1.15). Overall, previous studies have shown that, all the 
highly conserved regions within U6 snRNA, which are suggested to be essential for the 
catalysis, are base paired with U4, making them unavailable for the reactions161. 
In order to be activated and to be involved in the catalysis, first, U6 needs to be 
unwound from U4 and then base pair with U2 to form the U2/U6 complex. Hence, it has 
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been proposed that U4 may act primarily as a negative regulator, sequestering U6 in a 
catalytically inert conformation161. Taken together, despite its absence in the activated 
complex, U4 also plays an essential role in spliceosome assembly by preventing U6 
from premature activation and formation of unfavourable conformations.  
The in vitro splicing complementation assays have shown that affinity purified U4 
snRNP and U6 snRNA couldn’t assemble into U4/U6 duplex without nuclear extract 
complementation, suggesting the requirement of other protein factor or factors for the 
formation of U4/U6 duplex. Also the formation of a very stable duplex in vitro (Tm ~ 53 
oC) by extensive base pairing between U4 and U6 proposes  an activity of ATP 
dependent RNA helicase or a RNA chaperone on the unwinding process of U4/U6 
complex178. Moreover, an RNA binding protein may be involved in the stabilization of U4 
and U6, which is energetically less favourable when compared to that of duplex179. A 
mutational analysis study indicates that the G14C mutant, where G is mutated to C at 
the 14th position of U4 snRNA, has shown the most dramatic cold sensitive phenotype 
when compared to other U4 mutations179. Also, this mutant has shown a Tm of ~ 37 oC, 
suggesting that the base pair G14 – C67 plays an important role on the stabilization of 
U4/U6 helix179.  
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Figure 1.15: A schematic representation of current models for the secondary 
structure of U6 in free U6 snRNP, in U4/U6 duplex and in U2/U6 duplex. Highly 
conserved regions of U6 are shown in red; ACAGAGA loop, AGC triad and U80.  
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1.9.3: U2/U6 complex makes the catalytic core of the spliceosome  
Although splicing requires the assembly of all five snRNPs, only U2, U5 and U6 have 
been shown to be present in the catalytically active spliceosome5. Previous studies 
have also shown that U5 loop I is functionally dispensable for both steps of splicing79,180. 
All these findings have led to the suggestion that the U2/U6 complex is responsible for 
the catalysis and it acts as the active site of the spliceosome. Similarly, in the minor 
spliceosome U12/U6atac forms the catalytic core143,146,148. This has been demonstrated 
in studies done with protein-free U2/U6 complexes, which are able to catalyze reactions 
similar to both steps of splicing115,181. U6 needs to dissociate from U4 and base pair with 
U2, in order to form the active spliceosomal complex. During this transition, the 
structure of U6 undergoes dramatic rearrangements, where the regions participate in 
base pairing with U4 open up and reform the 3’ stem-loop (ISL) as in free U6 snRNA 
(Figure 1.15)43,160,161. The ISL domain contains AGC triad and metal ion coordinating 
dynamic bulge (U80), which have been shown to be important for the first step of 
catalysis. Sequences upstream to ISL are basepaired with the 3’ end of U2 to form the 
helix I and helix III (may not be found in yeast) in U2/U6 complex, separated by a bulge 
containing highly conserved ACAGAGA domain (Figure 1.16d and e)171,182. This 
ACAGAGA loop is known to interact with the 5’ SS during the spliceosomal activation 
(Figure 1.16d)172. On the other hand, the downstream sequence of U6 base pairs with 
U2 to form the helix II (Figure 1.16d and e)87,182. 
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1.9.3.1: Secondary structure of U2/U6 
The catalytically important conformation of the U2/U6 complex has been debated for 
many years.5 According to genetic studies (Guthrie lab87), NMR studies (Butcher lab183) 
and structural probing studies (Luhrmann lab184), the AGC triad of U6 base pairs with a 
region in U2 and forms a three-helix structure consisting of helix Ia, Ib, and III (Figure 
1.16d).  On the other hand, mammalian genetic studies (Manley lab182) and NMR 
studies (Butcher lab171), have proposed a four-helix structure, in which the AGC triad 
base pairs with U6 itself and forms an extended ISL (Figure 1.16e).  These two 
conformations may be present at different states of spliceosomal activation.  Minor 
spliceosomal U12/U6atac complex also forms a similar secondary structure to U2/U6 
complex, which consists of helix Ia and Ib, helix III and ISL region within U6atac 
corresponding to those regions in U2/U6 complex (Figure 1.16f).38,143,146,148 However 
since the 5’ end of U12 is truncated when compared to U2, it’s unable to form the helix 
II structure as in U2/U6 complex (Figure 1.16f).38,143,146  
 
1.9.3.2: U2/U6 adopts multiple conformations 
Single-molecule fluorescence resonance energy transfer (smFRET) studies carried out 
in our lab have shown that the minimal U2/U6 complex from yeast can adopt at least 
three distinct conformations in dynamic equilibrium, corresponding to three distinct 
FRET states, 0.2, 0.4 and 0.6, as a function of Mg2+ concentration (Figure 1.17a)185. At 
zero or very low Mg2+ concentrations, the U2/U6 complex adopts a conformation 
corresponding to a high FRET state (0.6), whereas at high Mg2+ concentrations, it forms 
the low FRET (0.2) conformation185. The intermediate FRET state (0.4) corresponds to 
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an intermediate conformation. The high and low FRET states are assigned as four-helix 
structure and three-helix structure respectively (Figure 1.17a).  
In three-helix structure, distance between ACAGAGA loop and the ISL is increased 
due the formation of helix IB , resulting in a low FRET state (Figure1.17a). Six-fold 
mutations that prevent formation of helix IB and A91G mutation which stabilizes the 
helix IB have shown a low FRET population, confirming three-helix structure gives rise 
to 0.2 FRET state (Figure 1.17b and c)185. On the other hand, in four-helix structure, 
AGC triad base pair with U6 bases to form an extended ISL and ACAGAGA loop bring 
closer to ISL resulting in a high FRET (Figure 1.17a).  
Furthermore,  studies have shown the formation of base-triple interactions within U6 
snRNA, involving the ACAGAGA loop, AGC triad and U80 which brings ACAGAGA loop 
closer to ISL similarly in group II intron (Figure 1.16a and b)186,187. It has been proposed 
that these interactions are vital for the catalysis, since they bring all the components 
together. At low Mg2+ concentrations, U80 tends to flip out and favours the formation of 
the base triple interactions, which bring the ACAGAGA loop closer to U80 and results in 
a high FRET state (Figure 1.17a). In contrast, with higher Mg2+ concentrations, U80 
stacks within the U6 ISL and disrupts base triples, leading to a low FRET state (Figure 
1.17a).186  
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Figure 1.16: Structural similarities between Group II intron, U2/U6 complex and 
U12/U6atac complex. The catalytic triad and the metal ion coordinating bulge regions 
are present in both (a) domain 5 of group II intron, (b) ISL domain of U6 and (c) ISL 
domain of U6atac. Both group II intron and U6 snRNA have shown to form base triple 
interactions in a similar way. Similarities between U6 and U6atac structure and 
sequence suggest formation of base triple interactions similar to U6 as shown in (c). 
Major spliceosomal U2/U6 complex undergoes structural dynamics. (d) The proposed 
three-helix junction, where the invariant AGC triad of U6 forms intermolecular base pairs 
with U2. (e) The proposed four-helix junction, where AGC triad forms intramolecular 
base pairing with U6 resulting an extended ISL. (f) U12/U6atac complex present in the 
catalytic core in the minor spliceosome and shares many similarities with their 
correspondents; U2 and U6. This figure is adapted and reproduced from (160, 176 and 
178).  
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These results support the notion that the 5’ splice site and the branch-site adenosine 
are juxtaposed, and bring the metal-ion binding site closer for the catalysis.172,180 
Overall, the dynamic nature of the U2/U6 complex between different structures may 
play a vital role in different stages of catalysis.5 The structural similarities between two 
types of spliceosomal complexes suggest that minor spliceosomal U12/U6atac complex 
may also adopt similar conformational dynamics and act similarly on the catalysis as in 
major spliceosomal U2/U6 (Figure 1.16d and f). Also, sequence and structural 
similarities between U6 and U6atac suggest that U6atac can also form base triple 
interactions similar to U6 snRNA (Figure 1.16c).  
 
1.9.4: Structural rearrangements at the catalytic core 
During the transition from the first to second step, the active site needs to be rearranged 
in order to remove the first step products and juxtaposes the second step 
components188. As an example, before the second step the lariat intermediate needs to 
be removed and the 3’ SS has to be placed in the active site. Thus it has been 
proposed that the active site may toggle between two distinct conformations, one 
promotes the first step and other promotes the second step of catalysis188. Similar to 
ribosomal conformational switch between open and close states, spliceosome may also 
undergo transition between two structures, where some interactions are broken and 
reformed. Many studies have shown that the structural rearrangement occurs in the 
catalytic core during the activation of the spliceosome and the first step of catalysis. 
Upon activation, U1 and U4 are released from the spliceosome and U2, U6 and U5 
interact with the pre-mRNA to facilitate catalysis. During activation, the ACAGAGA loop 
of U6 interacts with the 5’ SS by displacing U1, which is important for 5’ SS recognition 
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and initiation of the first step (Figure 1.18). U2 stays bound with the BS as in the pre-
spliceosome. Taken together, the base pairing network between U2 and U6 in activated 
spliceosome allows ACAGAGA loop and ISL to come closer and form tertiary 
interactions. As a result, both 5’SS and BS move closer to the metal ion binding site 
(U80), which is crucial for the first step of splicing (Figure 1.18) 5,172,180  
Studies have shown that U2 snRNA also exhibits structural dynamics similar to U6. 
The stem II of U2 adopts two conformations; stem IIa and stem IIc proposed to form at 
different stages of spliceosomal assembly (Figure 1.10a)57,58. In the pre-spliceosome U2 
adopts stem IIa conformation and interacts with BS, whereas during the first step of 
splicing U2 interacts with BS through stem IIc structure57,58. Also, it has been shown 
that, after the first step, U2 reforms the helix IIa conformation which is involved in the 
second step of splicing57,58. U5 helps to join 5’ exon to the spliceosome after the first 
step and form interactions with the exon nucleotides downstream to 3’ SS (Figure 
1.18)78,189,190. Furthermore, it is involved in the alignment of the two exons for the 
second step of catalysis (Figure 1.18)79,190. Structural rearrangements, how all the 
components interact within the second step of splicing such as how 3’ SS position at the 
active site, where it comes from, what happen to U2/BS interaction are not yet clear and 
further studies need to be done.  
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Figure 1.17: Spliceosomal U2-U6 snRNA complex adopts multiple conformations 
in dynamic equilibrium. (a) In the absence or low [Mg2+], the U2/U6 complex adopts a 
high FRET (0.6) conformation through the formation of base-triple interactions (blue 
dash lines) between the highly conserved ACAGAGA loop, AGC triad, and U80 (red). 
Binding of Mg2+ induces a conformational change in the U2/U6 complex by disrupting 
the base-triple interaction and eventually stabilizes a low FRET (0.2) conformation via 
an intermediate (corresponding to 0.4 FRET).185,186 U2 and U6 sequences are shown in 
blue and purple respectively. Schematic representation of different U6 mutations and 
resulting time trajectories and corresponding FRET histograms are shown.  (b) Six-fold 
mutant of U6 snRNA which destabilises the low FRET conformation. (c) A91G mutant 
which stabilises the low FRET conformation. Reprinted by permission from Macmillan 
Publishers Ltd: NSMB (177), copyright (2009).   
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After the completion of exon ligation to form the mature mRNA, all the components 
at the catalytic core need to be dissociated from each other in order to engage in 
another cycle of splicing. Although previous studies have proposed a role for Brr285 and 
Prp43120,191 in the dissociation of spliceosomal components at the end of splicing cycle, 
the exact mechanism of how U2/U6 and U5 dissociate from each other is still poorly 
understood. Furthermore, some studies have suggested that other than the 
aforementioned helicases there could be some other protein factors involved in the 
dissociation of snRNAs after the completion of splicing. One possible candidate could 
be Prp24; U6 snRNP associated chaperone, which is known to be promoting structural 
rearrangements of U6 during the assembly cycle and thus proposed as a recycling 
factor. 
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Figure 1.18: Interactions between U snRNA and premRNA in A, B* and C 
complexes. Protein component of U snRNPs are shown as purple spheres, U snRNAs 
in black lines, 5’ exon in red, 3’ exon in blue and intron in green. In A complex, U1 
interact with 5’ SS and U2 with BS. In complex B*,U2 and U6 base pair with each other. 
U6 and U5 recognise the 5’ exon-intron junction, whereas U2 binds with BS. In C 
complex, U5 SLI interacts with both 5’ and 3’ exons facilitating the alignment of two 
exons for the ligation. Reprinted with permission from (42). Copyright (2012) American 
Chemical Society. 
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1.10: Prp24 is an U6 associated chaperone 
The spliceosomal protein, Prp24 plays a major role in the spliceosomal assembly. 
Prp24 is thus an essential component of the U6 snRNP and it is considered as the RNA 
chaperone of U6, since it does not hydrolyze ATP160,192-196.  Studies on Prp24 have 
suggested that it helps U6 to remodel the catalytically important structure179,197. Prp24 
accelerates the annealing of U4 and U6, allowing U6 to enter into the assembly 
pathway102. Prp24 binds to U6 as well as with Lsm (‘like sm’) proteins, another member 
of the U6 snRNP193. It has been shown that after formation of the U4/U6 complex, 
Prp24 leaves the complex and helps to re-anneal two snRNAs for the next cycle of 
assembly, suggesting its role as a recycling factor102,198 Some studies proposed that 
Prp24 returns during the activation of the spliceosome, in which it is involved in 
unwinding of U4, allowing U6 to bind with U2 to form the catalytically activated 
complex.101,199,200 Tight binding of Prp24 to U6, but not with U4, has led to the proposal 
that Prp24 may also play other roles in spliceosomal assembly, such as helping to 
stabilize free U6 until it is ready to bind with U2 to form the active complex, after helping 
to dissociate U4/U6. In other words, Prp24 may prevent the premature formation of the 
active conformation of U6 snRNA.101,179,199 
 
1.10.1: Structure of Prp24 
Prp24 is a 51-kDa protein, present in eukaryotes, from yeast to human, and consists of 
four RNA recognition motifs (RRMs); RRM1-4 and a C terminal sequence that interacts 
with the LSm proteins (Figure 1.19a)100,192. RRMs are a special arrangement of amino 
acids into a four stranded antiparallel β-sheets through two conserved RNP motifs and 
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present in many proteins providing extensive binding sites for single-stranded RNA 
sequences. RRMs-containing proteins are mostly involved in the post-transcriptional 
gene expression processes (i.e. mRNA processing, RNA export and stability) including 
PTB (polypyrimidine tract binding protein, 4 RRMs)201,202, U2AF65 (2 RRMs)106 and 
SRp20 (1 RRM)203 and Prp24 (4 RRMs)192. Almost all the RRM domains are made up 
with ~ 90 amino acids and consist of canonical topology of β1-α1-β2-β3-α2-β4  forming a 
four stranded β sheets packed along with two α helices204. The number of nucleotides 
that binds with the RRMs are also varied ranging from minimum two to maximum of 
eight204. Previous crystal and/or NMR structures have shown that the first three RRMs 
of Prp24 adopt the canonical topology as described earlier (Figure 1.19b, left) 192, 
whereas the fourth RRM4 folds non-canonically, in which it has additional flanking α-
helices compared to the canonical RRM-fold, thus it was named as occluded RRM 
(oRRM4, Figure 1.19b, right)205. Based on the previous crystal structures of Prp24-N123 
(doesn’t contain RRM4 and C terminal), residues in or close to all four β-strands of 
RRM1 interact with residues in or close to the β-strands 2 and 3 of RRM2192. On the 
other hand, residues in or close to the β-strands 1, 3 and 4 of RRM2 interact with 
residues in α-helices 1 and 2 of RRM3192. These results suggest that, despite the 
interacting residues being buried within protein-protein interactions, RRM1 and 2 are the 
mandatory domains to bind with U6 snRNA. Hence, either a dramatic structural 
rearrangement of Prp24 is required for the association of Prp24 with U6 snRNA, or the 
binding of U6 occurs through non-canonical interactions. A recent crystal structure of 
the full length Prp24 shows that a β-sheet  of RRM1 is masked by the interactions with 
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RRM2 and β-sheet of oRRM4 is obstructed by two flanking α-helices, suggesting only 
RRM2 and 3 interact with U6 snRNA in a canonical way164. 
 
1.10.2: Binding of Prp24 to U6 snRNA 
According to gel shift assays done by Kwan and co-workers, RRM1 and 2 are important 
for high-affinity binding of Prp24 to U6, and RRM3 and 4 may have a function in 
controlling the stoichiometry of Prp24 binding206. Previous studies have shown that the 
high-affinity binding site for Prp24 is mainly located between the nucleotides 45-87 of 
U6 snRNA206. Based on the early NMR chemical shift mapping studies, RRM2 interacts 
sequence specifically with the GAGA region in the ACAGAGA loop, and RRM1 
destabilizes a 3’ downstream weakly paired region (nucleotides 54-61: 86-91) of U6 
snRNA.100,205 NMR data on the Isolated RRM3 have shown that RRM3 binds to the U6 
ISL region 48 whereas oRRM4 disrupts base pairing within the bases at the bottom of 
the U6 ISL.205,207 According to these findings, unwinding of base pairs in U6 by RRM1 
and 4 may allow U4 to base pair with U6, in order to form the U4/U6 complex.  
A recently published crystal structure of Prp24 bound to U6 with A62G mutation has 
helped to fill the missing pieces of information on how Prp24 binds to U6, what 
structural requirements need etc (Figure 1.19c)164. Moreover, it provides new insight in 
to the role of Prp24 during the spliceosomal assembly cycle. Although there are many 
proteins containing multi RRMs, this study is the first to reveal a crystal structure for a 
protein containing more than two linked RRM motifs. According to this crystal structure, 
the internal bulge region of U6 creates an interaction network with RRM2, 3, oRRM4 
and area prior to RRM1.   
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Figure 1.19: Structure of yeast U6-Prp24 complex. (a) Domain architecture of yeast 
Prp24. The first 33 and last 44 nucleotides (white) are absence in the construct used in 
the crystal structure. PDB: 4NOT (b) Prp24 consists of 3 canonical RRM motifs (RRM1, 
2 and 3) and one non-canonical RRM, which were named as ‘occluded RRM (oRRM4). 
This figure illustrates the differences between canonical and non-canonical RRM motifs. 
(c) Crystal structure of U6-A62G-Prp24 complex, with U6 RNA in purple and four RRMs 
of Prp24 which is coloured as in a. Figures were generated from PyMOL (PDB: 4NOT).  
(d) A cartoon of the interlocked RNP topology formed by Prp24. Colours are the same 
as in c. This figure is reproduced from (157).  
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According to this new crystal structure, RRM1 interaction with U6 belongs to an 
adjacent complex in the crystal. This interaction occurs via a wide electropositive groove 
enclosed by RRM1 as well as RRM2 and oRRM4 with U6 ISL. RRM2 binds to the 
nucleotides 46-58, which encloses the highly conserved ACAGAGA loop. In contrast to 
previous studies, RRM3 has been shown to interact with more upstream region of U6; 
nucleotides 39-44. Also compared to the interactions observed in the free protein, in the 
presence of U6, RRM3 makes 180o rotation and 20 Å shift, which let RRM2 to bind with 
U6 (Figure 1.19c). This is in consistent with previous NMR studies showing that RRM3 
does not interact with RRM2 in solution, and thus, does not interfere with RRM2 binding 
to RNA. In oRRM4, the occluded α-helices have been shown to interact with both ISL 
and telestem thus form non canonical contacts with double stranded RNA (Figure1. 
19c). These differences in the binding modes could be a result of cooperativity in RNA 
recognition by multi RRM proteins when compared to the isolated protein domains.  
More interestingly, this study has proposed an interlocked RNP topology for the 
Prp24 binding on U6, which has not been found for any other RNA-protein interaction. 
Within this arrangement, the C terminus of RRM3 wraps around the U6 bulge region in 
a way in which oRRM4 has moved to the opposite face of U6 (Figure 1.19d). Then, the 
RRM2 and oRRM4 form tertiary interactions which lead to the formation of a ring of 
protein residues around the asymmetric bulge (Figure 1.19d).  Hydrogen bond formation 
by the last residue of RRM3; an aspartate with A42 and G55 within the asymmetric 
bulge, is shown to be involved in stabilization of the proposed Interlocked topology. This 
unique RNP architecture could be the reason for previously observed low nanomolar 
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apparent dissociation constant for Prp24 binding to U6206, and for the stability of Prp24-
U6 complex even at higher salt concentrations (2M)179. 
Analysis of A62G suppressor mutations in both Prp24 and U6 point out the 
relationship between the suppressor site and protein-RNA interaction, indicating that the 
suppression of A62G mutation is due to the destabilization of U6-Prp24 interactions. As 
an example, components are involved in the aspartate bridge between RRM3-RRM4 
junction and the bulge, acting as suppressor substitutions. Similarly, mutations in RRM3 
residues; Asn216, Asn253 and Ser283 which form hydrogen bonds with the last two 
nucleotides of telestem result in suppression of cold sensitive mutations.  In accordance 
with this, previous studies have also shown that mutations within RRM3 suppress the 
cold-sensitive mutations in U4 (ex. G14C in U4/U6 stem II) that destabilize the U4/U6 
duplex.179 
With all of these findings, it has been proposed that, together, all four RRMs in 
Prp24 induce the conformational remodelling of U6 snRNA, and the protein acts as a 
recycling factor during spliceosomal assembly.198,199 Nevertheless, the mechanism of 
how Prp24 binds with U6 and its function on the formation and dissociation of U4/U6 
complex are still not clear. The recent crystal structure study has proposed how Prp24 
acts as a U6 chaperone, where it facilitates the formation of U4/U6 duplex as well as 
dissociation of U2/U6 to release free U6 snRNP164.   According to that study, the 
electropositive groove of RRM1, 2 and 4 could provide a platform for the RNA annealing 
and thus RRM1 could facilitate the association of U6 with U4. U6 nucleotides 54-60 
which shown to be interact with RRM1-RRM2 are found along one face of 
electropositive groove suggesting that RRM1-RRM2 bound to U6 is an intermediate 
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within the U4/U6 assembly. These interactions may prevent re-annealing of U6 ISL 
residues in free U6 snRNP, allowing the base pairing with U4 to form U4/U6 duplex. 
After the release of lariat intron, Prp24 may directly interact with U2/U6 complex, where 
RRM2 recognises the U6 nucleotides 49-53. This leads to the dissociation of U2 from 
the complex, allowing U6 to form the telestem region and thus Prp24 create the 
interlocked topology.  
 
1.11: Defects in splicing and spliceosomal components can be lethal 
Proper assembly of the spliceosomal components is critical for its function, and thus 
defects in its assembly can be lethal.14,34 According to many studies done on splicing, it 
has been shown that defects in splicing or in spliceosomal assembly are associated 
with many disease conditions such as various cancers (leukemia, ovarian cancer, etc.), 
neurodegenerative disorders such as Parkinson’s, genetic disorders such as Cystic 
fibrosis and many more.7,208,209 Studying the structural dynamics and distinct functions 
of snRNA complexes and the factors that affect the stability of those complexes can 
provide an overall idea about the structure and function of the spliceosome, which will 
guide us to discover novel therapeutics for splicing-related diseases. 
 
1.12: Detection of spliceosomal dynamics 
Spliceosomal assembly and catalysis have been extensively studied over many years 
and many techniques have been used. Several biochemical assays, genetic studies and 
mutational assays have been used to determine the role f each component of the 
spliceosome at different steps of the assembly cycle. Also various structural studies; 
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NMR spectroscopy, EM studies and X-ray crystallography have been used to resolve 
the structures of the sub complexes and dissect the components of each sub complex.   
Also, to understand RNA-RNA and RNA-protein interactions within the spliceosomal 
components and importance of such interactions in the assembly and catalysis, several 
methods have been used such as the electrophoresis mobility shift assays (EMSA), 
chemical probing and hydroxyl radical foot printing. Altogether, these studies have 
revealed an immense amount of information on the composition of spliceosome, 
structure of sub-complexes and splicing mechanism. However, structural 
rearrangements within spliceosomal subcomplexes, kinetics information about 
association/dissociation of spliceosomal components have not yet been elucidated.  
Although many techniques have been used in the past to understand the structural and 
functional details of spliceosome, all of them have certain disadvantages making them 
less effective in providing a quantitative measure of structural dynamics and distinct 
interactions of spliceosomal components at different steps. To overcome most of such 
shortcomings, fluorescence based techniques have been introduced, where the analyte 
is associated with a fluorescent dye (ex. Cyanine dyes; Cy3, Cy5) or a fluorescent 
protein (Green fluorescent protein; GFP).  
                                                                                                                                                   
1.12.1: Fluorescence spectroscopy 
Fluorescence, a form of luminescence, is the emission of light from a substance as a 
result of absorption of light or other electromagnetic radiation. The compounds that emit 
fluorescence are known as fluorophores. When molecules absorb energy they get 
excited into higher energy level, and the subsequent relaxation can occur via several 
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processes as described in a Jablonski diagram (Figure 1.20)210. When a molecule 
absorbs light at a certain wavelength, it is excited from its ground state (S0) to one of the 
vibrational levels in the first excited singlet state (S1, Figure 1. 20, black arrows). This 
excitation process is radiative and emission can be radiative if it releases a photon. The 
relaxation occurs through different processes. The electrons in the higher vibrational 
levels relax to the lowest vibrational level of the excited state. This is known as 
vibrational relaxation (Figure 1.20, brown arrows). Internal conversion (IC, Figure 1.20, 
Purple curved arrows) is a process where the vibrational level of an electronically 
excited state is coupled to a vibrational level of a lower electronic state. Molecules can 
have two types of excited states, namely singlet and triplet, which differ based on the 
spin multiplicity. If energy levels of singlet state are overlapped with that of a triplet 
state, a vibrational coupling can occur between singlet excited state and triplet state 
named as intersystem crossing (ISC, Figure 1.20, orange curved arrow). This transition 
is non-radiative and which is technically forbidden. Phosphorescence, which is a slow 
and forbidden transition, takes place when molecules in a triplet state relax into ground 
state by emitting light (Figure 1.20, red arrows). 
On the other hand, fluorophores absorb energy and excite, relax from singlet excited 
state to singlet ground state; they emit light as fluorescence (Figure 1.20, green arrows). 
Because of its short life time (~10-8 s), fluorescence is more favourable when compared 
to the external relaxation, intersystem crossing or phosphorescence. Fluorescence light 
is lower in energy and observed at longer wavelength, whereas the excitation has 
higher energy and shorter wavelength. Thus, fluorescence can be used as a 
spectrochemical method of analysis, where the analyte is attached with a fluorophore, 
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which is then excited by irradiation at a particular wavelength and emit radiation at 
different wavelength. The resulting emission spectrum provides both qualitative and 
quantitative information about the analyte and thus can be used to determine properties 
of the analyte.  
Fluorescence spectroscopic techniques are powerful tools that can be used to 
visualize interactions among biomolecules, and more importantly, these assays can be 
done under biologically relevant conditions. Also, fluorescence imaging has several 
advantages over traditional imaging methods (such as radioisotope labelling and 
electrochemical detection) including, use of low volumes of nonradioactive, 
homogeneous samples, use of readily available instruments and detection is highly 
sensitive and safe211. Another very important advantage of these assays is that the 
fluorescence signal of the analyte can be modified in a way that the detection of signal 
is more accurate and correlates with the properties of the analytes, such as existence, 
orientation and concentration211. There are several fluorescence based assays that 
have been employed in spliceosome studies, including fluorescence anisotropy based, 
fluorescence intensity measurement based and fluorescence resonance energy transfer 
(FRET) based. 
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Figure 1.20: Jablonski diagram showing the electronic transition between energy 
levels. Once a molecule absorbs energy (black) and excite into higher energy levels 
from ground state (S0). These excited molecules then come to the lowest level in the 
excited state (S1), by releasing energy by vibrational relaxation (brown). Further 
releasing energy can occur in different ways as shown in the figure, such as internal 
conversion (IC, purple), intersystem crossing (orange), fluorescence (green), 
phosphorescence (red).  
  
94 
 
1.12.2: Fluorescence anisotropy 
Fluorescence anisotropy can be used to study the interaction between nucleic acid 
molecules and proteins. In fluorescence anisotropy,  a sample with fluorophore is 
excited using vertically polarized light (i.e. the electric vector is parallel to the z axis, 
Figure 1.21a)210. The emission intensity is detected through a polarizer. When the 
polarizer is parallel to the polarized excitation intensity then we denote it as 𝐼ǁ and if it’s 
perpendicular then it’s shown as 𝐼⊥G is an instrument dependent correction factor. The 
anisotropy can be calculated using following equation;  
 
𝑟 =  
𝐼ǁ − 𝐺𝐼⊥
(𝐼ǁ + 2𝐺𝐼⊥)
 
 
The idea under this technique is that, when a fluorophore is excited with polarized 
light, the emission light will also be polarized within a certain range of angles. If the 
fluorophore is rotating freely the degree of polarization of emitted light will be reduced 
resulting in a low anisotropy value (Figure 1.21b). In contrast, when the fluorophore 
attached molecule is bound to a larger molecule such as a protein, the free rotation of 
fluorophore is hindered, resulting in a higher degree of polarisation of emitted light 
giving rise to high anisotropy (Figure1.21b). Therefore this technique can be used to 
study the binding of Protein to the RNA. 
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1.12.3: Fluorescence resonance energy transfer (FRET) 
Fluorescence resonance energy transfer (FRET) is a powerful technique that can be 
used to study inter- and intra-molecular dynamics in biological systems212. In this 
technique, energy is transferred between two fluorophores through non-radiative dipole-
dipole coupling. Many fluorophore pairs such as; Cy3-Cy5, Alexa488-Cy3, Fluorescein- 
Tetramethylrhodamine (TAMRA) and Cyan fluorescent protein (CFP)-Yellow fluorescent 
protein (YFP) have been used in FRET studies.  First, a fluorophore (donor, D) is 
excited to higher energy level and eventually relax by releasing energy. This releasing 
energy will then be transferred to an adjacent molecule, an acceptor (A, Figure 1.22a) 
via long-range dipole-dipole interactions212,213. The concept behind this radiationless 
energy transfer is that dipole oscillation of donor molecule undergoes energy exchange 
with an adjacent molecule (acceptor) having a similar resonance frequency by inducing 
a dipole oscillation of acceptor molecule210.  To have energy transfer between donor 
and acceptor, certain conditions need to be fulfilled214. First both dyes need to have high 
quantum yield and absorption coefficient.  Second, the dipole moments of two 
fluorophores need to be in proper orientation. Third, the donor emission spectrum 
should be overlapped with absorption spectrum of the acceptor. In figure 1.22b, 
absorption and emission spectrum for cy3 and cy5 pair, as donor and acceptor 
respectively, are showing, where emission spectrum of cy3 is overlapping with 
excitation spectrum of cy5. Finally, the distance between donor and acceptor should be 
in the range of 10-100Å. The rate of energy transfer between two fluorophores is given 
by210,212,213,215, 
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𝑘𝑇 =  (
1
𝜏𝐷
)  ×  (
𝑅0
6
𝑅6
) 
 
where, 𝜏𝐷is the fluorescence life time of donor molecule, R is the distance between the 
donor and the acceptor, R0 is the Förster distance, which corresponds to the distance 
resulting in 50% efficiency of energy transfer. The energy transfer efficiency can be 
given by the Förster equation210,212: 
𝐸𝐹𝑅𝐸𝑇 =
1
1 + (
𝑅
𝑅0
)
6 
This shows that efficiency of energy transfer depends on the inverse sixth power of 
the distance between donor and acceptor. R0 depends on the spectral overlap between 
donor and acceptor fluorophores and the relative orientation of their transition 
dipoles216.  
𝑅0
6 = 8.79 × 10−25
Ҡ2∅𝐷 𝐽
𝑛4
 
where, Ҡ2 is the orientation factor (2/3 in average), ∅𝐷 is the quantum yield of the 
donor in the absence of the acceptor, n is the refractive index of the solution (1.33 for 
aqueous solutions) and 𝐽 is the spectral overlap between donor emission and acceptor 
excitation. 
In general, the apparent FRET value can be calculated using the following 
equation210; 
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𝐹𝑅𝐸𝑇 =
𝐼𝐴
(𝐼𝐴 +  𝐼𝐷 )
 
In which, IA is the acceptor intensity and ID is the donor intensity. The figure 1.22c 
illustrates the energy transfer efficiency as a function of distance between two 
fluorophores, where it shows a sharp change in efficiency within the distance range of 
25 – 75 Å. Since, most of the biomolecular interactions fall within this distance range; 
FRET can be used as a ‘molecular ruler’ to study the interactions and dynamics of 
biomolecules, which cannot be obtained using other light microscopy methods. 
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Figure 1.21: Fluorescence anisotropy to study RNA-protein interactions. (a) A 
schematic representation of fluorescence anisotropy measurement. A sample with 
fluorophore is excited using a vertically polarised light and the electric vector is parallel 
to the z axis. The emission intensity is detected through a polarizer. When the polariser 
is parallel to the polarised excitation intensity then we denote it as 𝐼ǁ and if it’s 
perpendicular then it’s shown as 𝐼⊥. (b) A schematic diagram illustrating effect of larger 
compound (protein) binding on the fluorescence anisotropy of a fluorophore attached to 
a small molecule (RNA or DNA). When a fluorophore is attached to a small molecule 
like RNA it can move freely (fast tumbling) and hence when it excites with a polarized 
light, the degree of polarisation of the emitted light will be reduced (more depolarised) 
resulting low anisotropy. On the other hand, when a larger molecule like a protein is 
bound to the small molecule with the fluorophore attached, the degree of free rotation of 
the fluorophore is reduced (slow tumbling) resulting in an increase in the polarised 
emitting light, which gives rise to high anisotropy. Adapted from (199).1.12.3: Single-
molecule fluorescence microscopy 
In biological complexes, the components can form a wide range of interactions with 
each other, adopt multiple conformations at different stages and undergo significant 
changes in the composition during their activity. Several conventional methods have 
been used to study the structural details and interactions of biological molecules, such 
as NMR spectroscopy, X-ray crystallography, cryo-EM and chemical probing. However, 
each of these techniques has some limitations; moreover they fail to give quantitative 
understanding about the biological systems, their interactions and dynamics. Also, most 
of the conventional methods provide an ensemble or bulk measurements of a sample, 
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which represent the average of all the molecules present in the sample. In a sample at a 
given time, molecules can behave differently, can have different dynamics and can 
adopt different conformations. But in a bulk study, all these different properties are 
summed together and provide an average result, which could hide information about the 
behaviour of each individual molecule in real time. Although some methods such as EM, 
X-ray crystallography and atomic force microscopy can be used to reveal structural 
information of individual molecules, the molecules need to be fixed in a particular 
conformation. Therefore these techniques cannot provide any structural dynamics and 
kinetic information of the molecule of interest. In order to provide a better picture about 
the biomolecular interactions, conformational dynamics and kinetics in biological 
systems, scientists have developed single-molecule microscopic approach.  
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Figure 1.22: Fluorescence resonance energy transfer (FRET). (a) Energy diagram 
showing the electronic transitions during FRET. Energy release from one fluorophore is 
absorbed by an adjacent fluorophore, so that it will excite and eventually release 
energy. This transfer of energy from one molecule to another is known as FRET. (b) 
Spectral overlap between donor and acceptor fluorophores. Absorption and emission 
spectrum of cy3 (donor) and cy5 (acceptor) are in green and red respectively. The 
overlap region within the emission spectrum of cy3 and the absorption spectrum of cy5 
is shaded in purple. (c) Efficiency of FRET as a function of distance is shown. This 
indicates that the energy transfer efficiency is inversely proportional to the distance 
between two fluorophores. Within the region between 25-100Å (shaded in pink), energy 
transfer efficiency is more sensitive to the distance. Adapted by permission from 
Macmillan Publishers Ltd: Nature methods (204), copyright (2008). 
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The major advantage of single-molecule microscopy is its ability to distinguish 
different populations present in a heterogeneous sample217. As an example, when a 
sample is composed of different populations and the distribution of each population can 
change rapidly, the conventional ensemble methods will give information by averaging 
all the molecules in the sample, and thus, show presence of only one population. In 
contrast, single-molecule approach differentiates each individual member of a 
heterogeneous sample, and characterise each population quantitatively217.  Also this is 
an ideal method to study the structural dynamics of biological systems as well as to 
recognise interactions (association/dissociation) between components at different 
stages of both time dependent and independent reaction mechanisms217. With the 
advances of single molecule microscopy, the molecules can be detected with sub-
nanometer spatial resolution,  which is important in detecting inter and intra molecular 
interactions and dynamics. Since single-molecule approaches have better time 
resolution; mostly in milliseconds to nanoseconds, it can be used to detect the transient 
or short-lived intermediates that are present in the reaction pathways. This method also 
provides kinetic information on transitions of molecules between different 
states/conformations, rate of reaction mechanisms including shift to/from intermediates. 
Another advantage of this approach is small sample size. Mostly this technique requires 
only µM to pM concentrations and thus it is very useful when the isolation of some 
biomolecules is challenging and resulting in very low yield.  
Single-molecule techniques have been used extensively to study the biological 
systems and all these approaches can be divided into two major groups; fluorescence 
based and force based. Fluorescence based single molecule studies include FRET, 
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localization, polarization, life time and intensity. On the other hand the force based 
studies are optical and magnetic tweezers and AFM. Optical tweezers is a technique 
where the molecule of interest (eg. nucleic acid) is attached to a bead/microsphere via 
avidin-biotin interaction, which is attached to a surface from the other side and trapped 
in a laser beam218,219. This can be used to manipulate the beads by applying a small 
force in the piconewton range, which in turn measures displacement of biomolecules in 
the nanometer range and the amount of force need to break a bond or associated 
length changes. In AFM, a nanometer size tip on a cantilever is attached to a 
biomolecule and a force is applied to unfold the molecule and study the properties of 
that molecule.  
Single-molecule studies based on fluorescence have developed many reporter 
systems during last few years. Colocalization Single Molecule Spectroscopy (CoSMoS) 
provides information about the localization of molecules within the cell, which indicates 
the interactions between different molecules220.  Similarly in fluorescence anisotropy, 
single-molecule fluorescence polarization anisotropy uses polarized light and gives 
information about interactions or the binding of molecules with others. Single-molecule 
fluorescence life time imaging (SM-FLIM) is used to quantify the fluorescence lifetime, 
which is a reflection of constitution and surrounding of molecules221. The time-resolved 
fluorescence microscopy/ time-correlated single photon counting (TCSPC) measures 
the intensity of fluorophore decay which can be used to monitor the distance distribution 
of molecules. In the fluorescence recovery after photobleaching (FRAP) approach, the 
equilibrium of fluorophores are disturbed by photobleaching and then the increase in 
intensity on the initially bleached sites are measured221. FIONA, or ‘fluorescence 
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imaging with one-nanometer accuracy’, is another single-molecule fluorescence 
approach218. This method detects the location of molecules with ~1.5nm accuracy. 
Analysis of fluorescence image and fit it into a Gaussian distribution will result in such 
higher resolution. Among all these approaches, the single molecule assay combined 
with FRET (sm-FRET) is known to be the most widely used method.  
This method can be used to determine the distance, conformational dynamics, and 
kinetic properties of individual molecules within biological systems. Some of the 
advantages of sm-FRET over other single-molecule approaches are less prone to 
environmental noise since it is a ratiometric technique and easy data acquisition.  
Two main setups to measure the fluorescence at single molecule level have been 
developed, namely, confocal microscopy and total internal reflection fluorescence 
microscopy (TIRF)218,219,222.  
In confocal microscopy, only a small volume is excited by focusing a laser through 
the objective lens of the microscope as well as it uses much diluted samples218,219. This 
helps to reduce the background signal. Also in this setup, a pinhole barrier is used in 
between objective and detector, to reduce the out-of-focus fluorescence emission 
(Figure 1.23a). These characteristic features increase the signal-to-noise ratio and the 
sensitivity that leads to detect single fluorophores. One of the advantages of confocal 
microscopy is that it gives better time resolution, with an order of microseconds. This 
setup can be used for the samples with free diffusing molecules as well as for the 
molecules that are tethered to a surface. 
In TIRF, the excitation sample volume is confined to a small area by placing it in a 
channel made in between a quartz slide and a cover slip218. The laser beam use in this 
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setup arrives at the interface between the quartz slide and the aqueous solution with an 
incident angle larger than its critical angle, achieving a total internal reflection of the 
laser. Although the laser is reflected completely, an evanescent wave is created at the 
slide-solution interface which penetrates and excites the molecules closer to the slide 
surface, typically within the range of ~200 nm. This prevents the penetration of laser 
through the sample, which in turn minimizes the background fluorescence and 
increases the sensitivity for single molecule detection. The emitted fluorescence from 
the individual biomolecules is then captured by the objective and detected through a 
charge-coupled device (CCD) camera. The TIRF setup allows detecting signals from 
hundreds of molecules at the same time, permitting rapid data acquisition.  One major 
limitation of the TIRF is its time resolution, which depends on the time resolution of CCD 
camera, mostly between ten to hundred milliseconds, and thus it cannot detect faster 
dynamics. Based on how the laser beam directed to the sample TIRF can be 
categorised into two systems; prism-based and objective-based TIRF. 
In objective-based TIRF the evanescent wave is created through the objective, 
hence the sample can be manipulated easily223. Also inexpensive glass slides can be 
used for this setup. However, alignment of laser beam in the objective in order to 
achieve a total internal reflection is challenging. Also the excitation beam needs to be 
passed parallel to the vertical axis (Figure 1.23b)223. In this setup, first the laser beam 
needs to be expanded by using lenses and then the beam is aligned into the 
microscope using mirrors. Another lens needs to be used to focus the beam onto the 
back focal plane (BFP). A dichroic mirror (DM) is used to reflect the shorter wavelength 
excitation light and transmit the longer wavelength emission light. 
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As the name implies the prism-based TIRF uses a prism to reflect the laser beam 
entirely and thus the incident angle can be much larger when compared to the objective 
based setup (Figure 1.23c) 223. Advantage of having a larger incident angle is that the 
evanescent wave will only penetrate to a small area of the sample, which helps to 
minimize the sample volume and improve signal-to-noise ratio. It also allows separating 
the excitation and emission paths completely. A few major limitations of prism-based 
TIRF include, most of the sample chamber is covered by a prism, making it difficult to 
manipulate, requirement of expensive and fragile quartz slides, emission wave passing 
through the sample to reach to the detector, resulting in background scattering. Despite 
these disadvantages, the prism-based setup has been used widely when compared to 
the objective-based TIRF. Hence, smFRET using prism-based TIRF is a very powerful 
tool to detect interactions between molecules and their conformational changes. 
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Figure 1.23: Schematic representation of different types of fluorescence 
microscopy. (a) A schematic representation of confocal microscopy.  In this setup, 
laser beam is focused through the objective to excite only a small volume of a sample, 
which minimizes the background signals. Also the pinhole barrier between objective and 
detector helps to reduce the out-of-focus fluorescence emission. (b) A schematic 
representation of objective-based TIRF microscopy. In this setup, first the laser beam 
needs to expand by using lenses and then the beam is aligned into the microscope 
using mirrors. Another laser is used to focus the beam onto the back focal plane (BFP). 
A dichroic mirror is used to reflect the shorter wave length fluorescence (excitation) and 
transmit the longer wave length fluorescence (emission). (c) A schematic diagram of 
prism-based TIRF. In this setup a prism is used to bring the laser beam onto the slide-
solution interface and reflect totally. This creates an evanescent wave which only 
excites the molecules closer to the surface. An inverted objective is used to collect the 
emitted wave of donor and acceptor, which will then send to the light-tight box through a 
slit. Inside the light-tight box, donor and acceptor signals are separated and detected 
side by side via the CCD camera. This figure is adapted and reproduced from (207 and 
211).                   
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1.12.4: Detection of spliceosomal assembly at single molecule level 
(This section is adopted from Warnasooriya C. and Rueda D., Biochem.Soc.Trans. 
(2014), 42) 
Spliceosomal assembly is a highly dynamic process that consists of hundreds of 
components, which associate/ dissociate at different stages in the assembly cycle, 
making it difficult to study the dynamics of these components using traditional bulk 
studies. Hence, single molecule fluorescence studies are ideal to study the dynamics of 
spliceosomal components. During the past few years many single molecule approaches 
have been made to study the spliceosomal assembly dynamics and catalysis.  
Single molecule FRET studies on protein-free yeast U2/U6 complex revealed that it 
adopts at least three conformations which are in Mg2+- dependent dynamic 
equilibrium185. These three conformations are assigned as three-way junction structure, 
four-way junction structure in consisting with previous studies and a novel intermediate 
conformation. Furthermore, it suggested that in the four way junction structure, 
ACAGAGA loop and U80 are in close proximity allowing 5’SS and metal binding sites to 
juxtapose with each other, facilitating the splicing reaction. Similarly, single molecule 
studies with protein-free human U2/U6 also revealed the structural and dynamics 
similarities between yeast and human supporting previous studies224. Moreover, authors 
demonstrated the role of post-transcriptional modifications on the stability of human 
U2/U6 complex.  
Other than spliceosomal components, pre-mRNA itself undergoes structural 
rearrangements during splicing. Several studies have been done to monitor the pre-
mRNA dynamics at single molecule level. One of such assays was developed to track 
109 
dynamics and removal of introns in whole cell extract (WCE) with single-molecule 
resolution, using colocalization single molecule spectroscopy (CoSMoS) technique. This 
study suggests that free pre-mRNA adopts multiple conformations which results in 
multiple FRET states225. Furthermore, binding of U1snRNA stabilizes a low FRET 
conformation of pre-mRNA in which 5’SS and BS are far apart, preventing any chemical 
reaction prior to the spliceosomal activation. Higher FRET states observed after addition 
of NTC complex reveal that binding of NTC stabilizes the interactions between U5, U6 
and pre-mRNA which facilitates formation of activated complex to carryout both splicing 
reactions.  Hence this study proposed the importance of dynamic nature of pre-mRNA. 
Another approach was taken to determine the distance changes between 5’SS and BS 
using smFRET226. Similar to the CoSMoS study, this study has also shown that the pre-
mRNA is maintained a conformation where the 5’ SS and the BS are away from each 
other until the formation of catalytically active spliceosome,  which prevents the 
premature catalysis. Moreover, this study has also shown pre-mRNA adopts several 
conformations which are present in dynamic equilibrium and upon completion of first 
step of splicing, the equilibrium shift towards a high FRET conformation.  
Another CoSMoS study has been carried out to monitor the spliceosomal assembly 
pathway, more specifically to observe the order of spliceosomal components 
assembly227. Over many years it has been considered as U1 binds first to the pre-
mRNA followed by U2.  This new study, strikingly, has shown that either U1 or U2 can 
binds first, followed by the other snRNP, suggesting that these alternative assembly 
pathways can be useful in alternative splicing.    
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In addition to these in vitro studies, several approaches have been made to visualise 
splicing and assembly dynamics in living cells by tracking labelled pre-mRNAs, which 
have provided new insight into the splicing machinery. Nevertheless, many studies have 
been done using single-molecule approaches both in vitro and in vivo, to obtain 
information regarding spliceosomal assembly and catalysis processes, a vast number of 
important questions remain unanswered. For example, the machinery of how 
spliceosomal components recycle after completion of splicing and what factors are 
involved,  how spliceosomal sub-complexes assemble, the global conformation of the 
sub-complexes and how binding of proteins affect the overall conformation, and what 
are the structural and functional similarities/ differences between major and minor 
spliceosomes, what role do protein factors and regulatory motifs play in spliceosomal 
assembly, how do these factors affect related biological processes such as alternative 
splicing, and co- and post-transcriptional splicing in cells, what is the structure-function 
relationship between most of the spliceosomal components and what are the 
differences in splicing kinetics among different organisms. Since single-molecule 
microscopy is a powerful tool to study the structural dynamics of large, complex 
biological systems, the single molecule approaches including its novel advances; ex. 
super resolution microscopy, can be used to solve most of the un-answered questions 
related to spliceosomal assembly and catalysis. 
 
1.13: Objective of this study 
Studying the structural dynamics and distinct functions of snRNA complexes, as well as 
the factors that affect the stability of those complexes provides an overall idea regarding 
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the structure and function of the spliceosome. Defects in splicing machinery, 
spliceosomal components or in cis/trans-acting splicing factors are associated with 
many disease conditions. A thorough understanding of splicing machinery and 
assembly is important for advancement in diagnosis and treatment of these diseases. 
Although the spliceosome has been studied extensively, many aspects of its structure 
and function are yet to be known. Some of such information that needs to be unveiled 
are; How snRNPs are dissociated from each other at the end of splicing cycle? What 
factors involve in this process? How  spliceosomal sub complexes are assembled? How 
the associated components affect on the global structure of each of these sub 
complexes? What are the structural and functional similarities among major and minor 
spliceosomal components?.  
Conventional bulk studies that cannot provide information on transient intermediates 
and population heterogeneity may not be a better approach to explore aforementioned 
aspects.  Hence, the aim of this study is employing smFRET technique to monitor the 
structural dynamics and assembly of snRNA complexes and the effect of protein factors 
on those dynamics with single molecule resolution. This could eventually contribute for 
a much clearer picture of spliceosomal components rearrangements within the 
assembly cycle and catalysis, which lay another step towards the progress of 
understanding the structure and function of spliceosome. Following are the three 
specific aims that I’m addressing in this thesis work to achieve the main goal. 
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1.13.1: Specific Aim 1: Elucidating the role of Prp24 in U2 and U6 snRNP recycling  
Prp24 is a U6 snRNP associated chaperone which plays an important role in 
spliceosomal assembly as a recycling factor. Previous studies have proposed that 
Prp24 involves in association/dissociation of U4/U6 and helps U6 to interchange its 
conformations at different stages of assembly cycle. Hence, we suggest that it may also 
be involved in unwinding of U2/U6 and allowing the reformation of U4/U6. I have used 
sm-FRET to test our hypothesis; Prp24 may unwind the U2/U6 complex after the 
catalysis helping these snRNAs to recycle. 
 
1.13.2: Specific Aim 2: Study the assembly and global structure of U4/U6 complex 
Although U4 is not present in the activated complex, the formation of U4/U6 complex is 
important for spliceosomal assembly. Binding of U4 with U6 is necessary to prevent U6 
from premature activation and formation of unfavourable conformations. Several 
proteins are involved in the assembly of U4/U6 di-snRNP, which has been suggested to 
play an important role in the formation of global structure. The aim of this study is to 
characterize the relative orientation and the global structure of U4/U6 duplex in the 
presence of its associated proteins (Snu1 3, Prp31 and Prp3/4) using single-molecule 
spectroscopy and electrophoretic mobility shift assays (EMSA). 
 
1.13.3: Specific Aim 3: Study the structural dynamics of U12/U6atac snRNA 
complex in minor spliceosome.  
Two spliceosomes with distinct composition have been identified; major (U2-dependent) 
and minor (U12-dependent)5,38,138. The major spliceosome is present in all eukaryotes 
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and splices the highly abundant U2-type introns38,139. The minor spliceosome splices 
less abundant U12-type introns. Previous studies have shown that, despite its low 
abundance, the minor spliceosome plays an important role in processing of many 
genes. As an example, defects in minor spliceosome assembly due to mutations in 
U4atac snRNA cause the Taybi-Linder Syndrome (TALS)155-157. According to early 
studies U12/U6atac forms a complex similar to U2/U6 and forms the catalytic 
core150,228,229. The aim of this study is to monitor the structural dynamics of U12/U6atac 
complex and compare the similarities and differences between major and minor 
complexes using single molecule FRET. 
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CHAPTER 2: Material and Methods 
 
2.1 Materials 
Table 2.1: List of chemicals used in this study 
Chemical Name Company 
Acetic acid  
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Acetone 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Acetonitrile Sigma-Aldrich Company Ltd, Dorset, UK 
Acylamide: Bis acrylamide 40%  
Alconox (VWR International Inc.) 
 
VWR International Inc., Leicestershire, 
UK 
3-aminopropyltriethoxysilane 
(VECTABONDTM reagent) 
Vector Laboratories, Inc., Burlingame, 
CA 
 Ammonium  hydroxide (ACS grade) 
 
Mallinckrodt Chemicals, USA 
Ammonium persulfate (APS) 
 
Fisher Scientific UK Ltd, Loughborough, 
UK 
Biotin-BSA 
 
Fisher Scientific UK Ltd, Loughborough, 
UK 
Boric acid 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Bromophenol blue 
 
Fisher Scientific UK Ltd, Loughborough, 
UK 
Biotin Polyethylene Glycol Succinimidyl 
Carboxymethyl (BIO-PEG-SCM, 
MW 5000) 
Laysan Bio. Inc, AL, USA 
Cy3 and Cy5 NHS esters GE healthcare, 
Little Chalfont Bucks, UK 
Dimethyl sulfoxide Fisher Scientific UK Ltd, Loughborough, 
UK 
Ethanol 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
EDTA 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
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Glycerol 
 
Fisher Scientific UK Ltd, Loughborough, 
UK 
Hydrochloric acid (HCl) 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Hydrogen peroxide (H2O2, 30 %) Fisher Scientific UK Ltd, Loughborough, 
UK 
Magnesium Chloride 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Magnesium acetate Fisher Scientific UK Ltd, Loughborough, 
UK 
Methanol 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Methoxy Polyethylene Glycol 
Succinimidyl Carboxymethyl (m-PEG-
SCM, MW 5000) 
Laysan Bio. Inc, AL, USA 
Protocatechuic acid (PCA) and 
Protocatechuate dioxygenase (PCD) 
Sigma-Aldrich Company Ltd, Dorset, UK 
Sodium acetate (NaOAc) Fisher Scientific UK Ltd, Loughborough, 
UK 
Sodium bicarbonate and Sodium 
carbonate 
 
Fisher Scientific UK Ltd, Loughborough, 
UK 
Sodium chloride 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Sodium hydroxide 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Streptavidin Invitrogen, Life technologies Ltd, Paisley, 
UK 
Triethylammine 
 
Fisher Scientific UK Ltd, Loughborough, 
UK 
Triethylammine trihydrofluoride 
(TEA.3F) 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
Tris base Sigma-Aldrich Company Ltd, Dorset, UK 
Trolox Fisher Scientific UK Ltd, Loughborough, 
UK 
Xylene cylanol 
 
Sigma-Aldrich Company Ltd, Dorset, UK 
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2.2: Methods-Single-molecule FRET study 
Single-molecule fluorescence resonance energy transfer (sm-FRET) can be used to 
detect interactions between molecules and their conformational changes. Sm-FRET is a 
very important technique in which we can focus on one molecule at a time.230,231 This 
technique provides an idea about how individual molecules behave in a bulk solution, 
revealing their structural dynamics and heterogeneity in the system. Also, this is a very 
important tool to understand and identify transient intermediate states that cannot be 
revealed from bulk experiments.185,186,216,231,232 
 
2.2.1: Surface preparation- cleaning of slides and coverslips 
In sm-FRET studies, a quartz slide is used to make the microfluidic channel. Two holes 
were drilled on the quartz slide using a hand drill and a diamond drill bit with a diameter 
of 1mm. Slides need to be passivated before introducing the sample and the following 
steps were done to passivate the slides as explained in previous study233. 
As the first step of slide preparation, slides are needed to be cleaned well, since 
impurities can increase the back ground fluorescence. First the reaction containers 
(staining jars/ coplin jars) were cleaned well and dried using Nitrogen gas. The Quartz 
slides were cleaned with the detergent; Alconox to remove any debris remaining on the 
slide. First a small amount of Alconox mixed with water to make a paste. Then each 
slide was scrubbed for few minutes with this paste and washed well with distilled water 
to remove the detergent completely. Next, the slides were cleaned well by scrubbing 
several minutes with distilled water, ethanol and distilled water respectively. Then the 
cleaned slides were placed in a cleaned beaker and filled with the “basic piranha 
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solution” (100 ml distilled water, 20 ml of 30% Hydrogen peroxide and 20 ml of 
Ammonium hydroxide) and boiled for about 30-40 minutes. Next, the slides were 
washed thoroughly with distilled water and flame dried using a Bunsen burner. These 
two steps help to remove any organic compound stuck on to the slide surface and 
restore the silanol groups on the surface.  
 
2.2.2: Aminosilanisation of slides and coverslips  
As the next step, the slides and coverslips are needed to be activated prior to the 
PEGylation process. During this step an amino group is attached to the slide surfaces 
which will later react with the N-hydroxysuccinimide (NHS) ester group on the PEG 
molecules we use for PEGylation (Figure 2.1a). First, reaction containers (coplin jars/ 
staining jars) were cleaned and dried well. Then the cleaned and dried slides from 
previous step and new cover slips were placed in the coplin jars separately. These jars 
were then filled with 1 M KOH and sonicated for > 20 minutes. Next, the KOH solution 
was removed and slides were rinsed with distilled water followed by methanol. Later the 
jars were filled again with methanol and sonicated for another > 20 minutes. Finally, the 
methanol solution was discarded and the slides were rinsed again with new batch of 
methanol solution. For the aminosilanisation of the slide surface, first a reaction mixture 
was made with 100ml of methanol, 5ml of glacial acetic acid and 1ml of 3-
aminopropyltriethoxysilane (VECTABONDTM, Vector Laboratories, Inc., Burlingame, 
CA). Slides and coverslips were incubated with this solution for 10 minutes, sonicated 
for 2 minutes followed by 10 minutes incubation. Then the reaction solution was 
removed from the reaction jars and the slides were rinsed with methanol, distilled water 
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and methanol respectively. Finally the slides and coverslips were dried well with 
nitrogen gas. Now the slides are ready for the PEGylation. 
 
2.2.3: Surface PEGylation  
Passivation of slide surfaces with a polymer is important for the prevention of non-
specific binding or the adsorption of proteins to the slide surface. Linear polyethylene 
glycol (PEG) is the most common polymer used in slide passivation (Figure 2.1a). A 
10% biotin polyethylene glycol succinimidyl carboxymethyl (BIO-PEG-SCM, MW 5000) 
solution was made by mixing biotin-PEG with methoxy polyethylene glycol succinimidyl 
carboxymethyl (m-PEG-SCM, MW 5000) and dissolve in PEGylation buffer (100mM 
sodium bicarbonate, pH 8.4). For five slides, 50 mg of m-PEG/ biotin-PEG mixture (total 
10% biotin-PEG) was dissolved in 360 µl of PEGylation buffer, vortex gently and 
centrifuged at ~10,000 rcf for few minutes. Then the cleaned and dried slides from 
previous step are placed in a reaction chamber (a pipette box) filled ~10% with distilled 
water. Next 70 µl of PEGylation reaction mixture was added on to each slide and a 
coverslip was placed carefully on the top of each slide and reaction solution without 
making any bubbles. Then the slides were incubated with the reaction solution in dark 
for overnight. The next day, slides and coverslips were carefully separated out, rinsed 
well with distilled water and dried with nitrogen gas. 
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Figure 2.1: Slide preparation, sample immobilization and Imaging in single-
molecule experiments. (a) Schematic representation of stepwise process of slide 
passivation and sample immobilization. (b) Preparation of flow channel using double 
sided tape between the quartz slide and coverslip (top), and the top view of an 
assembled slide. (c) Schematic representation of microscope for single-molecule 
experiments.This figure is adapted and reproduced from (226) with the permission from 
Elsevier.   
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2.2.4: Preparation of flow channel  
The cleaned slides and coverslips are then assembled to make a flow channel, which 
will be used to immobilize molecules and flow buffers. The slides were kept on a rack 
placing the PEGylated side up. Then two layers of double-sided sticky tape were 
applied to each side of the holes, making a microfluidic channel with ~ 200 µm deep 
and ~5 mm wide as shown in Figure 2.1b. Then a coverslip was placed carefully on 
each slide covering the two holes and the channel made. The extra tapes were 
removed from the coverslip edges by cutting with a razor blade. The epoxy glue (5min 
Epoxy) was applied on the edges of the coverslips to seal the channels and let them 
completely set for ~20 minutes (Figure 2.1b). Finally the assembled slides were stored 
in covered 50 ml falcon tubes under nitrogen gas.  Now the slides are ready for 
experiments. 
 
2.2.5: Sample purification  
The samples (DNA, RNA or Protein) that are used in the single-molecule FRET 
experiments need to consist of two fluorophores to obtain a fluorescence energy 
transfer, which corresponds to conformational changes between the molecules. Also 
one of the molecules needs to be biotinylated for surface immobilization. Sample 
preparation procedure for single-molecule experiments is as follows. 
The RNA samples used in this thesis work were purchased from the Keck 
Foundation Resource Laboratory at the Yale University School of Medicine unless 
otherwise stated. The 2’-hydroxyl protective groups were removed and the RNAs were 
purified as described previously215,232. In summary, dried RNA sample was dissolved in 
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200 µl DMSO and take only half of the solution for deprotection reaction while storing 
other half in -80 oC. Next, 125ul Triethylamine trihydrofluoride (TEA.3HF) was added to 
the tube containing RNA dissolved in DMSO and thoroughly mixed by vortexing.  Then 
the reaction mixture was mixed at 65 oC and at 650 rpm speed for 2.5 hours followed by 
a brief cooling in the freezer for few minutes. Then 25 µl 3 M sodium acetate (pH5.2) 
and 1 ml of butanol were added to the RNA solution, mixed well and kept in -20 oC over 
night or in -80 oC 2-3 hours. Next, the RNA solution was centrifuge at 8900 rpm for 10 
minutes to precipitate RNA and poured out the butanol solution. The pellet was then 
rinsed with 0.75 ml 70% Ethanol twice and dried in vaccum dryer. Finally the dried RNA 
pellet was dissolved in distilled water. Then RNA was purified by denaturing gel 
electrophoresis (20% wt/vol polyacrylamide and 8 M urea), cut out the desired band and 
eluted against 4ml elution buffer (0.5 M Sodium acetate and 0.1 mM EDTA, 10 mM 
Tris.HCl) overnight at 4 °C. The eluted solution containing RNA was then mixed 
thoroughly with chloroform: isoamyl alcohol (25:1) solution, centrifuged at 1000 rpm for 
10 minutes and the aqueous layer was separated into a new tube.  Next, a 1/10th 
volume of 3 M Sodium Acetate and 2-2.5x volume of 100% Ethanol were added to the 
tube, shake well and placed in -20oC overnight. Then the solution was centrifuged at 
12500 rpm, supernatant was discarded and the pellet was washed with 70% ethanol 
twice. Finally the pellet was dried in vaccum dryer. The RNA samples that are not used 
for further labelling were then dissolved in HPLC buffer (50 % Acetonitrile, 14 % 
Triethylammine in distilled water, pH 7.0) and purified using C8 reverse-phase (column- 
Supelco, PA, USA) HPLC (Shimadzu, Kyoto, Japan).  
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2.2.6: Fluorophore labelling of sample 
The substrates use in single-molecule FRET experiments required to be labelled with a 
donor and an acceptor fluorophore.   
 
2.2.6.1: Fluorophores 
A fluorophore, which is bright (with a higher quantum yield) and photostable is ideal for 
single-molecule FRET studies. Also it needs to be a small, water-soluble molecule 
containing some bio-conjugation groups. A good FRET fluorophore pair requires a well 
separated emission spectra, similar quantum yields and similar detection efficiencies, in 
order to obtain a better signal215. Several pairs of fluorophores have commonly been 
used in FRET studies. Fluorescein and Tetra-methyl rhodamine (TAMRA) pair has 
extensively been used in bulk experiments, whereas cyanine dyes have been known as 
a good dye pair for single-molecule FRET studies (Table 2.2, Figure 2.2). In this study I 
have used Cy3 and Cy5 as donor and acceptor fluorophores respectively (Table 2.2, 
Figure 2.2). 
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Table 2.2: Photophysical properties of some common fluorophores use in FRET studies 
 
 
 
 
Figure 2.2: Common fluorophores use in FRET studies. Fluorescein and TAMRA 
are commonly used in bulk studies where as Cy3 and Cy5 are extensively used in 
single-molecule FRET studies.  
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2.2.6.2: Sample labelling 
The fluorophores need to be attached at a specific position on the RNA, DNA or protein 
samples to detect the inter- and intra-molecular conformational changes. A fluorophore 
can be added as a dye-phosphoramidite to an oligonucleotide during the chemical 
synthesis process. Also oligonucleotides can be synthesised with an amino linker at a 
desired position, on a dT residue. Succinimidyl ester group attached to a fluorophore 
reacts with the amino linker attached to the RNA or DNA. On the other hand, proteins 
are modified to have only one cysteine residue, which then can be labelled with 
fluorophores containing mono-functional maleimide group. During RNA labelling, first, 
dried mono reactive N-Hydroxysuccinimide (NHS) ester form of cy3 or cy5 dye is mixed 
in 14 µl of DMSO, vortexed and dissolved completely. Then the desired RNA sample (~ 
50-100 µg) is dissolved in labelling reaction solution (7 µl dye mixture, 20 µl 100 mM 
Sodium Carbonate, pH 8.5 and 73 µl water) and incubated overnight at 25oC with 
mixing at 350 rpm. Following day, 10 µl 3 M Sodium Acetate (pH 5.2) and ~ 390 µl of 
100 % Ethanol are added to the reaction mixture, mixed well and kept at -20oC 
overnight. Then the reaction mix was centrifuged and discarded the supernatant, 
followed by washing with 70% ethanol twice. Finally the pellet is dried and dissolved in 
100 µl of HPLC buffer and purified in HPLC to separate the labelled RNA from 
unlabelled RNA.   The RNA concentrations of all samples are measured by UV-Vis 
absorbance at 260 nm. 
                         
2.2.7: Sample immobilization 
The RNA samples in standard buffer prepared in saturated Trolox solution is heated at 
94 °C for 45 s and annealed by cooling to room temperature over 20 min. First, 100 µl 
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streptavidin (0.2 mg/ml in 50 mM Tris.HCl, pH 7.5 and 50 mM NaCl) is injected to a 
PEGylated slide containing ~10% biotin PEG and incubated 10 minutes allowing the 
formation of streptavidin-biotin interaction (Figure 2.1b). Unbound streptavidin is 
washed out with T50 buffer (50 mM Tris-HCl, pH 7.5 and 50 mM NaCl). The annealed, 
biotinylated, fluorophore-labelled complex is diluted to 25 pM and then injected to the 
slide to immobilize via biotin-streptavidin interaction to generate a surface density of 
~0.1 molecules/µm2 and incubated 10 minutes (Figure 2.1b). Finally, 200 µl oxygen 
scavenging system (OSS) is injected and after several minutes the slide is ready for 
imaging.  
 
2.2.8: Prevention of photobleaching and blinking 
Two of the major limitations that occur in fluorescent based techniques are 
photobleaching and blinking. Oxygen molecules present in the solution can cause faster 
photobleaching of the fluorophores under the laser excitation. To obtain single-molecule 
movies for longer time without photobleaching of fluorophores, it is important to deplete 
the oxygen molecules present in the microfluidic chamber. An oxygen-scavenging 
system (OSS) plays an important role in single-molecule studies by removing oxygen. A 
solution mixture containing 5 mM Protocatechuic acid (PCA) and 0.1 µM 
Protocatechuate 3, 4-dioxygenase (PCD) is a commonly used OSS system in smFRET 
studies to diminish the oxygen level in the solution and reduce photo-bleaching234. 
Protocatechuate 3, 4-dioxygenase (PCD) is an enzyme, which uses 1 moles of oxygen 
to produce two moles of protons by converting 1 moles of PCA to β-carboxy-cis, cis-
muconic acid (Figure 2.3a).   
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The intersystem crossings of fluorophores from singlet state to triplet state (dark state) 
could result in short intermittencies in fluorescence emission, which is known as 
blinking. The time that fluorescence emission stays in the dark state can vary from 
microseconds to tens of milliseconds depending on the molecule. To quench the triplet 
state blinking, a saturated solution of Trolox (6-hydroxy-2,5,7,8-tetramethylchroman-2-
carboxylic acid, a vitamin E analogue, Figure 2.3b) is used to prepare all the imaging 
buffers solutions used in smFRET experiments. This also acts as an antibleaching 
reagent in the experiments.  Although the actual working mechanism of trolox has not 
been found, a study using a combination of an oxidizing and reducing system (ROXS) 
has shown that the antiblinking property of trolox is a result of quinoid derivatives of 
Trolox, which arise from the reaction with molecular oxygen.   
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Figure 2.3: Chemicals commonly use in smFRET to minimize photobleaching and 
blinking. (a) Chemical reaction for PCA/PCD system; a commonly use oxygen 
scavenging system (OSS) in smFRET studies, illustrating how PCD consumes oxygen 
molecules to convert PCA to β-carboxy-cis, cis-muconic acid. (b) Chemical structure of 
Trolox, a commonly use antiblinking agent.  
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2.2.9: Data acquisition and analysis 
The donor fluorophores are excited using a home-built prism-based, total internal 
reflection (TIRF) microscope and a 532 nm laser (3 mW, Spectra-Physics Excelsior) as 
described (Figure 2.1c)223.  An evanescent wave is created by reflecting incident laser 
beam completely, which will only excite the molecules in the environment near the 
surface (~100 nm)223,235. The excited signals were captured through a water immersion 
objective (60X) as single molecules. The Labview software was used to record the data 
with 33 ms exposure time. Resulting donor and acceptor emissions were separated 
using appropriate dichroic mirrors (610DCXR, Chroma) and recorded as two side-by-
side images on a back-illuminated electron-multiplied CCD camera (Andor I-Xon Ultra 
897). To match the signals from each half, a sample with bright fluorescent beads was 
used as a reference, which maps the corresponding spots in two channels. These 
smFRET data were then analysed as explained in previous studies215,223.  
First, for mapping the spots in two channels corresponding to the signal from donor 
and acceptor, a sample of fluorescent beads (0.2 µm modified red microsphere, 
Invitrogen, Carlsbad, CA) was immobilized and taken a short movie. Then the IDL 
software is used to map spots in two channels, which will then be used as a reference 
to analyse data from each single experiment (Figure 2.4a). Another IDL script is used to 
find the donor and acceptor molecules in each half based on the bead map. The 
individual donor (ID) and acceptor (IA) intensity time trajectories for each molecule were 
obtained by integrating their relative spot intensities. Then a home written MATLAB 
script is used to select real single molecules (Figure 2.4b). When picking up real 
molecules, there are few factors that need be considered such as continuous 
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fluorescence emission and single step photobleaching of both fluorophores and anti-
correlated relationship between donor and acceptor emission intensities. Next, the 
intensity traces are converted to the apparent FRET time trajectories using the 
equation; 
𝐸𝐹𝑅𝐸𝑇 =
1
1 + (
𝑅
𝑅0
)
6 
The resulting FRET time trajectories are time binned to obtain population distribution 
histograms for each RNA sample using IGOR program (Figure 2.4c and d). Each peak 
in the histogram represents different conformation of the RNA sample and their ratio, 
which illustrates the conformational dynamics of these samples. The corresponding 
FRET value indicates the distance between two fluorophores which in turn provides 
information regarding the conformation of the RNA sample used.  
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Figure 2.4: Single-molecule data analysis. (a) A side-by-side image recorded on 
CCD camera illustrating emission of donor and acceptor signals. (b) Image of MATLAB 
analysis program, illustrating intensity and FRET trajectory for corresponding molecule 
selected. (c) Redrawn images of intensity and FRET trajectories and (d) corresponding 
distribution histogram obtained using IGOR program.  
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2.3: Methods: Elucidating the role of Prp24 in U2 and U6 snRNP recycling 
2. 3.1: Sample preparation  
RNA samples for single-molecule experiments were purchased from the Keck 
Foundation Resource Laboratory at the Yale University School of Medicine. U6 was 
ordered with a 5’-Cy3, an internal amino C6 dT and 3’ – biotin (U6; Table 2.3). U2 was 
ordered with or without 3’ – C7 amino linker (U2 and U2-cy5, respectively; Table 2.2). 
All the Protein samples (full length and truncated Prp24) were obtained from the 
Butcher’s lab in University of Wisconsin-Madison. Protein samples came in the storage 
buffer containing 50% glycerol, 25mM Tris, 125 mM NaCl, 1.25 mM DTT and 0.2 mM 
EDTA. 
2.3.2: Sample purification and fluorophore labeling 
The 2’-hydroxyl protective groups were removed and the RNAs were purified as 
described earlier (Section 2.2.5).215,232 The C6 amino linker in U6 and C7 amino linker in 
U2-cy5 were labelled with Cy5 (GE Healthcare) as described earlier (Section 2.2.6).   
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Table 2.3: RNA sequences used in this study 
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2.3.3: MALDI-MS experiments 
Matrix-assisted laser desorption ionization-mass spectrometry was carried out to 
confirm the position of the modified nucleotide used for cy5 labelling in U6 RNA as 
described.236 The U6 RNA (300 pmol) were RNase T1 (~100 units) digested for 15 
minutes in order to produce smaller fragments. The molecular weights of the fragments 
were calculated by using the Mongo Oligo Mass Calculator v2.06. After RNase T1 
digestion, the reaction was stopped in dry-ice, dried and dissolved in 1ul of distilled 
water. 1 ul of MALDI matrix (3-hydroxypicolinic acid (HPA) in 50% acetonitrile), 0.5 µl of 
100 mM ammonium citrate and 1µl of RNA sample were mixed on the MALDI plate in 
the given order. The spot was dried for about 30min and used in MALDI experiment. 
Representative spectrum for Cy3-U6 with internal amino linker sample is shown in 
Figure 2.5. The fragment that appears at 2654.716 is the fragment with the modified 
nucleotide used for Cy5 labelling in U6. In addition to the fragment with the modified 
nucleotide, all the other digested fragments were also observed within a reasonable 
error (Table 2.4).  
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Table 2.4: The expected and observed masses from MALDI-MS experiments for the 
RNaseT1 digested U6 RNA.  All the masses are observed within a 5% error. * Not 
observed.  
 
 
 
Figure 2.5: MALDI result reveals the mass of the fragment that is used for Cy5 
labelling in U6.The peak at 2654.716 is corresponding to the fragment containing 
the modified nucleotide for Cy5 labelling in U6. The other two peaks at 1963.249 
and 2391.170 are two of other fragments resulting from RNase T1 digestion. 
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2.3.3: Fluorescence electrophoresis mobility shift assay (EMSA) 
U2/U6 complex was made by mixing U2 (4 µM)/ U6 (2 µM) or U2-cy5 (2 µM)/U6-cy3 (2 
µM) in buffer (50 mM Tris-Cl, pH 7.5, 100 mM NaCl, 10 mM MgCl2) and heating at 94 
°C for 45 s, followed by 20 min incubation at room temperature for annealing. Prp24 (full 
length and truncated-first RRM is removed, denoted as 234C; 4 µM each) was added 
and incubated for ~10 min. After incubation, an equal volume of 40% glycerol was 
added to the reaction mixture. Non-denaturing (29:1 acrylamide:bisacrylamide ratio, 
15%) gel electrophoresis was performed in 50 mM Tris-acetate, pH 7.5, 100 mM 
sodium acetate, 10 mM magnesium acetate, and 5 mM DTT at 4 °C for >18 hrs at 100 
V. The gel was scanned using a Typhoon 9210 Variable Model Imager (GE Healthcare) 
and analyzed with ImageQuant software (Amersham Bioscience). 
 
2.3.4: Fluorescence anisotropy experiments 
Anisotropy experiments were carried out using a spectrofluorometer with automated 
polarizers (Varian, Carry Eclipse). The U6 RNA with 5’ fluorescein (U6-Fl, 25 nM, Table 
2.3) and U2 RNA (50 nM) were mixed in a standard buffer (50 mM Tris-HCl, pH 7.5, 100 
mM NaCl, and 10 mM MgCl2) and heated at 94 °C for 45 s and then annealed at room 
temperature for 20 min. Anisotropy was measured for Prp24 concentrations of 0 to 1 
µM. Fluorescein was excited at 490 nm (5 nm bandwidth), and parallel (𝐼ǁ) and 
perpendicular (𝐼⊥)  emission intensities were measured at 520 nm (5 nm bandwidth).  
The resulting anisotropy values were plot into a binding curve as a function of Prp24 
concentration and the data was fitted into quadratic equation to obtain the dissociation 
constant (KD) for Prp24 binding.  
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𝑓(𝑃𝑟𝑝24) =  𝑟𝑂 + (𝑟𝑚𝑎𝑥 − 𝑟𝑂) [
𝐾𝐷 + [𝑅𝑁𝐴𝑂] + [𝑃𝑟𝑝24] − √(𝐾𝐷 + [𝑅𝑁𝐴𝑂] + [𝑃𝑟𝑝24])2 − 4[𝑅𝑁𝐴𝑂][𝑃𝑟𝑝24]
(2 ∗ 𝑅𝑁𝐴𝑂)
] 
 
 
In the equation above, ro is lowest anisotropy value, rmax is highest anisotropy value, 
[Prp24] is the corresponding protein concentration, [RNA] is the concentration of U6-fl 
used and KD is the dissociation constant. 
 
2.3.5: Single molecule study 
2.3.5.1: Sample immobilization 
Single molecule experiments were performed as described.232, 223 Two RNA strands (2 
µM U6 and 4 µM U2) in standard buffer (50 mM Tris.HCl, pH 7.4, 100 mM NaCl, and 10 
mM MgCl2) were heated at 94 °C for 45 s and annealed by cooling to room temperature 
over 20 min. The annealed, biotinylated, fluorophore-labelled complex was then diluted 
to 25 pM and immobilized on a PEGylated surface of Quartz slides via a biotin-
streptavidin interaction.  
In concentration-based experiments, the measurements were obtained under 
variable Protein concentrations (0 – 100 nM full length and truncated Prp24, 234C) at 
room temperature in the presence of OSS solution.   
In time-dependent experiments, cy3-U6 (2 µM) and U2-cy5 RNA (2 µM) strands 
(Table 2.2) were used and samples were prepared as described earlier. The 
measurements were done every five minutes and histograms were drawn for each time 
point. Data acquisition is carried out similarly as explained in previous section.  
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2.3.5.2: Data analysis 
In concentration-based experiments resulting time trajectories were separated based on 
the FRET value and time binned to draw FRET histograms, which represent the 
frequency of the population at a particular FRET value. A cut off FRET value of 0.3 was 
used to distinguish between high and low FRET conformations. To determine 
dissociation constant (KD) values for binding of full length Prp24 and truncated proteins; 
the fraction of molecules with low FRET state was plotted as a function of the 
concentration of protein and fitted to a modified Hill equation: 
 
𝑓(𝑃𝑟𝑝24) =  𝑓0 + (𝑓𝑚𝑎𝑥 − 𝑓0)
[𝑃𝑟𝑝24]𝑛
𝐾𝐷
𝑛 + [𝑃𝑟𝑝24]𝑛
 
 
in which f0 is the initial fraction of molecules at  low FRET state, fmax is the final fraction 
of molecules at low FRET state, n is the Hill coefficient, KD is the dissociation constant 
and [Prp24] is the concentration of protein . 
In time-dependent experiments, a cut off FRET value of 0.14 was used to distinguish 
the FRET states corresponding to the conformations with and without U2. To determine 
the rate constant (Kobs) for dissociation of U2, the fraction of molecules with zero FRET 
state was plotted as a function of time and fitted to an exponential fit. 
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2.4: Methods- Study the assembly and global structure of U4/U6 complex 
2. 4.1: EMSA 
2.4.1.1: U4/U6 duplex formation 
For substoichiometric electrophoretic mobility shift assays, in-vitro transcribed, 
fluorescein labelled U4 snRNA was mixed with unlabelled U6 snRNA (Table 2.3) to a 
final concentration of 1 μM  and 2 μM respectively in 10 mM K-HEPES (pH 7.5), 100 
mM KCl.  The mixture was heated to 90 °C and slow-cooled to 4 °C at -0.03 °C/s.  The 
RNA duplex was then gel purified on a native gel at 4 °C, band excised, RNA eluted by 
the “crush and soak” method into 10 mM K-HEPES (pH 7.5), 100 mM KCl, and 
concentrated in an ultra-centrifugation filtration device (Amicon).   
 
2.4.1.2: Substoichiometric assembly analysis 
Direct binding EMSA experiments were performed with samples containing 2 nM 
fluorescein labelled RNA and protein typically within the range ∼0.3 pM to 2.5 μM in an 
EMSA sample buffer consisting of 10 mM K-HEPES (pH 7.5), 100 mM KCl, 0.01% NP-
40, 20 μg E. coli tRNA in a volume of 100 μL.  For step-wise assembly (Table 1) protein 
concentrations for pre-assembled components were Snu13 (200 nM), Prp31 (120 nM), 
Sm proteins (64 nM) and LSm proteins (240 nM). Reactions were allowed to equilibrate 
on ice for 60 min before loading on native polyacrylamide gels (4% at 37.5:1 
acrylamide:bis-acrylamide) run in 0.5x TBE buffer at 4 °C. Gels were imaged on a 
Typhoon variable-mode scanner and the signals in the gel bands corresponding to 
protein bound and unbound RNA were integrated. Parameters in the following function 
were fit to the data for fraction of RNA bound versus protein concentration: 
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𝜃 = [
𝑎 − 𝑏
1 + (
𝐾𝑑
[𝑝𝑟𝑜𝑡𝑒𝑖𝑛]
)
𝑛] +  𝑏 
 
where θ is fraction bound, Kd is the apparent dissociation constant, a is the upper 
baseline and b is the lower baseline, and n is the Hill coefficient. At least two gel shifts 
were performed for each sample and associated error is reported as one standard 
deviation from the mean (Table 4.1).   The shifts in Table 1 are for entirely wild-type 
components with the exception of the LSm complex wherein LSm 4 was truncated 
(amino acids 1-114) so as to remove the C-terminal region absent from the human 
homolog and predicted to be disordered (DISOPRED) and a truncated Sm complex was 
used (SmB 1-105).   
Concentrations used in figures are as follows: Supplementary Figure 2a had U4 (4 nM), 
U6 (4 nM), U4/U6 snRNA duplex (4 nM), Snu13 (200 nM), Prp31 (120 nM), and the shift 
with LSm was conducted with 2-fold dilutions and a maximum concentration of 1 μM.  
Supplementary Figure 2b had H46 hybrid RNA (10 nM), Snu13 (100 nM), Prp31 (150 
nM) and the shift with LSm was conducted with 2-fold dilutions and a maximum 
concentration of 500 nM.  Figure 1b had U4 (4 nM), U6 (4 nM), U4/U6 snRNA duplex (4 
nM), Snu13 (180 nM), Prp31 (120 nM), Sm proteins (64 nM), LSm proteins (240 nM), 
and Prp3/4 (500 nM).   
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2.4.2: Single-molecule assay 
2.4.2.1: Sample preparation 
Three U6 RNA strands and one U4 RNA strand were utilized for the single-molecule 
experiments to study the orientation of three helices (Table 2.3). The U4 and U6-II 
strands were purchased from Dharmacon, whereas U6-I and U6-III strands were 
purchased by Keck Foundation Resource Laboratory at the Yale University School of 
Medicine (Table 2.3). 
 
2.4.2.2: Sample purification and fluorophore labelling 
The 2’-hydroxyl protective groups were removed and the RNAs were purified as 
described (section 2.2.5). The C6 amino linker in U6-II was labelled with Cy3 (GE 
Healthcare) and the C6 amino linker in U6-III was labelled with Cy5 (GE Healthcare) as 
described earlier (section 2.2.6). Also, a sample of Prp31 was modified for cy5 labelling. 
The naturally occurring cysteine residues within the Prp31 were removed and new 
cysteine residue was introduced. Then the protein was labelled with cy5 as explained 
(section 2.2.6). 
 
2.4.2.3: Sample immobilization 
Single molecule experiments were performed as described223,232. Two RNA strands (2 
µM U4 and 2 µM U6-I, U6-II or U6-III) in standard buffer (10 mM Tris.HCl, pH 7.4, 100 
mM NaCl) were heated at 94 °C for 45 s and annealed by cooling to room temperature 
over 20 min. The annealed, biotinylated, fluorophore-labelled complex was then diluted 
to 10 pM and immobilized on a quartz slide via a biotin-streptavidin interaction. In 
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protein binding experiments, the measurements were obtained in the presence of 
Snu13, Prp31 or Prp3/4.  
In single molecule experiments using labelled Prp31, unlabeled U4, cy3 labelled U6 
and cy5 labelled Prp31 were used. Two RNA strands (unlabelled U4, 2 µM and cy3 
labelled U6, 2 µM) in standard buffer (10 mM Tris-HCl, pH 7.4, 100 mM NaCl) were 
heated at 94 °C for 45 s and annealed by cooling to room temperature over 20 min. The 
annealed, complex was then diluted to 10 pM and immobilized on a quartz slide via a 
biotin-streptavidin interaction. Then cy5 labelled Prp31 in the presence of Snu13 and 
Prp3/4 is injected along with oxygen-scavenging system (OSS) in standard buffer. 
Before imaging excess cy5-labelled Prp31 protein was washed with the standard buffer. 
The sample was first imaged through 532nm (Green) laser for ~ 2-3 minutes. Then 
switch the laser to 637nm (red) and imaged for another ~2min, followed by imaging 
again with 532nm (green) laser for 2 min.  Similar experiment was carried out with 
unlabelled Prp31 as a control. Data acquisition is carried out similarly as explained in 
previous section.  
 
2.4.2.4: data analysis 
In this study, the resulting time trajectories; RNA alone and in the presence of proteins 
were separated based on the FRET value and time binned to draw FRET histograms, 
which represent the frequency of the population at a particular FRET value. Average 
FRET values for each population were determined by fitting the histograms to 
Gaussians. These values then used to fit the peaks in overall histograms which 
combine all the single molecule trajectories of each RNA complex. Percentage of each 
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population is calculated by collecting all individual molecules at each population as a 
fraction of total number of molecules. The percentage of population 1 under different 
conditions (RNA alone, with different proteins) was then illustrated as a bar graph.  
 
2.5: Methods-Minor spliceosome 
2.5.1: Sample preparation 
RNA samples for single-molecule experiments were purchased from the Keck 
Foundation Resource Laboratory at the Yale University School of Medicine. U6atac was 
ordered with a 5’-Cy3, an internal amino C6 dT and 3’ – biotin (U6atac; Table2.3). U12 
was ordered without any modification (Table 2.3). 
 
2.5.2: Sample purification and fluorophore labelling 
The 2’-hydroxyl protective groups were removed and the RNAs were purified as 
described (section 2.2.5).  The C6 amino linker in U6atac was labelled with Cy5 (GE 
Healthcare) and purified using HPLC (section 2.2.6). 
 
2.5.3: Single-molecule study 
2.5.3.1: Sample immobilization 
U6atac RNA strand was diluted to 25pM in standard buffer (50 mM Tris.HCl, pH 7.4, 
100 mM Sodium chloride, and 10 mM Magnesium chloride) and heated at 94 °C for 1.5 
min before flash cooling on ice. This flash cooling was done to avoid homodimerization. 
The U6atac RNA was then immobilized to the quartz slides via a biotin-streptavidin 
interaction and then U12 RNA in standard buffer was introduced to the slide.  
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In concentration-based experiments with U12, the measurements were obtained 
under variable U12 concentrations (0 – 50 nM). In the studies with varying Mg2+, the 
standard buffer was made by adding corresponding Mg2+ (0 - 50nM) concentration.  
Data acquisition is carried out similarly as explained in previous section.  
2.5.3.2: Data analysis 
In this study, the resulting time trajectories were separated based on the FRET value 
and time binned to draw FRET histograms, which represent the frequency of the 
population at a particular FRET value. Average FRET value was determined by fitting 
the histograms to Gaussians, which is 0.2 FRET.  
To determine dissociation constant (KD) values for binding of U12; the fraction of 
molecules with 0.2 FRET state was plotted as a function of the concentration of U12 
and fitted to a modified Hill equation: 
𝑓(𝑈12) =  𝑓0 + (𝑓𝑚𝑎𝑥 − 𝑓0)
[𝑈12]𝑛
𝐾𝐷
𝑛 + [𝑈12]𝑛
 
 
in which f0 is the initial fraction of molecules at  0.2 FRET state, fmax is the final fraction 
of molecules at 0.2 FRET state, n is the Hill coefficient, KD is the dissociation constant 
and [U12] is the concentration of U12 . 
In Mg2+ titration, KMg is obtained in a similar way as explained in previous paragraph, 
where the fraction of molecules stay at 0.2 FRET has plotted against the concentration 
of Mg2+ ions, and fitted to the modified hill equation; 
𝑓(𝑀𝑔2+) =  𝑓0 + (𝑓𝑚𝑎𝑥 − 𝑓0)
[𝑀𝑔2+]𝑛
𝐾𝑀𝑔
𝑛 + [𝑀𝑔2+]𝑛
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in which f0 is the initial fraction of molecules at  0.2 FRET state, fmax is the final fraction 
of molecules at 0.2 FRET state, n is the Hill coefficient, KMg is the dissociation constant 
for Mg and [Mg2+] is the concentration of Mg2+.  
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CHAPTER 3: Elucidating the role of Prp24 in U2 and U6 snRNP 
recycling 
 
3.1: Objective 
The objective of specific aim 1 is to understand how snRNP complexes dissociate from 
each other after the completion of splicing and what are the factors involved in this 
process. To address these questions, I selected to study the role of Prp24 on the 
dissociation of U2/U6. 
U6 snRNP associated chaperon Prp24 has been studied by many groups and it was 
determined to function as a recycling factor.  Prp24 is also found to be involved in 
U4/U6 complex association and proposed involvement in U4/U6 unwinding prior to the 
spliceosomal activation102,164,192,197,206. Considering the tight association of Prp24 with 
U6 and its role as a recycling factor, I hypothesize that after catalysis, Prp24 may 
facilitate the dissociation of U2/U6 complex allowing U2 and U6 to participate in another 
round of splicing. Hence the main objective of this study is to determine the role of 
Prp24 in unwinding U2/U6 complex.  
To address this, I employed Fluorescence based techniques including, 
electrophoretic mobility shift assay (EMSA), anisotropy, and sm-FRET. The EMSA and 
anisotropy data reveal the binding of Prp24 to the U2/U6 complex. The sm-FRET data 
show that the binding of Prp24 affects the conformational changes of the U2/U6 
complex and stabilizes a low FRET conformation. Furthermore, EMSA and sm-FRET 
data show that the binding of Prp24 facilitates the removal of U2 from U6, revealing its 
role in U2/U6 unwinding. Moreover, the removal of Prp24 RRM1 has shown a lesser 
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effect on the stabilization of low FRET conformation and the removal of U2, suggesting 
its requirement for a high affinity binding. 
 
3.2: Experimental design 
Throughout this study, I have used a minimal U6 strand (nucleotides from 45-104) and a 
minimal U2 strand (nucleotides from 1-44), which together catalyze both steps of 
splicing237. These two strands were heated to 94oC for 45 s and annealed for ~20 min in 
the reaction buffer to form the duplex which is denoted in the thesis as ‘U2/U6 complex’, 
unless otherwise stated (Table 2.3, Figure 1.18a, b). Alternative labelling of U6 and U2 
strands were used for different experiments. For the anisotropy experiments U6 was 
labelled with fluorescein (yellow) at the 5’ end and U2 was not labelled (Figure 3.1a), 
this labelling strategy results in higher anisotropy upon binding with protein. For the 
single-molecule studies and EMSA studies, doubly labelled U6 was used containing cy3 
(blue) and cy5 (red) at the 5’ end and near ISL loop (U70) respectively (Figure 3.1b). 
The 3’ end of U6 was attached with biotin-BSA (orange) for surface immobilization. For 
the unlabelled U2 strand annealed opposite a labelled U6 strand, different FRET states 
were observed based on the conformational changes within the U2/U6 complex. For 
experiments with U6 labelled with cy3 at the 5’ end and U2 labelled with cy5 at the 3’ 
end a high FRET (1.0) state is expected for the U2/U6 complex formation and a low or 
zero FRET state upon U2 removal (Figure 3.1c). Two proteins were used in this study 
namely, a full length Prp24 and a truncated Prp24; where RRM1 and the N-terminus 
were removed (denoted in the thesis as ‘Prp24’ and ‘234C’ respectively, unless 
otherwise stated, Figure 3.1d).  
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Figure 3.1: Schematic representation of RNA strands and proteins used in this 
study. (a) U2/U6 complex used in the fluorescence anisotropy study, where U6 is 
labelled with fluorescein (yellow)  at the 5’ end and U2 is unlabelled. (b) U2/U6 complex 
used in the first part of the study, where U6 is labelled with cy3 (blue) at the 5’ end, cy5 
(red) around ISL loop and biotin (orange) at the 3’ end. U2 is unlabelled. (c) U2/U6 
complex used in the second part of the study, where U6 is labelled with cy3 at the 5’ 
end and biotin at the 3’ end. U2 is labelled with cy5 at the 3’ end. In (a), (b) and (c) U6 
snRNA strand is in purple and U2 snRNA strand is in blue colour.  (d) Two proteins 
used; full length Prp24 (Prp24, upper) and a truncated Prp24 where first RRM and the 
N-terminus region have been removed (234C, bottom).  
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3.3: Results 
3.3.1: EMSA and anisotropy measurements reveal binding of Prp24 with the 
U2/U6 complex  
To characterize binding of Prp24 to U2/U6 complex, I have first used EMSA by 
incubating Proteins (Prp24 and 234C, 4 µM each) with preformed U2 (4µM)/U6 (2 µM) 
complex with doubly labelled U6 (Figure 3.2a).  Figure 3.2a, lane 1 has U6 only, 
represented by the high intensity band. The low intensity band, migrating slower than 
the main band in lane 1, may correspond to randomly folded U6, given that it was not 
observed in a denaturing gel. The shift in the band in the second lane corresponds to 
formation of the U2/U6 complex. The slow migrating band in the 3rd lane corresponds to 
Prp24 binding with U2/U6 complex. Interestingly, the band corresponding to the protein-
RNA complex seems to have a lower FRET state (yellow) compare to the U2/U6 
complex (orange), suggesting that Prp24 binding induces a rearrangement in the U2/U6 
complex, resulting in a low FRET value. The 4th lane has a very faint band that 
corresponds to the protein-RNA complex, suggesting that the binding of truncated 
protein 234C is decreased in comparison to that of the full-length protein, in agreement 
with the previously published data206. In the 3rd and 4th lanes, some of the samples were 
retained in the wells, which could be due to formation of higher order complexes with 
RNA and proteins. 
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Figure 3.2: Prp24 binds to U2/U6 complex. (a) Gel-shift assay with Prp24 (full length 
and truncated; 234C, 4 µM each) and the pre-formed U2 (4 µM) /U6(2 µM) complex in 
which U6 is labelled with both cy3 and cy5 . Gel was scanned by exciting with 532 nm 
and 635 nm lasers to detect Cy3-U6 and Cy5-U4, respectively. Resulting image is an 
overlay of both channels.  Lane 1: U6 only, Lane 2: U2/U6 complex, Lane 3: U2/U6 with 
Prp24, Lane 4: U2/U6 with 234C. (b) Fluorescence anisotropy experiment with pre-
formed U2 (50 nM)/U6 (25 nM) complex at different Prp24 concentrations. Anisotropy 
data was plotted against Prp24 concentration and fitted to a quadratic binding equation. 
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For further characterization of Prp24 binding to the U2/U6 complex, fluorescence 
anisotropy experiments was performed. For these studies, a pre-formed U2 (50 nM)/U6 
(25 nM) complex were utilized, in which the 5’ end of U6 was labelled with a fluorescein 
dye. A relatively low anisotropy value (r= 0.087, Figure 3.2b) was obtained for the 
U2/U6 complex under standard conditions (50mM Tris-HCl, pH 7.5, 100mM NaCl, 
10mM MgCl2). In the presence of Prp24, the anisotropy value was increased, indicating 
the binding of protein to the complex, as a result of the hindrance of free rotation of the 
fluorescein dye attached to the U6 strand. This result demonstrates that the anisotropy 
value has gradually increased with increasing concentration of Prp24 and saturated 
nearly 1µM (anisotropy value of ~ 0.26), yielding a dissociation constant (KD) of 42 ± 6 
nM (Figure 3.2b). Since, in fluorescence-anisotropy experiments RNA concentration is 
limited (at least 25nM fluorescein-labelled RNA needs to be used for a better signal), 
the result in binding affinity is not the actual but an apparent value. The apparent KD 
value obtained from the anisotropy experiments is in accordance with the previously 
published gel shift data with an apparent KD value of 43 ± 11 nM206.  
 
3.3.2: Binding of Prp24 affects the structural dynamics of U2/U6 complex 
To determine the influence of Prp24 binding on the conformational dynamics of the 
U2/U6 complex, sm-FRET experiments were done in the absence and presence of 
Prp24. Preformed U2/U6 complexes were diluted and then immobilized on a quartz 
slide and correspondingly the protein was introduced. The sample was then excited 
using a 532 nm laser and the resulting intensities were captured through the objective 
and detected through a CCD camera (Figure 3.3a). The data shows that the U2/U6 
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complex has different conformations as three colours of dots; green, yellow and red, 
represented in the single molecule image (Figure 3.3b). The resulting trajectories and 
the corresponding histograms (Figure 3.3c,d and e) illustrate that the U2/U6 complex 
adopts three different FRET populations; 0.2, 0.4 and 0.6, similar to a previous study 
done by our lab, which proposed that U2/U6 is in a dynamic equilibrium with at least 
three distinct conformations (Figure 1.17)185. 
In order to compare the results I obtained with the previous study, single molecule 
experiments were performed using the construct used in the previous study, where the 
U6 ISL loop is removed (named as three-piece construct; Figure 3.3f). With this 
construct, I have observed three interchanging FRET populations (Figure 3.3g) 
consistent with the previous study with a similar construct and with the construct 
containing the ISL loop, validating that the presence of ISL loop has no effect on the 
dynamic nature of the complex observed185. 
In the presence of 100nM Prp24, mostly green dots appeared in the single molecule 
image (Figure3.4a), suggesting that the Prp24-bound U2/U6 complex adopts a single 
conformation compared to the three dynamic FRET states observed for RNA alone. 
However, the resulting FRET trajectories and the histograms show that the Prp24-
bound U2/U6 complex has two static FRET populations; 0.2 and 0.4 (Figure 3.4b and 
c). Upon analysis of the total number of molecules in the presence of 100nM Prp24 
(n=156), a majority of the molecules were in the static 0.2 state (~85%), indicating that 
the binding of Prp24 affects the structural dynamics of U2/U6 complex (Figure 3.4b).  
Only about 15% of the molecules were in the static 0.4 state, suggesting that this minor 
population can be a misfolded population.   
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Figure 3.3: U2/U6 adopts three distinct conformations. (a) Single molecule 
experimental setup for U2/U6 complex. The U2/U6 complex is immobilized on quartz 
slide via streptavidin-biotin interactions. Donor molecules (cy3, blue) are excited by a 
532 nm laser and energy transfer from the donor to the acceptor (cy5, red) molecules 
are measured and corresponding FRET values are calculated.  (b) Single-molecule 
movie obtained for the U2/U6 RNA duplex alone, showing that the molecules adopt 
three colours; green, orange and red. (c) Intensity and (d) FRET time trajectories and 
(e) the corresponding histogram for the RNA duplex alone showing three interchanging 
FRET states naming 0.2, 0.4 and 0.6. (f) The RNA construct used in the previous study 
where the U6 ISL loop was removed and (g) resulting histogram for the single-molecule 
experiment using the three-piece construct (U6-1, U6-2 and U2) indicating that U6 ISL 
loop has no effect on the dynamic nature of U2/U6 complex. U2 and U6 are colour 
coded as same as previous. 
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Figure 3.4: Binding of Prp24 affect the dynamic nature of the U2/U6 complex. (a) A 
single-molecule movie obtained in the presence of 100nM Prp24, showing majority of 
the molecules are green in colour. (b) Single-molecule FRET time trajectories and (c) 
the corresponding histogram in the presence of Prp24 showing two static populations; 
0.2 and 0.4. Binding of Prp24 has shifted the dynamic population to a static population, 
revealing a conformational change in the U2/U6 complex. Histograms for the single-
molecule control experiments with (d) 100nM PTB and (e) 100nM Mss116 proteins 
reveal that conformational change in U2/U6 is specific for Prp24.  
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In order to confirm that the binding and stabilizing low FRET state of U2/U6 complex 
is Prp24-specific, single-molecule FRET experiments with PTB (polypyrimidine tract 
binding) protein and Mss116 at 100 nM concentrations were done. PTB protein is a 
RNA binding protein with RNA recognition motifs similar to the Prp24192, whereas, 
Mss116 is an ATP-dependent RNA helicase, which unwinds RNA helices238. 
Interestingly, resulting histograms (Figure 3.4d, e) show that there is no change in the 
FRET populations even at a higher concentration of both PTB and Mss116. This 
suggests that the stabilization of low FRET state is corresponding to Prp24-specific 
conformational changes in the U2/U6 complex.  
 
3.3.3: Effect of RRMs on Prp24 binding with U2/U6 complex 
To characterize the effect of Prp24 binding on the dynamic nature of U2/U6, single-
molecule experiments at various concentrations of Prp24 and 234C were performed206. 
As shown in the histogram (Figure 3.5a, top), in the absence of Prp24, molecules were 
dynamic between three FRET states (0.2, 0.4 and 0.6). On the other hand, with 
increasing concentrations of Prp24, molecules tended to stay in the 0.2 FRET state 
compare to the other two states. Also at 5nM or higher concentrations, more molecules 
were present at a static 0.2 state, suggesting that binding of Prp24 stabilizes a low 
FRET conformation of the duplex (Figure 3.5a). Moreover, the 0.6 FRET population 
decreased upon the increase in Prp24 concentration, whereas at concentration above 5 
nM it has completely disappeared (Figure 3.5a).   
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Figure 3.5: Prp24 binding to U2/U6 stabilizes a low FRET (0.2) conformation. (a) 
Effect of Prp24 on the conformational dynamics of U2/U6. Each panel corresponds to 
an average smFRET histogram from >100 single-molecule trajectories at the indicated 
full-length protein concentrations. The fraction of molecules in the 0.2 FRET state at 
each protein concentration was calculated and demonstrated as a percentage. (b) The 
fraction of molecules in the 0.2 FRET state is plotted against Prp24 concentrations and 
fitted to a Langmuir equation to yield the KD for the protein binding.  
157 
Although the 0.4 population has also decreased with the increasing concentration of 
Prp24, a minor fraction of molecules (~15%) showed a static 0.4 FRET state even at 
100nM of Prp24. The fraction of molecules remaining at 0.2 FRET state was then 
plotted against Prp24 concentration to determine the binding affinity of Prp24 to the 
U2/U6 complex (Figure 3.5b). This clearly shows that increases in Prp24 concentration 
leads to an increase in the 0.2 population, which eventually reaches a plateau around 5 
nM of Prp24 and yields a KD of ~0.2 nM.  This indicates a tight binding of Prp24 with 
U2/U6 and stabilizing a conformation that corresponds to a FRET of 0.2. This could be 
a conformation that contains either U2/U6 or U6 only. Further experiments were done to 
determine whether binding of Prp24 unwinds U2 or not as explained in later section. 
Previous studies have shown that the first RNA recognition motif of Prp24 is important 
for the high affinity binding of the protein with U6206. To characterize the function of 
RRM1 in Prp24 binding and its effect on U2/U6 unwinding by Prp24, I have done single-
molecule experiments using 234C protein in which the RRM1 was truncated. 
Experiments were done in the presence of different concentrations of 234C, where an 
increase in the 0.2 FRET state was observed with increasing concentrations of the 
234C protein. However, the increase in the 0.2 population in the presence of 234C is 
comparatively lower than that of Prp24, where even at 100nM 234C concentration only 
~58% of molecules were found to be in 0.2 FRET state (Figure 3.6a). Binding curve 
drawn with the fraction of molecules stay at 0.2 FRET state as a function of 234C 
concentration yields a KD of ~0.4nM, which is a two fold increase than that of Prp24 
(Figure 3.6b). This suggests that RRM1 is important for high affinity binding of Prp24 
with U2/U6 complex and thus removal of RRM1 has lesser effect on the protein binding 
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to the complex, which in turn lowers the effect on stabilization of low FRET 
conformation.  
 
3.3.4: Binding of Prp24 facilitates the unwinding of U2 
Once Prp24 unwinds the U2/U6 duplex it could remain bound to U6. This bound U6-
Prp24 complex can form a different conformation compared to that of the U2/U6 
complex. This new conformation of U6 may correspond to the 0.2 FRET population 
observed with higher concentrations of Prp24.  To determine whether the Prp24 
facilitates the removal of U2 and stabilizes a U6 conformation by remaining bound to it, 
EMSA studies followed by single-molecule experiments were done. For this set of 
experiments, the same U2/U6 construct was used, however with a different labelling 
pattern, where U6 is labelled with cy3 and U2 is labelled with cy5 (Figure 3.1c). In the 
resulting EMSA gel, the green and red bands in lane 1 and 2 correspond to U6 and U2 
RNA respectively.  The shifted band in the lane 3 corresponds to the U2/U6 complex 
(Figure 3.7a). Based on the labelling pattern, the reddish colour of the shifted band in 
lane 3 represents a higher FRET state, which indicates the formation of U2/U6 complex. 
The slow migrating band in lane 4 corresponds to the binding of Prp24. Interestingly, an 
increase in free U2 can be seen in the lane 4 compared to lane 3 containing U2/U6 
duplex, suggesting that the binding of Prp24 has resulted in removal of U2 from the 
complex. Hence, the slow migrating green band in lane 4 possibly corresponds to the 
free U6 (labelled with cy3), after the removal of U2 strand. Altogether, these results 
suggest that the 0.2 FRET population observed in the previous set of experiments 
results from the formation of a U6 conformation upon U2 removal. The very faint band in 
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the 5th lane containing the truncated protein (234C), corresponds to the RNA-protein 
complex, illustrating that the removal of RRM1 causes a lesser effect on the U2 removal 
compared to the full length protein.  
To determine the role of Prp24 in U2/U6 unwinding, single-molecule flow 
experiments were performed, in which Prp24 was introduced to the slide in real time. In 
this experiment, a single-molecule movie was taken for a few minutes in the absence of 
Prp24 and then Prp24 was introduced while the movie was recording. The resulting 
FRET trajectory shows that in the absence of Prp24, the molecule stayed in the high 
FRET state (FRET = 1.0), whereas, upon addition of 50nM Prp24, the FRET state 
changed from one to zero via an intermediate state of 0.2 (Figure 3.7b). In order to 
validate this result, a control experiment was done by introducing the buffer solution 
without Prp24.  The resulting trace shows that the molecules remain at a higher FRET 
state, even after the buffer flow was introduced (Figure 3.5c). This suggests that the 
observed zero FRET state correspond to the U2 dissociation upon binding of Prp24. 
The short lived 0.2 FRET state may corresponds to an intermediate conformation with 
partially unwound U2/U6 complex. Characterization of this intermediate has shown that 
~ 15% of total molecules are going through the 0.2 FRET state during the transition 
from high FRET to zero FRET, with an average life time of 14s. 
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Figure 3.6: Removal of RRM1 affects the binding of Prp24 to the U2/U6 complex. 
(a) Effect of 234C on the conformational dynamics of U2/U6. Each panel corresponds to 
an average smFRET histogram from >100 single-molecule trajectories at the indicated 
full-length protein concentrations. (b) The fraction of molecules in the 0.2 FRET state is 
plotted against 234C concentrations and fitted to a Langmuir equation to yield the KD for 
the protein binding.  
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Figure 3.7: Prp24 facilitates the U2/U6 unwinding. (a) EMSA with Prp24 (full length 
and truncated; 234C, 4µM each) and pre-formed U2 (2µM)/U6 (2µM) complex, in which 
the U2 is labelled with cy5 and U6 with cy3. Gel was scanned by exciting with 532 nm 
and 635 nm lasers to detect Cy3 and Cy5, respectively. Resulting image is an overlay of 
both channels. In the image each lane contains; lane 1: U6-cy3, lane 2: U2-cy5, lane 3: 
U2/U6 complex, lane 4: U2/U6 with Prp24, lane 5: U2/U6 with 234C.  Characteristic 
FRET trajectories for single-molecule flow experiment (b) with Prp24 and (c) without 
Prp24, illustrating the introduction of Prp24 results in a FRET change from one to zero 
through an intermediate at 0.2, as a result of U2 removal.  
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Next, single-molecule time dependent experiments were done at different 
concentrations of Prp24 and 234C to verify the zero FRET state observed. Upon 
addition of 1nM Prp24, the zero FRET population was increased over time and at 45 
min ~99% molecules were in zero FRET state (Figure 3.8a). Whereas, in the presence 
of 234C, the zero FRET population was relatively low (Figure 3.8b). As a control, similar 
sets of experiments were done with the RNA complex without protein. The observed 
zero FRET state in the absence of Protein represent the fluorophore photobleaching 
(Figure 3.8c).  Each time point was corrected for photobleaching by considering the 
difference between two zero FRET fractions; in the absence and in the presence of 
Prp24. The corrected value corresponds to the actual change in the zero FRET 
population as a result of U2 removal upon Prp24 binding.  These data were then fitted 
to a mono-exponential function, indicating that the zero FRET population was increased 
over time and saturated nearly 25 minutes, yielding a U2 removal rate (kobs) of ~ 0.15 
min-1 (Figure 3.9a). Similar experiments were done in the presence of 1nM 234C, which 
has shown a decrease in the U2 removal rate by four fold (kobs ~ 0.8 min-1, Figure 3.9b). 
This indicates that the truncated protein has a lesser effect on the U2 removal, 
suggesting that RRM1 is important for the binding of Prp24.  
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Figure 3.8: Binding of Prp24 facilitates the removal of U2. Histograms correspond to 
single molecule time dependent experiments with (a) Prp24, (b) 234C and (c) buffer 
only, showing the change in zero FRET state along with the time. (d) Fraction of 
molecules at zero FRET state as a function of time was plotted to obtain the rate of 
U2removal in the presence of Prp24 (red) and 234C (green). (e) Fraction of molecules 
at zero FRET state as a function of Prp24 concentration (red) and 234C concentration 
(green) was plotted to obtain the dissociation constant for U2 removal. In both (b) and 
(c), each point has corrected for the photobleaching rate.  
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Likewise, the fraction of molecules at zero FRET state corresponds to the last time 
point (45 min) that was plotted as a function of Prp24 concentration and fitted into a 
modified hill equation. The resulting plot demonstrates an increase in the zero FRET 
population over Prp24 concentration and yields a KD of ~ 0.3 nM (Figure 3.9c). 
Contrary, in the presence of 234C the binding affinity was reduced by ~ 10-fold 
compared to that of Prp24 (KD ~ 3.0 nM, Figure 3.9d). These results suggest that Prp24 
facilitates the dissociation of U2 from U6 as a function of time and Prp24 concentration. 
On the other hand, the removal of RRM1 reduced the Prp24 binding and thus showed a 
reduced effect on the U2 removal rate.  
With these data we proposed a model for the role of Prp24 in the removal of U2 from 
a minimal U2/U6 complex. When Prp24 binds with the minimal U2/U6 complex, first the 
RRM2 interacts with nucleotides 46-58, containing the ACAGAGA loop and then 
disrupts the base pairing between U2 and U6 in helix I. According to a recent crystal 
structure, RRM3 undergoes a 180o rotation and threads through U6. During this 
rearrangement, RRM3 interacts with the U6 nucleotides at the 5’ end, which results in 
an unwinding of helix III of the complex. Furthermore, the rearrangement of RRM3 
pushes RRM4 towards the opposite side of U6, which eventually interacts with the lower 
region of U6 ISL and destabilizes the U6 ISL base region. These disruptions in the helix 
I, III and lower region of ISL, result in the formation of partially unwound complex as 
shown in Figure 3.9, which could correspond to the intermediate FRET population (0.2 
FRET) that was observed in the flow experiments.  These sequential events will 
ultimately lead to a destabilization of helix II, facilitating the complete removal of U2, as 
proposed in the recent crystal structure study. The conformation adopted by the free U6 
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binding to Prp24 after the U2 removal could represent the low FRET population 
obtained with the doubly labelled U6 and the zero FRET population obtained with the 
singly labelled U6. On the other hand, when RRM1 is removed, the truncated protein, 
234C cannot bind to the U2/U6 complex as tight as full-length protein and thus it cannot 
destabilize the base pairing as efficiently as full-length protein, hence resulting in a 
lower rate and a lower dissociation constant than that of full-length protein.  
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Figure 3.9: The proposed model for the role of Prp24 in U2/U6 complex 
unwinding. In the presence of Prp24, base pairing between U2 and U6 RNAs are 
disrupted and U2 is unwound from U6. The RNA recognition motifs of Prp24, U2 and U6 
snRNA strands are colour coded as same as previous. The dash lines indicate the 5’ 
nucleotides of U6 present in the crystal structure study but absent in our study.   
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CHAPTER 4: Study the assembly and global structure of U4/U6 
complex 
 
[This study has done as collaboration with the Kiyoshi Nagai Lab, MRC-LMB, 
Cambridge. The EMSA studies with the full length construct were done by Dr. John 
Hardin and Dr. Yasushi Kondo] 
 
4.1: Objective 
The objective of specific aim 2 of my research is to understand the conformational 
changes and formation of global structure of spliceosomal sub-complexes during the 
spliceosomal assembly cycle and the role of particle-specific proteins on these 
structural arrangements.  
One of the important spliceosomal sub-complexes is U4/U6.U5 tri-snRNP, which 
consists of U4/U6 di-snRNP and U5 snRNP. Little is known about the U4/U6 di-snRNP 
structure and the only information available is a cryoEM structure of U4/U6.U5 tri-
snRNP as a whole at ~30 nm resolution77. The relative orientation of the three helices of 
the U4/U6 duplex, the conformational dynamics of duplex upon protein binding, and the 
global structure of di-snRNP remains structurally unresolved.  
To reveal aforementioned structural information and understand the assembly 
process of U4/U6 di-snRNP assembly, I have used single-molecule approach. First, 
EMSA studies were performed by the Nagai Lab to determine the order and affinities 
with which the proteins bind to the U4/U6 duplex.  This allowed us to obtain step-wise 
reconstitution of the U4/U6 di-snRNP in vitro, and provided a protocol for complete 
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assembly of di-snRNP, which can be used for further studies, even for the assembly of 
other complexes with minor alterations. The single-molecule data then revealed that the 
two stems of the duplex; stem I and II are coaxially stacked. Moreover, it also shown 
that the U4/U6 di-snRNP adopts a pre-formed rigid structure, which does not change 
upon protein binding. 
 
4.2: Experimental design 
A full length U4 and U6 strands were used in the EMSA studies, where RNAs were 
labelled with fluorescein at the 3ʹ end of U4 (Table 2.3, Figure 4.1a). For single-
molecule FRET studies, I have used a minimal U6 strand (nucleotides from 54-80) and 
a minimal U4 strand (nucleotides from 1-70, Table 2.3, Figure4.1b). The U4 strand was 
labelled internally with cy5 (at the 5’ stem-loop) and at the 3’ end with biotin-BSA for 
surface immobilization (Figure 4.1b). To study the relative orientation of the helices, 
three U6 strands were used with different labelling schemes but with the same 
sequence (Figure 4.1b). All proteins (Snu13, Prp31, Prp3, Prp4, Sm proteins and LSm 
proteins) were expressed and purified by the Nagai Lab.  
 
4.3: Results 
4.3.1: In-vitro reconstitution of the U4/U6 di-snRNP 
To characterize the step-wise assembly of the U4/U6 di-snRNP, EMSA studies were 
done by incubating purified proteins of the U4/U6 snRNP complex (Snu13, Prp31, 
Prp3/Prp4, Sm proteins and LSm proteins, Figure 1.11a) with a pre-formed full length 
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U4/U6 RNA complex. Binding was monitored as changes in electrophoretic mobility. 
The apparent binding affinities (KD) are summarized in Table 4.1.  
First each U4/U6 associated protein or protein sub-complex was titrated against the 
pre-formed U4/U6 snRNA duplex. The fraction of protein bound to U4/U6 duplex was 
measured as a function of protein concentration to obtain apparent binding affinities 
(KD). Since previous studies have shown that Snu13 facilitates binding of other proteins, 
the U4/U6 RNA duplex was first titrated with different concentrations of Snu13, resulting 
in a  KD = 17 ± 1 nM (Figure 4.2a).  The tight binding of Snu13 with U4/U6 duplex is in 
accordance with the previous studies70. Similarly, the snRNA duplex was titrated with 
Prp3/4, which gives an apparent KD of 57 ± 2 nM (Figure 4.2b). A previous study on 
human spliceosomal components has shown that binding of human Snu13 ortholog to 
the U4/U6 duplex is required for further binding of hPrp3/469, which suggests that yeast 
Prp3/4 binding may utilize a different pathway than human Prp3/4. Similarly, Sm 
proteins exhibit a KD of 89 ± 4 nM (Figure 4.2c). The binding affinity of Prp31 to the 
duplex is very low (KD = 243 ± 16 nM, Figure 4.2d), which is in accordance with the 
previous studies showing that binding of Snu13 to the duplex facilitates the Prp31 
binding72. On the other hand, titration of LSm2-8 complex with the full-length U4/U6 
complex exhibits a very high affinity (KD = 5.0 ± 0.2 nM, Figure 4.2e).  Titrations with 
individual proteins have shown that Snu13 exhibits very tight binding, and the smallest 
shift in the gel is due to its small size. This suggests that Snu13 could be the starting 
point for the further assembly of other proteins, which also in agreement with the 
previous findings72. Therefore, we have determined the binding affinity of each protein 
(Prp31, Sm, LSm, and Prp3/Prp4) with a fully formed U4/U6 +Snu13 complex.   
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Figure 4.1: U4/U6 snRNA duplex. (a) Sequence of full length U4 and U6 used in the 
EMSA studies. (b) Minimal U4 and U6 sequences used in the single-molecule studies, 
which don’t contain the single-stranded regions of U4 and U6 known to be the binding 
sites for Sm and LSm proteins, respectively. The U6 strand is labelled with Cy3 at the 5’ 
end, and a C6 amino modifier is attached at the 3’ end. In stem I-II construct, Cy5 is 
attached to this amino modifier. The U4 strand consists of an amino modifier at the 5’ 
stem-loop to attach Cy5  and Biotin is attached to the 3’ end.      
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Table 4.1: Apparent Kd (Kd, app) measurements for step-wise in vitro assembly of the 
Saccharomyces cerevisiae U4/U6 di-snRNP as determined by EMSA studies.  
Associated error is reported as one standard deviation from the weighted mean (The 
binding affinities were kindly provided by Dr. J. Hardin and Dr. Y. Kondo). 
 
Components 
Titrated 
Component 
KD 
U4/U6 Snu13 17 ± 1 nM 
U4/U6 Prp3/4 57 ± 2 nM 
U4/U6 Sm 89 ± 4 nM 
U4/U6 Prp31 243 ± 16 nM 
U4/U6 LSm 5 ± 0.2 nM 
U4/U6/Snu13 Prp31 50 ± 4 nM 
U4/U6/Snu13 Sm 92 ± 9 nM 
U4/U6/Snu13 LSm 26 ± 1 nM 
U4/U6/Snu13 Prp3/4 88 ± 8 nM 
U4/U6/Snu13/Prp31 Sm 108 ± 9 nM 
U4/U6/Snu13/Prp31 LSm 98 ± 34 nM 
U4/U6/Snu13/Prp31 Prp3/4 417 ± 43 nM 
U4/U6/Snu13/Prp31/Sm LSm 154 ± 15 nM 
U4/U6/Snu13/Prp31/Sm Prp3/4 557 ± 75 nM 
U4/U6/Snu13/Prp31/Sm/LSm Prp3/4 20 ± 1 nM 
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Figure 4.2: Gel shifts and binding curves for the interaction between the pre-
formed U4/U6 duplex RNA and proteins. The pre-formed U4/U6 duplex RNA is 
titrated with varying concentrations of (a) Snu13, (b) Prp3/4, (c) Sm proteins, (d) Prp31, 
and (e) LSm proteins. The concentration of pre-formed U4/U6 duplex is 2 nM.  The 
concentration of proteins ranges from 0 to ~2 μM in two-fold increments. The apparent 
KD and estimated Hill coefficient (n) is given for a single representative binding curve 
(The gel pictures and binding data were kindly provided by Dr. J. Hardin and Dr. Y. 
Kondo).  
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The binding curve indicates that in the presence of Snu13, binding of Prp31 has 
greatly increased (KD = 50 ± 4 nM, Figure 4.3a).  On the other hand, the binding of Sm 
proteins shows no increase in the presence of Snu13 (KD= 92 ± 9 nM, Figure 4.3b), 
indicating there is no direct interaction between Sm proteins and Snu13. Also, LSm 
binding to the pre-formed U4/U6 +Snu13 complex remains high (KD = 26 ± 1 nM, Figure 
4.3c), despite the ~5 fold decrease in the affinity compared to that for naked duplex 
RNA. Similarly, the binding affinity of Prp3/4 for the pre-formed U4/U6 +Snu13 complex 
is slightly reduced (KD = 88 ± 8 nM, Figure 4.3d) from that observed for binding to the 
naked U4/U6 duplex RNA. 
As the next assembly step, we have used pre-formed U4/U6 +Snu13 +Prp31 
complex to examine the binding affinities of each of the remaining components (Sm, 
LSm, and Prp3/Prp4).  The binding affinity for Sm proteins shows no significant change 
from what has observed for the binding of these proteins to the naked U4/U6 duplex (KD 
= 108 ± 9 nM, Figure 4.4a). On the other hand, LSm proteins show a substantially lower 
binding affinity (KD = 98 ± 34 nM, Figure 4.4b). Prp3/4 exhibits significantly weaker 
binding to the pre-formed U4/U6 +Snu13 +Prp31 complex than that observed for the 
naked RNA duplex (KD = 417 ± 43 nM, Figure 4.4c).   
Next, we have examined the binding of LSm and Prp3/4 proteins to the fully formed 
U4/U6 +Snu13 +Prp31 +Sm complex.  Both LSm proteins and Prp3/4 show drastic 
reduction in apparent binding affinities (KD = 152 ± 15 nM and KD = 557 ± 75 nM 
respectively; Figure 4.4d and e) compare to the naked U4/U6 duplex.   
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Figure 4.3: Gel shifts and binding curves for the interaction between the pre-
formed U4/U6/Snu13 complex and proteins. The pre-formed U4/U6 duplex RNA is 
titrated with varying concentrations of (a) Prp31, (b) Sm proteins, (c) LSm proteins, and 
(d) Prp3/4. The concentrations of component used are; 2 nM pre-formed U4/U6 duplex 
and 200 nM Snu13. The concentration of proteins ranges from 0 to ~2 μM in two-fold 
increments. The apparent KD and estimated Hill coefficient (n) is given for a single 
representative binding curve (The gel pictures and binding data were kindly provided by 
Dr. J. Hardin and Dr. Y. Kondo).  
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Finally, we have examined binding of Prp3/4 to the pre-formed U4/U6 +Snu13 
+Prp31 +Sm +LSm complex.  Interestingly, when all other U4/U6 components are 
present, the Prp3/4 binding affinity increases dramatically (KD = 20 ± 2 nM, Figure 4.5a).  
This may be due to the presence of alternative conformations of the U6 3’-end, which 
may hinder the binding of Prp3/4.  However the presence of LSm proteins may minimize 
these alternative conformations, clearing the path for Prp3/4 binding.  
In summary, we have showed the stepwise assembly of U4/U6 di-snRNP complex 
(Figure 4.5b). To our knowledge, this is the first  in vitro reconstitution of complete 
U4/U6 di-snRNP, and the first time of step-wise assembly of any snRNP with all its 
components in vitro. 
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Figure 4.4: Gel shift assays and binding curves for the interaction between the 
pre-formed U4/U6/Snu13/ Prp31complex and proteins. The pre-formed U4/U6 
duplex RNA is titrated with varying concentrations of (a) Sm proteins, (b) LSm proteins, 
and (c) Prp3/4. Gel shift assays and binding curves for the interaction between the pre-
formed U4/U6/Snu13/ Prp31/Sm complex and (d) LSm proteins, and (e) Prp3/4. The 
concentrations of the component used are; 2 nM pre-formed U4/U6 duplex, 200 nM 
Snu13 and 120 nM Prp31 in d and e panels.  Protein concentration ranges from 0 to ~2 
μM in two-fold increments. The apparent KD and estimated Hill coefficient (n) is given for 
a single representative binding curve (The gel pictures and binding data were kindly 
provided by Dr. J. Hardin and Dr. Y. Kondo).  
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Figure 4.5: Assembly of complete U4/U6 di-snRNP. (a) Gel shift assays and binding 
curves for the interaction between the pre-formed U4/U6/Snu13/ Prp31/Sm/LSm 
complex and Prp3/4 proteins. The concentrations of the components used are; 2 nM 
pre-formed U4/U6 duplex, 200 nM Snu13, 120 nM Prp31, 64 nM Sm proteins, and 240 
nM LSm proteins.  (b) Step-wise assembly of complete U4/U6 di-snRNP. The binding of 
each protein shows a complete shift (The gel pictures and binding data were kindly 
provided by Dr. J. Hardin and Dr. Y. Kondo). 
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4.3.2: SmFRET studies revealed that the stems I and II are coaxially stacked 
Single-molecule FRET experiments were performed (as described in chapter 2) to 
characterize the relative orientation of the three helical arms and the global structure of 
the U4/U6 snRNA 3-way junction.  Hence, a minimal U4 and a minimal U6 strands were 
used, in which the Sm and LSm binding sites are removed, the constructs were 
biotinylated, and fluorophore labelled in order to monitor the position of each helix 
relative to the others (Figure 4.1b)239,240. First, I have done an EMSA study with this 
truncated construct to confirm the formation of U4/U6 duplex and the binding of proteins 
(Figure 4.6). Next, I have investigated the relative orientation of stem I and II. For this 
experiment, I have used a doubly labelled minimal U6 strand with Cy3 at the 5’ end and 
Cy5 at the 3’ end, along with unlabelled U4 is biotinylated at the 3’ end (Figure 4.7a). 
Pre-formed U4/U6 duplex was immobilized on a quartz slide and fluorophores were 
excited with 532 nm laser.  The single-molecule trajectories reveal a single static 
confirmation around 0.2 FRET (Figure 4.7b and c, n= 108) for this construct. This 
suggests that stem I and II adopts a rigid position, with no structural dynamics. Using 
the Forster’s equation and R0 = 60 Å for the Cy3/Cy5 pair241, I have estimated the 
distance between two fluorophores corresponds to the aforementioned 0.2 FRET state, 
which is ~76 Å (Figure 4.7d). I have also calculated the length of each helix based on 
the size of each stem assuming them as A-form helices. The stem I (~10 bp) is ~28 Å 
long and stem II (~17 bp) is ~48 Å long, which adds up to a total length of 76 Å (Figure 
4.7d), suggesting that stem I and stem II are coaxially stacked in solution (Figure 4.7d).    
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Figure 4.6: Minimal fluorophore labelled U4/U6 snRNA duplex binds with proteins. 
Gel was scanned by exciting with 532 nm and 635 nm lasers to detect Cy3-U6 and Cy5-
U4, respectively. Resulting image is an overlay of both channels. Lane 1: Cy5-U4 
snRNA (red band). Lane 2: Cy3-U6 snRNA (green band). Lane 3: U4/U6 snRNA duplex 
(yellow band). Lane 4: U4/U6 snRNA/Snu13 (shifted yellow band). Lane 5: U4/U6 
snRNA/Snu13/Prp31 (further shifted band). Lane 6: U4/U6 snRNA/Snu13/Prp31/Prp3/4 
(top band). The complete snRNP complex forms in presence of all proteins.  
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Figure 4.7: Stems I and II are coaxially stacked. (a) Single molecule setup for the 
U4/U6 snRNA complex, in which U6 is labelled with Cy3 and Cy5 at the 3’ and the 5’ 
ends respectively, and U4 is biotinylated at the 3’ end. Pre-formed U4/U6 duplex is 
immobilized on a quartz slide using biotin-streptavidin interaction and the fluorophores 
are excited with a 532 nm laser. (b) FRET time trajectory and (c) histogram for the stem 
I and stem II construct shows a single static FRET state at 0.2. (d) The calculated 
distance between two fluorophores based on the FRET value (76 Å) is similar to the 
total length of two helices (stem I and stem II are 28 Å and 48 Å, respectively), 
suggesting that these two stems are coaxially stacked.  
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4.3.3: The U4/U6 3-way junction is static 
Next, the orientations of stem I and II relative to the 5’ stem-loop was examined. First, 
the orientation of stem II relative to the 5’ stem-loop was tested by using a U4/U6 
duplex, where 5’ end of U6 was labelled with Cy3 (Figure 4.8a). Three static and non-
interconverting conformations at 0.2 (44 ± 7%), 0.3 (45 ± 7%), and 0.4 (11 ± 3 %) FRET 
were observed for these experiments (Figure 4.8b and c, n= 102).  These results 
indicate that the 5’ stem-loop adopts multiple conformations compare to the coaxially 
stacked stem I and II, which are non-interconverting on the timescale of the experiment, 
which is on the order of minutes.  Then the orientation of stem I relative to 5’ stem-loop 
was studied to support above results (Figure 4.9a). These results indicate that two 
helices adopt three static populations with FRET values of 0.3 (41 ± 6%), 0.4 (51 ± 6%) 
and 0.5 (8 ± 3%) similar to what observed for stem II, confirming the static heterogeneity 
for 3-way Junction (Figure 4.9b and c, n= 105). Based on the FRET values observed for 
both constructs, these populations were assigned to different orientations of 5’ stem-
loop relative to the stems I and II. Population 1 is likely to be a conformation where the 
5’ stem-loop is closer to the stem I. On the other hand, population 2 is where the 5’ 
stem-loop is closer to the stem II. Population 3 could be a minor population such as a 
misfolded state that is always present. This minor population could correspond to the 
small fraction that migrating between U6 and U4/U6 duplex in the fluorescence EMSA 
(Figure 4.6). 
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Figure 4.8: Stem II and 5’ stem-loop of U4 adopts three static relative orientations. 
(a) Schematic representation of the U4/U6 snRNA duplex used to study the orientation 
of stem II relative to the 5’ stem-loop of U4. U6 is labelled with Cy3 (blue) at the 3’ end 
stem II. U4 is biotinylated at the 3’ end and labelled with Cy5 (red) within the stem-loop 
as shown. (b) Time trajectories indicating three static, non-interconverting FRET 
populations observed for the stem II - 5’ stem-loop. (c) FRET histogram showing three 
distinct FRET peaks (n= 102). 
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In order to determine the effect of divalent metal ions on the different FRET 
populations observed, then the single-molecule experiments were done in the presence 
of different concentrations of Magnesium ions along with 100 mM NaCl, which also 
results in no observable FRET changes or relative populations (Figure 4.10a). These 
observations are in contrast with what have been observed for other RNA 
complexes185,239,240,242,243. A possible explanation for these conformations could be due 
to the rotation at the kink-turn motif in the 5’ stem-loop upon its stabilization 71,244,245, or 
rotation around three-way junction as observed for the Hammerhead ribozyme and the 
VS ribozyme 240,242,246. Then experiments were done in the presence of particle-specific 
proteins (Snu13, Prp31 and Prp3/4) to test these two suggestions. First a fluorescence 
scanning experiment were done to determine the effect of protein binding on the 
fluorescence emission (Figure 4.11). Resulting emission spectrum and the relative 
intensity change for Cy3 (Figure 4.11a) and Cy5 (Figure 4.11b) in the absence and 
presence of proteins suggest that binding of proteins to the fluorophore labelled U4/U6 
duplex does not affect the fluorescence properties of Cy3 and Cy5.  
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Figure 4.9: Stem I and 5’ stem-loop of U4 adopts three static relative orientations. 
(a) Schematic representation of the U4/U6 snRNA duplex used to study the orientation 
of stem I relative to the 5’ stem-loop of U4. U6 is labelled with Cy3 (blue) at the 5’ end of 
stem I. U4 is biotinylated at the 3’ end and labelled with Cy5 (red) within the stem-loop 
as shown. (b) Time trajectories indicating three static, non interconverting FRET 
populations observed for the stem I - 5’ stem-loop. (c) FRET histogram showing three 
distinct FRET peaks (n= 105).  
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4.3.4: The kink-turn is pre-formed to accelerate Snu13 binding 
To test the hypothesis that different orientations of the kink-turn motif correspond to the 
observed multiple conformations; I have introduced Snu13 to the immobilized U4/U6 
duplex, which is expected to stabilize only one conformation of the kink-turn upon 
binding247,248.  Single-molecule FRET trajectories for each construct show that binding 
of Snu13 to the 5’ stem-loop does not cause any change in the observed FRET 
populations relative to either stem II or stem I compared to RNA alone (Figure 4.12a, b 
and 4.13a, b, n> 100). Similar experiments were done at saturating concentrations of 
Snu13 (200nM) also show no significant change in the populations (Figure 4.14a, b). 
However, previous study with L7Ae protein, an archaeal Snu13 homolog 244,249, has 
shown that the Snu13 homolog stabilizes a single conformation of a minimal kink-turn 
construct 247. This suggests that the multiple orientations of the kink-turn motif in the 5’ 
stem-loop are not responsible for the observed different FRET populations. 
Furthermore, the conformation of stems I and II remain coaxially stacked even in the 
presence of Snu13 (Figure 4.12c and Figure 4.14c). Taken together, these results raise 
the interesting possibility that under these experimental conditions, the U4/U6 kink-turn 
is pre-formed and thus promotes further snRNP assembly. 
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Figure 4.10: Multiple conformations of U4/U6 duplex are Mg2+ independent. FRET 
histograms for single-molecule experiments with the stem II-5’ stem-loop construct in 
the presence of 0.1 -50 mM Mg2+, indicating that Mg2+ ions have no effect on the 
multiple FRET populations observed.  
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4.3.5: Prp31 preferentially binds to one of two internal stem-loop conformations 
Since kink-turn orientation is not the cause for the observed multiple FRET populations, 
experiments were done to test whether these conformations result from different 
orientations of the three-way junction. Prp31 protein, which interacts with the 5’ stem-
loop and stem II (Figure 1.13a) was used to test this and an effect on the relative 
orientation of the three-way junction was expected. First, the orientation of stem II 
relative to the 5’ stem-loop (Figure 4.12a) was examined. Single-molecule FRET 
trajectories in the presence of Prp31 show a significant decrease in population 1(from 
44 ± 7% to 28 ± 5%, p < 0.05, Figure 4.13a, n= 107). This result indicates that Prp31 
binding stabilizes the three-way junction in a conformation, where the 5’ stem-loop is 
farther from stem I and closer to stem II. To confirm this interpretation, the orientation of 
5’ stem-loop relative to stem I (Figure 4.12b) was tested. In the presence of Prp31 this 
construct also shows a decrease in the population 1 (from 51± 6% to 41 ± 6%, Figure 
4.13b, n= 104), consistent with previous results.  As expected, stem I-stem II shows no 
FRET change in the presence of Prp31 (Figure 4.12c), further supporting the idea that 
these two helices are rigidly and coaxially stacked even in the presence and absence 
snRNP proteins. Taken together, these data show that Prp31 preferentially binds and 
stabilizes a conformation of the U4/U6 3-way junction that brings the 5’stem-loop closer 
to stem II and further from stem I.  
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Figure 4.11: Fluorescent intensities of Cy3 and Cy5 do not change in the 
presence of protein. Fluorescence emission spectra of (a) Cy3 and (b) Cy5 the U4/U6 
RNA duplex (black) and in presence of Snu13 (red), Snu13 + Prp31 (green), Snu13 + 
Prp31 + Prp3/4 (blue). The spectra remain unchanged, indicating that the proteins do 
not affect the fluorescence properties of Cy3 and Cy5. 
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Figure 4.12: Single molecule assembly for individual proteins onto the U4/U6 
duplex. Binding of Snu13, Prp31 and Prp3/4 individually to the (a) stem II-5’ stem-loop 
construct, (b) stem I-5’ stem-loop construct, and (c) stem I- stem II construct. Presence 
of individual proteins has no effect on the stem I-stem II complex, further confirming that 
these two arms are coaxially stacked. The presence of Snu13 also has no effect on the 
multiple populations observed with the naked RNA duplex. Prp31 stabilizes a 
conformation where 5’ stem-loop is closer to stem II, where as Prp3/4 stabilizes a 
conformation where 5’ stem-loop is closer to stem I.
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4.3.6: Prp3/4 preferentially binds to the alternative internal stem-loop 
conformation 
Furthermore, to study the effect of Prp3/4 binding on the orientation of the three-way 
junction, the experiments were done in the presence of Prp3/4. Previous studies have 
shown that Prp3/4 binds around stem II and the 5’ stem-loop, which is expected to 
cause changes in the U4/U6 orientation (Figure 1.13a). First the orientation of stem II 
relative to the 5’ stem-loop (Figure 4.12a) was examined.  In contrast to Prp31 binding, 
the FRET trajectories show a significant increase in the population 1 (from 44 ± 7% to 
58 ± 7%, p < 0.05, Figure 4.13a, n= 105).  Next, the orientation of the stem I relative to 
5’ stem-loop (Figure 4.12b) was tested. This also shows an increase in population 1 
(from 51 ± 7% to 58 ± 7%, Figure 4.13b, n = 106) consistent with previous result, 
indicating that binding of Prp3/4 stabilizes the three-way junction in a conformation 
where the 5’ stem-loop is farther from stem II and closer to stem I.  As expected, the 
relative orientation of Stems I and II remains unchanged in the presence of Prp3/4, 
confirming that these two helices remain coaxially stacked in presence of any of the 
proteins (Figure 4.12c). Taken together, these data indicate that binding of individual 
proteins Prp31 and Prp3/4 favours the stabilization of two different orientations of the 5’ 
stem-loop relative to the coaxially stacked stems I and II.   
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Figure 4.13: Binding of proteins affect on the local conformation of U4/U6 duplex. 
Fraction of molecules at population 1 in the presence of each protein or protein sub 
complex is shown for (a) stem II-5’ stem-loop construct, (b) stem I-5’ stem-loop 
construct. This illustrate that binding of Prp31 reduces the fraction of population 1 
whereas Ppr3/4 increases the fraction of population 1. The p values are calculated 
using t-test and represent as * - p<0.05, ** - p<0.01 and *** - p<0.001. 
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Figure 4.14: Binding of Snu13 has no effect on the multiple conformations of 
U4/U6 duplex. Histograms for (a) stem II-5’ stem-loop construct  (b) stem I-5’ stem-loop 
construct  and (c) stem II- stem I construct in the presence of saturating concentration of 
Snu13 (200nM), illustrating the FRET populations are similar to that observed for 20nM 
Snu13 and naked RNA duplex.  
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4.3.7: Single molecule assembly of multiple proteins onto the U4/U6 3-way 
junction RNA 
Next, I have examined the possible conformational changes upon simultaneous 
binding of multiple proteins to the U4/U6 duplex.  First, I have tested the orientation of 
stem II relative to the 5’ stem-loop, in the presence of both Snu13 and Prp31 proteins 
(Figure 4.15a). Upon binding of both proteins, the percentage of population 1 has 
reduced compare to the percentage obtained for RNA only (from 44 ± 6% to 32 ± 5%, 
Figure 4.13a, n= 103). These data are consistent with the previous observation that 
binding of Prp31 with the U4/U6 duplex results in a shift in the 5’ stem-loop towards the 
stem II and away from the end of stem I, whereas Snu13 doesn’t cause any change to 
the duplex conformation. To further confirm this result, I have then examined the 
orientation of stem I relative to the 5’ stem-loop (Figure 4.15b), which also shows a 
decrease in the population 1, favouring the suggestion that Prp31 binding to the 
U4/U6/Snu13 complex facilitates a conformation where stem I is further from the 5’ 
stem-loop relative to the coaxially stacked stems I and II (from 51 ± 7% to 44 ± 6%, 
Figure 4.13b, n= 102). Testing the effect of multiple proteins binding to the orientation of 
stems I and II has therefore shown that none of the snRNP proteins affect the observed 
FRET distributions, indicating that these two stems remain coaxially stacked for the 
duration of entire snRNP assembly (Figure 4.15c).  I have then examined the 
subsequent binding of the proteins; Snu13, Prp31 and Prp3/4, to the U4/U6 duplex, and 
tested the conformational changes of the three helices. The orientation of stem II 
relative to the 5’ stem-loop was studied first, which has shown that binding of all 
proteins results in FRET population distributions  where  the percentage of population 1 
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is 47 ± 6 % (Figure 4.13a and 4.15a), which is almost similar to what is observed for the 
naked RNA  (44 ± 6 %, Figures 4.7 and 4.11a). Similarly, testing the orientation of stem 
I relative to the 5’ stem-loop, have shown that the percentage of population 1 in the 
presence of all proteins (49 ± 7 %, Figures 4.13b and 4.15b) is comparable with RNA 
alone results (51 ± 7 %, Figures 4.8 and 4.11b). As expected, stems I and II and remain 
coaxially stacked upon binding of all proteins (Figure 1.15c). Moreover, experiments 
were done in the presence of all the protein and data were taken for longer time (> 30 
minutes) at 500 ms time resolution (Figure 4.16). I have observed three static FRET 
populations (Figure 4.16a and b) similar to what have observed before (short movies 
with 30 ms time resolution). These data reveal that proteins remain bound to the U4/U6 
duplex for a long time, and do not show any association/dissociation dynamics within 
this experimental time window. 
Overall, these results suggest that complete assembly of U4/U6 di-snRNP (except 
Sm and LSm proteins) stabilizes the U4/U6 in a conformation that closely resembles the 
conformation for naked U4/U6 (Figure 4.17). This indicates that binding of both Prp31 
and Prp3/4 together prevents the relative stabilization of the alternative conformations 
observed upon binding of individual proteins.  
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Figure 4.15: Assembly of multiple proteins onto the U4/U6 duplex maintains a 
rigid conformation. Binding of multiple proteins to the (a) stem II-5’ stem-loop 
construct, (b) stem I-5’ stem-loop construct, and (c) stem I- stem II construct. The 
presence of multiple proteins has no effect on the stem I-stem II complex, further 
confirming that these two arms are coaxially stacked. Similar to individual binding, 
Snu13+Prp31 stabilizes a conformation where the 5’ stem-loop is closer to stem II, 
whereas binding of Snu13+Prp31+Prp3/4 returns U4/U6 duplex to a conformation 
similar to RNA alone.  
196 
 
Figure 4.16: The snRNP complex remains static for long times. (a) Single-molecule 
FRET time trajectories and (b) corresponding histogram for experiment recorded for >15 
min at 500 ms time resolution with the surface immobilized U4/U6 snRNA duplex in 
presence of 20 nM Snu13, 150 nM Prp31 and 150 nM Prp3/4. The complex does not 
exhibit any dynamics within this experimental time window. 
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Figure 4.17: U4/U6 adopts a rigid, pre-formed global conformation. Stepwise 
assembly of U4/U6 di-snRNP is shown here. Based on our EMSA data and previous 
studies, we propose that Sm and LSm proteins are pre-bound to the U4/U6 complex. 
During the assembly process, Snu13 binds first to the K-turn motif at the 5’ stem-loop of 
U4. Then, based on the binding affinities we obtained, either Prp31 or Prp3/4 can bind 
to the complex followed by the other protein (either Prp3/4 or Prp31). Prp31 
preferentially binds to a conformation where the 5’ stem-loop closer to the stem II. 
Prp3/4 preferentially binds to a conformation where the 5’ stem-loop closer to the stem 
I. Assembly of all proteins to the complex brings U4/U6 conformation back to the same 
as RNA alone, suggesting that U4/U6 maintains a rigid conformation throughout the 
assembly process. During the assembly process stems I and II remain coaxially stacked 
without being affected by protein binding.  
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4.3.8: Visualization of Prp31 binding to the U4/U6 duplex 
To confirm protein binding to the U4/U6 construct, and  that Prp31 stays bound upon 
addition of Prp3/4, I have performed single molecule experiments using labelled Prp31 
in the presence of Snu13 and Prp3/4. In this experiment, I have used biotinylated U4, 
Cy3 labelled U6 and Cy5 labelled Prp31. Single molecule experiments were conducted 
by switching the lasers from 532 nm (green) to 637 nm (red).  In the presence of Cy5 
labelled Prp31, a low FRET value was observed (Figure 4. 18a top and bottom 
panels).The direct excitation of Cy5 fluorophores by 637 nm laser results in an increase 
in the cy5 signal, indicating the binding of Cy5 labelled Prp31 to the U4/U6 duplex 
(Figure 4.18a, middle panel). In contrast, a sample containing all components as above 
but with unlabelled Prp31 shows zero Cy5 signal with both lasers (Figure 4.18b). These 
results confirm Prp31 binding to the U4/U6 duplex, which remains bound with the 
addition of Prp3/4.  
Taken together, the EMSA data illustrate a step-wise assembly of U4/U6 di-snRNP and 
report binding affinities for individual and sequential binding of proteins. Furthermore, 
the single-molecule data suggest that stems I and II are coaxially stacked and remain 
stacked throughout the whole di-snRNP assembly process (Figure 4.17). These results 
also demonstrate that despite local structural changes upon binding of individual 
proteins, U4/U6 duplex maintains a rigid global conformation during the assembly 
process (Figure 4.17).  
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Figure 4.18: Prp31 protein stays bound to the U4/U6 complex even in the 
presence of Snu13 and Prp3/4. Intensities of the excited fluorophores at 532 nm 
(upper panel) and at 637 nm (middle panel) and the corresponding FRET trajectories 
(lower panel) are shown for the experiments in the (a) presence of cy5-Prp31 and (b) 
absence of labelled Prp31.  
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CHAPTER 5: Study the structural dynamics of U12/U6atac snRNA 
complex in minor spliceosome 
 
5.1: Objective 
The objective of specific aim 3 in my research is to understand the structural and 
functional similarities between major and minor spliceosomal snRNA complexes.  
Other than the highly abundant major spliceosome, which is present in almost all 
eukaryotes, a less abundant, second spliceosome has been discovered, referred to as 
the minor spliceosome. The minor spliceosome consists of five snRNPs: U11, U12, 
U4atac, U6atac and U5, which are analogous to their major spliceosomal counterparts. 
Despite their sequence differences, snRNA complexes from both spliceosomes share 
structural similarities. For example, the U4atac/U6atac and U12/U6atac complexes are 
similar in structure to the U4/U6 and U2/U6 complexes, respectively. Also both 
spliceosomes share a similar splicing mechanism. Although several studies have been 
done on the minor spliceosome, the conformational dynamics and assembly of snRNA 
complexes remain poorly understood.  
The minor spliceosomal U12/U6atac complex is analogous to the major 
spliceosomal U2/U6 complex, which is known to be present in the catalytic core. The 
structural details of U12/U6atac complex will shed light on understanding the assembly 
process of the minor spliceosome and the role of each component. Hence, this work 
focuses on structural analysis of the U12/U6atac complex.  
To examine the conformational dynamics of the minor spliceosomal U12/U6atac 
complex, I have employed single-molecule FRET. The resulting preliminary data shows 
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the formation of U12/U6atac complex. The data also have shown that the U12/U6atac 
complex is stabilized by Mg2+ ions, which is similar to what has been observed for the 
U2/U6 complex from a previous study done by our lab185. Furthermore, these results 
suggest that U12/U6atac complex adopts a conformation similar to the three-helix 
junction structure of U2/U6.             
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
5.2: Experimental design 
In this study, I have used a minimal U12 and U6atac snRNA sequences (Table 2.3, 
Figure 5.1a). Similar to the U2 and U6 snRNAs used in the first part of my work, U12 is 
unlabelled and U6atac is labelled with Cy3 at the 5’ end, Cy5 internally, and biotinylated 
at the 3’ end. U6atac snRNA was heated to 94 oC and freeze cooled on ice for 20 min. 
Then diluted U6atac was immobilized on a quartz slide and U12 was introduced. The 
Cy3 fluorophores were then excited using 532 nm laser and resulting intensities were 
captured through the objective and detected through the CCD camera (Figure 5.1b). 
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Figure 5.1: Single-molecule studies on the minor spliceosomal U12/U6atac 
complex. (a) Schematic representation of the minimal U12 and U6atac construct used 
in this study. U6atac is labelled with Cy3, Cy5 and biotin. (b) Single-molecule 
experimental setup showing that labelled U6atac is immobilized on to a quartz slide via 
streptavidin-biotin interactions. Fluorescent molecules were excited using 532 nm laser, 
and the resulting signal is captured through the objective and detected through CCD 
camera. Upon addition of U12, the conformation of U6atac alone changes due to the 
formation of U12/IU6atac. 
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5.3: Results 
5.3.1: U12/U6atac complex stabilizes a low FRET conformation 
First, single-molecule experiments were done in the presence of varying concentrations 
of U12 in order to confirm the formation of the U12/U6atac complex. In the presence of 
U6atac only, almost all the molecules are at 1.0 FRET (Figure 5.2a), suggesting that 
U6atac may form a secondary structure with a high FRET value (Figure 5.1b). On the 
other hand, addition of U12 results in an appearance of a peak at the 0.2 FRET state, 
and molecules show dynamic transitions from 1.0 to 0.2 FRET (Figure5.2a). At lower 
concentrations of U12, very frequent transitions were observed, whereas at higher 
concentrations, molecules tend to stay more at the 0.2 FRET state (Figure 5.2a). The 
resulting histograms (Figure 5.2b) and the binding curve plotted with the fraction of 0.2 
FRET population against U12 concentration (Figure 5.2c) illustrate that addition of U12 
stabilizes a 0.2 FRET conformation, which corresponds to the formation of U12/U6atac 
complex (Figure 5.1b). When comparing the secondary structures of U2/U6 and 
U12/U6atac, it’s clear that the minor complex cannot form the four-helix conformation 
due to the truncation of U12 at 5’ end (cannot form the intramolecular U2 helix or 
intermolecular U2/U6 helix II). Therefore it only can form the three-helix structure, which 
previously has been assigned to 0.2 FRET state185. The short length of U12 snRNA 
explains the requirement of higher U12 concentration for the complex formation. The 
fewer number of base pairs between U12 and U6atac may result in easy dissociation of 
U12 from U6atac or weak interaction with U6atac, which gives rise to the dynamic 
nature observed. 
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Figure 5.2: U12/U6atac complex adopts a low FRET conformation. (a) Single-
molecule time trajectories and (b) histograms (n >100) for varying concentrations of 
U12, indicating that U6atac only forms a high FRET (1.0) conformation and the 
U12/U6atac forms a low FRET (0.2) conformation. (c) The binding curve obtained by 
plotting the fraction of molecules at 0.2 FRET state as a function of U12 concentration. 
The dissociation constant (KD) was obtained by fitting the data into the Hill equation.  
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5.3.2: Mg2+ ions stabilize the U12/U6atac complex 
A previous single-molecule study on the U2/U6 complex has shown that Mg2+ ions 
stabilize a low FRET (0.2) conformation of the U2/U6 complex, which then was 
assigned to three-helix junction structure185. Based on the structural similarities between 
U2/U6 and U12/U6atac complexes, Mg2+ may cause a similar effect on the minor 
spliceosomal complex. To characterize the Mg2+ ion requirement for the stability of the 
U12/U6atac complex, I have done experiments with varying Mg2+ concentrations. 
Trajectories showing a static 1.0 FRET state corresponding to the U6atac alone, were 
removed during data analysis in order to ensure that all the trajectories represent 
U12/U6atac complex. In the absence of Mg2+, the single molecules are more dynamic 
resulting in a broader peak ranging from 0.4 to 1.0 FRET (Figure 5.3a). In the presence 
of Mg2+ ions, the population of high and intermediate FRET states decreases and a new 
FRET state at 0.2 appears. At elevated concentrations of Mg2+ (10 mM and higher), a 
further increase in the 0.2 FRET population and a decrease in the 1.0 FRET state is 
observed, while intermediate FRET states have disappeared. Similar results have been 
obtained for the previous single-molecule studies with U2/U6 complex, where in the 
absence of, or in the presence of, lower concentrations of Mg2+, a broader peak was 
observed ranging through higher FRET states. On the other hand, in higher Mg2+ 
concentrations, the U2/U6 complex has shown an increase in the 0.2 FRET 
population185. These results indicate that Mg2+ ions stabilize the U12/U6atac complex in 
a low FRET conformation that is similar to the three-helix junction structure of U2/U6 
complex.  
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Figure 5.3: Mg2+ ions stabilize the U12/U6atac complex in a low FRET 
conformation. (a) Single-molecule time trajectories and (b) histograms (n >100) for 
varying concentrations of Mg2+, indicating that in the absence of Mg2+ ions, U12/U6atac 
complex structure is highly dynamic, where as in higher Mg2+ concentrations 
U12/U6atac complex stabilizes at a low FRET (0.2) conformation. (c) The binding curve 
obtained by plotting the fraction of molecules at 0.2 FRET state as a function of Mg2+ 
concentration. The KMg was obtained by fitting the data to the Hill equation.  
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Overall, my preliminary data reveal that minor spliceosomal U12/U6atac adopts a 
conformation similar to the three helix conformation of U2/U6 complex. Moreover, Mg2+ 
ions stabilize U12/U6atac complex in a conformation with a 0.2 FRET state, similar to 
what has been observed for U2/U6 complex. This suggests that both complexes require 
Mg2+ ions for their stability in a similar manner. Taken together, these results indicate 
that the major and minor spliceosomal complexes, U2/U6 and U12/U6atac share 
structural similarities, which may represent their functional similarities. 
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CHAPTER 6: Discussion 
 
The main goal of my research is to examine the spliceosomal snRNA complexes at the 
single-molecule level in order to obtain structural dynamic information that has not been 
revealed yet, such as assembly and conformational dynamics of snRNA complexes, 
factors involved in the dissociation of snRNP complexes after the completion of splicing, 
effect of associated proteins on the conformational rearrangements of spliceosomal 
sub-complexes and structural similarities between snRNA complexes of major and 
minor spliceosomes representing their functional relationships. To accomplish this goal, 
I have done single-molecule studies on three different snRNA complexes addressing 
three distinct aims; elucidating the role of Prp24 in U2 and U6 snRNP recycling, 
assembly and global structure of U4/U6 di-snRNP and structural comparison of minor 
U12/U6atac snRNA complex with major U2/U6 complex.   
 
6.1: Elucidating the role of Prp24 in U2 and U6 snRNP recycling 
To address the first question; how snRNA complexes get recycled, I have studied the 
effect of U6 snRNP associated protein Prp24 in U2/U6 complex dissociation.  
First of all, I have done EMSA and fluorescence-anisotropy experiments to check 
binding of Prp24 to the yeast minimal U2/U6 construct used in this study. Both studies 
have shown that Prp24 binds with the RNA construct used in this study. The resulting 
gel shifts and the binding affinity (KD) of Prp24 to the RNA complex used are in good 
agreement with previously published gel-shift results (Figure 3.2)206.  
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One of the limitations of the EMSA and the anisotropy experiments is that the 
experiments are limited by the RNA concentration used, thus an apparent binding 
constant is derived and not the actual value. As an example, in fluorescence-anisotropy 
experiments, the RNA concentration is limited to ~25 nM (in order to obtain a better 
signal) and thus the resulting binding constant will be an apparent KD value rather than 
the actual KD value. The apparent KD value for Prp24 binding to U6 was reported by 
previous gel shift assays and is similar to what I have obtained from these anisotropy 
experiments. Kwan and co-authors have determined the actual KD value by titrating 
higher concentrations of Prp24 until the saturation of U6 binding is achieved. The 
corrected binding affinity is reported as ~2 nM, which suggests that the binding of Prp24 
is much tighter than expected206. 
To overcome this issue, I have employed single-molecule studies. In single-molecule 
FRET experiments, since the RNA molecules are immobilized, the RNA concentration is 
considered as zero. Hence the resulting binding affinities are not limited by the RNA 
concentration. Also, sm-FRET allows us to detect binding of one protein molecule to 
one RNA molecule, which avoids averaging errors and gives rise to the actual KD 
values.  
Single-molecule studies in the presence and absence of Prp24 clearly indicate that 
binding of Prp24 causes a conformational change within the U2/U6 complex, results in a 
static low FRET conformation (0.2) in contrast to the three dynamic FRET states 
obtained for the U2/U6 complex alone (Figure 3.3 and 3.4). Another set of experiments 
in the presence of varying concentrations of Prp24 indicate that binding of Prp24 
stabilizes this 0.2 FRET conformation.  Here, the higher the protein concentration the 
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higher the fraction of molecules that stay at the 0.2 state.  Moreover, these experiments 
result in an actual KD of 0.2 nM, which is ~10 fold tighter than the corrected KD value 
obtained from the EMSA studies (2 nM)206. The difference between the two KD values 
may be due to the use of single-molecule experiments, where we consider one 
molecule at a time compare to the gel-shift experiments where they report an average 
change. Other than the major 0.2 FRET population, I also observed a minor population 
of 0.4 static FRET state, even at 100 nM of Prp24, which could be a misfolded state of 
the complex since it only appeared at elevated concentrations of Prp24. 
As shown in previous studies, the four RRMs of Prp24 have different functions in 
formation and destabilization of the U4/U6 complex101,179. Previous studies have shown 
that RRM1 interacts with the phosphate backbone of the 3’ downstream GAUCA 
sequence via electrostatic interactions100. Gel shift binding assays demonstrated that 
RRM1 and RRM2 are important for the high affinity binding of U6 snRNA and removal 
of RRM1 results in a five-fold reduction in the binding of Prp24206. Consistent with these 
results, in EMSA studies, I also have observed a less intense band corresponding to the 
234C binding compare to the band corresponding to Prp24 binding, indicating that the 
truncated protein results in a reduction in protein binding to the complex. Similarly, 
results from single-molecule experiments have demonstrated a two-fold difference 
between the KD for 234C (0.4 nM) and Prp24 (0.2 nM). These results suggest that the 
removal of RRM1 weakens protein binding, resulting in a less efficient stabilization of 
the low FRET state even at high concentrations of 234C. 
To test if Prp24 plays a role in unwinding U2 from the complex, I used an RNA 
construct with Cy3 on U6 and Cy5 on U2. Single-molecule flow experiments with this 
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construct illustrate that removal of U2 from U6 upon binding of Prp24 occurs through an 
intermediate conformation. This intermediate conformation, with FRET value 0.2, could 
be a result of partial unwinding of U2 from the complex. Data from the single-molecule 
time dependent experiments shows that upon addition of Prp24, the zero FRET state 
becomes populated over time exhibiting a U2 removal rate of 0.15 min -1, whereas when 
234C is added, an increase in the zero FRET state is comparable to the photo 
bleaching rate. Results obtained for the protein titration have given rise to binding 
affinities of 0.3 nM and >3 nM for Prp24 and 234C respectively, illustrating that rate of 
U2 dissociation has been affected by the removal of RRM1, similar to what I have 
observed with previous single-molecule experiments. The gel shift assay with this 
construct has also shown that addition of Prp24 increases the level of free U2, 
suggesting that binding of Prp24 facilitates the removal of U2 from the complex.  
In summary, these results suggest that Prp24 plays an important role in U2 and U6 
snRNA recycling by dissociating the U2/U6 complex. After U2 dissociates, Prp24 may 
remain bound to the U6 and could stabilize U6 in an intermediate conformation, 
preventing the premature activation of U6 and later binding with U4 to form the U4/U6 
complex and join with another spliceosomal assembly cycle. 
There are two possible pathways that Prp24 could be involved in the dissociation of 
full length U2/U6 complex. Prp24 may solely be involved in the complete unwinding of 
U2/U6 complex or may only initiate the disruption of base pairs within the U2/U6 
complex, which allows another protein factor to bind and facilitates the complete 
removal of U2. The recent crystal structure of Prp24 bound to a U6 sequence has also 
illustrated that Prp24 binding can disrupt the base pairs within helix I, III and base of 
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ISL, which could result in a partially opened complex.  However, disruption of helix II 
upon binding of Prp24 is not clear. The results obtained in this study clearly illustrate 
that Prp24 promotes a complete dissociation of two snRNAs from each other, though 
this could be as a result of the short helical lengths of the minimal U2/U6 complex used. 
Hence, I suggest that at the cellular level where full-length U2 and U6 snRNAs are 
present, it could be possible that other protein factors such as some helicases may also 
be involved in this process. Previous studies have proposed that the ATP-dependent, 
DExD/H-box family protein Prp43 is involved in releasing U2, U5 and U6 after the 
completion of catalysis2. Brr2; another DExD/H-box family protein, which is known to be 
involved in unwinding the U4/U6 complex, has also been proposed to have a role in 
U2/U6 dissociation250. Hence, in light of these results, I propose that Prp24 helps to 
unwind the minimal U2/U6 complex of yeast, similar to its function in dissociation of 
U4/U6. However in cellular conditions, in which full-length U2/U6 is associated with U5 
at the catalytic core, Prp24 may initiate the disruption of base pairs at 5’ end of U6 and 
form a partially unwound complex, but Prp43 and/or Brr2 may be involved in the 
complete unwinding, which results in dissociation of all three snRNAs from each other. 
 
6.1.1: Future directions 
To further investigate the role of Prp24 and specific binding sites of RRMs, the following 
experiments have been proposed.  One experiment is to use fluorescently labelled 
Prp24 in single-molecule experiments. Using labelled protein will confirm the presence 
of protein after the removal of U2. Also, having fluorophores attached to each of the 
RRMs separately will provide a better idea about how each RRM contributes to the 
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overall function of Prp24 by illustrating the regions in U6 that each RRM is interacting 
with. Another important study would involve single-molecule experiments under cellular 
conditions with spliceosomal extracts.  This would help to understand the exact role of 
Prp24, Prp43 and Brr2 and whether they act cooperatively in releasing U2, U5 and U6 
after completion of catalytic reactions.  This study can be done by using labelled 
proteins to see whether the U2 removal is solely carried out by Prp24 by sequestering 
U6 from the U2 or if Prp24 initiates the disruption of base pairs at the 5’ region of U6 
followed by Prp43 and/or Brr2 moving along the partially unwound U2/U6 complex using 
their ATPase activity to completely unwind U2 from U6. These results will provide novel 
insight to understand the spliceosomal assembly cycle and how components are 
recycled after the completion of splicing. 
 
6.2: Study the assembly and global structure of U4/U6 complex 
To address the second question; how snRNPs assemble and effect protein binding on 
their global structures, we have studied the U4/U6 di-snRNP assembly using single-
molecule FRET and EMSA studies.  
Our EMSA studies revealed that the U4/U6 associated proteins are assembled onto 
the RNA duplex efficiently in a stepwise manner. Based on the structural and 
biochemical studies, it has been known that, Snu13 preferably binds to the K-turn motif 
at the 5’ stem-loop of U465-67,233, where it has a role as a nucleating factor for the 
binding of other proteins69. Similarly our results indicate that Snu13 binds the U4/U6 
duplex very tightly and it enhances the binding of Prp31 significantly. Consistent with 
the previous studies69,138, similar binding affinities were observed for the binding of 
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Prp31 and Prp3/4 to the U4/U6/Snu13 complex, suggesting that each of these proteins 
can bind to the duplex independently. Furthermore our binding affinities suggest that 
Sm proteins and LSm proteins may be pre-bound to the U4 and U6 snRNAs 
respectively before the duplex formation. Previous studies have been shown that U6 
snRNA, which is transcribed by Pol III, assembled first with LSm proteins and remains 
in the nucleus49,251.  On the other hand U4 snRNA is exported to the cytoplasm where 
Sm proteins are assembled onto U4 and then transported back to the nucleus where it 
assembles with U6 and other proteins252,253. These findings suggest that Sm and LSm 
proteins are bound to individual snRNAs prior to their assembly into a duplex, which 
also in accordance with our results. All together, we propose that the assembly of 
U4/U6 di-snRNP occurs in a step wise manner, where Snu13 binds first to the U4/U6 
duplex containing Sm and LSm rings, and then either Prp31 or Prp3/4 can bind to the 
complex followed by the other to form the fully assembled di-snRNP.  
Prp3/4 binds to naked U4/U6 duplex snRNA tightly, but interestingly binding 
becomes substantially weaker when all other components, except LSm proteins, are 
pre-bound.  Prior to the binding of LSm proteins, single stranded region in the 3’ end of 
U6 could form multiple secondary structures. Assembly of Prp3/4 before the assembly 
of LSm could be weaker due to the steric hindrance of these multiple conformations on 
the 3’ end of U6. Consistent with this, our single-molecule data also shows that in the 
presence of a minimal U4/U6 duplex, without the 3’ single stranded region, Prp3/4 binds 
to the duplex with a higher affinity even without LSm proteins. Taken together, these 
results illustrate that binding of LSm is needed for the proper assembly of Prp3/4 on to 
the duplex. Moreover, tight binding of Prp3/4 in the presence of all proteins suggest that 
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it could be the last protein assembled onto the di-snRNP assembly. Consistent with our 
results, previous studies have shown that among the U4/U6 associated proteins, only 
Prp3 and Prp4 are U4/U6 duplex specific proteins whereas other proteins (Snu13, 
Prp31, LSm and Sm) are individual snRNP specific67,235,236. Hence assembly of Prp3/4 
required prior binding of other proteins, giving rise to a tighter KD for Prp3/4 in the 
presence of all other components. 
Although previous studies have provided some basic low-resolution information 
about the structure of the U4/U6 complex and how it associates within the tri-snRNP, 
the relative orientation and the global structure of the U4/U6 duplex in the presence of 
its associated proteins remains structurally unresolved. Also, the mechanism by which 
Brr2 disrupts the U4/U6 duplex is poorly understood. To understand the relative 
orientation of helices and the effect of protein binding on the global structure of the 
U4/U6 di-snRNP, I have employed single-molecule FRET.  
Single-molecule experiments were done with the U4/U6 duplex labelled at different 
helices to observe the relative orientation of the three helices. The single-molecule data 
revealed that the U4/U6 duplex adopts and maintains a rigid or static global structure 
throughout the formation of di-snRNP. Interestingly, the experimentally determined 
inter-fluorophore distance within stem I and II from the single-molecule data is identical 
to the calculated total length of the two helices (assuming ideal A-form helices), 
suggesting that these two helices are coaxially stacked, forming a family A three way 
junction conformation, which is in contrast with previous studies86,254. Interestingly, a 
new EM structure of U4/U6.U5 tri-snRNP deduced by T. Nguyen et al., has also shown 
that the stems I and II are coaxially stacked255. 
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Despite the static global conformation of the U4/U6 duplex, I have observed some 
heterogeneity within the population distribution of FRET states, where the two 
constructs designed to study the orientation of the 5’ stem-loop relative to stems I and II 
adopt two major, non-interconverting conformations. The minor high FRET population 
that was observed consistently in the absence as well as in the presence of proteins 
(~10%) likely corresponds to a misfolded conformation, which was also observed in the 
fluorescence EMSA study. 
Additionally, experiments were carried out to visualise the assembly of proteins at 
the single-molecule level. Single-molecule FRET and molecular dynamics simulation 
assays have shown that the K-turn motif in the 5’ stem-loop adopts two conformations 
(extended and compact structures), and binding of Snu13 stabilizes the latter 
conformation256.  Furthermore, studies have reported on salt dependent conformational 
changes of the K-turn motif into the compact structure247,256. Based on these studies the 
K-turn is folded into a more tight arrangement in the presence of 20 to 100 mM Na+ or ~ 
0.1 to 1 mM Mg2+. Our single-molecule data in the presence of 100 mM Na+ has 
indicated that the population percentages for the two conformations do not change upon 
binding of Snu13. This result indicates that under the experimental conditions used, the 
K-turn in the 5’ stem-loop of U4 is already folded into a compact conformation, which is 
in accordance with previous studies247,256.  Hence, binding of Snu13 would not cause 
further folding of the K-turn, which suggests that the observed population heterogeneity 
has no relationship with K-turn dynamics. 
Furthermore, our single-molecule data shows that binding of Prp31 stabilizes one 
observed population whereas Prp3/4 stabilizes another population, indicating that 
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binding of these two proteins to the U4/U6 duplex results in conformational changes 
within the duplex. Prp31 has been shown to interact with the 5’ stem-loop of U469,72 and 
Prp3/4 binds to the stem II86. Thus, based on our results we assigned the two 
populations to two conformations; population 1 where the 5’ stem-loop is closer to stem 
I and population 2 where the 5’ stem-loop is closer to stem II. No change was seen for 
the complex with and without Snu13, suggesting that although it facilitates the binding of 
Prp31, Snu13 doesn’t affect the overall structural changes occurring within the duplex 
upon binding of this protein. Similar to our gel shift data, single-molecule results have 
also shown that either Prp31 or Prp3/4 can bind to the U4/U6/Snu13 complex first, 
followed by the other. Interestingly, the fully assembled complex adopts a conformation 
similar to what we observed for RNA alone. Hence we propose that the binding of 
individual proteins or partial assembly of di-snRNP can cause some local structural 
rearrangement, mainly in the 5’ stem-loop of U4, whereas stem I and II orientations 
remain unchanged. Furthermore, our results indicate that binding of one protein (either 
Prp31 or Prp3/4) changes the 5’ stem-loop conformation in a way that facilitates the 
binding of the other protein (either Prp3/4 or Prp31). Otherwise, the fully assembled 
complex upholds a static global conformation.   
Maintaining a rigid conformation of U4/U6 may have a role in the function of U4/U6 
duplex as a negative regulator, which prevents U6 from premature activation. Also, the 
structure of U4/U6 may play an important role in Brr2 activity. As shown in previous 
studies, Brr2 plays an important role in the unwinding of U4 from U6 allowing U6 to 
base pair with U2 to form the catalytic core35,84,89,187. Nevertheless, the mechanism of 
Brr2 unwinding of these two snRNAs is not yet clear. Previous studies have also 
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proposed that U4/U6 associated proteins may also play an important role in the 
stabilization/destabilization of this duplex69. During the unwinding process, U6 needs to 
be free of proteins in order to be available for efficient pairing with U2 while U4 is 
released with U4 associated proteins. From our structural data, we deduce a possible 
mechanism for Brr2 function, where we propose that having a static conformation of 
U4/U6 duplex may favour the Brr2 activity by letting it move through the duplex easily, 
which in turn facilitates the unwinding of U6 from the complex, as a free snRNA while 
keeping most of the proteins with U4.  Releasing with most of the proteins bound could 
be an efficient way of recycling U4 after its release from spliceosome.  
Taken together, our EMSA data reveal a step-wise assembly of proteins onto the 
RNA duplex and we provide a protocol for full assembly of the di-snRNP, which could 
be useful in the reconstitution of other snRNP particles as well. Our single-molecule 
data revealed interesting information concerning the relative orientation of the three 
helices of the U4/U6 duplex, where we propose that stem I and stem II are coaxially 
stacked with each other and the overall di-snRNP maintains a rigid conformation. This 
static structure may promote Brr2 unwinding activity, by allowing it to remove U6 easily 
from U4. Overall, the resulting rigid structure for the U4/U6 complex suggests that 
U4/U6 adopts a preformed conformation and acts as a scaffold for protein binding, while 
preventing U6 from premature activation. 
 
6.2.1: Future directions 
To further understand and characterize the assembly of U4/U6 di-snRNP the following 
experiments are proposed. Since we have now found that the U4/U6 di-snRNP 
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maintains a rigid global structure, the immediate question arising is what will happen to 
this rigid conformation upon formation of U4/U6.U5 tri-snRNP. To answer this question, 
further experiments can be done using labelled U5 snRNP. These experiments will 
provide information about how U4/U6 duplex interacts with the U5 snRNA, how these 
snRNAs are rearranged and which conformation they adopt upon formation of tri-
snRNP. Also, as a further advancement of this project, CoSMoS studies can also be 
performed to visualise the colocalization of all components of the tri-snRNP; U4/U6 di-
snRNP and the U5 snRNP, revealing the formation of tri-snRNP at the single-molecule 
level. To understand the effect of other components present in the spliceosome on the 
assembly of U4/U6 di-snRNP, single-molecule experiments can be done with 
spliceosomal extracts. For this study, the endogenous di-snRNP needs to be depleted 
and the exogenous complex with fluorophore labels needs to be introduced. This would 
provide more information on how other spliceosomal components affect the global 
structure of U4/U6 di-snRNP and provide a clearer picture on the overall assembly 
process. Taken together, these experiments will help to elucidate the assembly of tri-
snRNP, determine the global structure of U4/U6 duplex within the tri-snRNP and reveal 
the relative orientations and interactions between U4/U6 duplex and U5 snRNA. Along 
with the recent cryo-EM structure of U4/U6.U5 tri-snRNP, these results may lay a 
further step on the progress of understanding the overall structure of U4/U6.U5 tri-
snRNP, hence understanding the overall picture of the spliceosome.  
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6.3: Study the structural dynamics of U12/U6atac snRNA complex in minor 
spliceosome 
To address the third aim; understand the structural and functional similarities and 
differences of major and minor spliceosomal snRNA complexes, I have studied the 
conformational dynamics of U12/U6atac complex using single-molecule FRET. 
Previous studies have shown that minor spliceosomal U12/U6atac complex forms a 
secondary structure similar to the three helix junction structure of major spliceosomal 
U2/U6 complex147.  Hence, I have carried out single-molecule experiments to determine 
whether minor U12/U6atac complex also undergoes conformational dynamics as 
observed for U2/U6 complex. The results from single-molecule data indicate that 
formation of a minimal U12/U6atac complex produces a FRET value of 0.2. Also, this 
study has revealed that U6atac adopts a static high FRET conformation, whereas in the 
addition of increasing concentrations of U12, molecules were oscillating between FRET 
1.0 and 0.2 and with higher U12 concentrations molecules adopting a static low FRET 
conformation (0.2). These complex dynamics could be due to the small size of U12, 
which may result in partial binding with U6atac.  Because of the unstable binding, U12 
could easily dissociate allowing for free U6atac to revert to the high FRET conformation. 
Furthermore, presence of only one FRET state (0.2) upon formation of U12/U6atac 
complex suggests that due to the short length of U12 snRNA, the U12/U6atac complex 
cannot undergo any conformational dynamics, as we observed for the U2/U6. Upon 
analysis of the sequence, it clearly shows that U12/U6atac cannot form the helix III 
structure as present in the major spliceosomal complex and the complex adopts a 
conformation similar to the three helix junction structure of U2/U6.  
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Furthermore, the single-molecule experiments were done to determine the effect of 
Mg2+ ions on the stability of U12/U6atac complex. The results indicate that in the 
addition of varying concentrations of Mg2+ the FRET trajectories change from static 1.0 
FRET state to a static 0.2 FRET state, through a dynamic state fluctuate between 1.0 
and 0.2 FRET states. These results suggest that the Mg2+ ions stabilize the U12/U6atac 
complex formed at a conformation similar to the three helix junction structure of U2/U6. 
As a whole, these data with the minor spliceosomal complex reveal the formation of 
minimal U12/U6atac complex and the conformation of this complex is similar to a three 
helix junction structure like its major spliceosomal counterpart. Also, these data illustrate 
that the presence of Mg2+ stabilizes this conformation. 
 
6.3.1: Future directions 
 As this study is on-going, there are additional experiments that need to be done in 
order to reveal the structural and functional relationship between minor and major 
spliceosomal snRNA complexes. For further investigation of the structural dynamics and 
the significance of minor spliceosomal U12/U6atac complex as the catalytic core, more 
single-molecule FRET studies can be done with U12/U6atac complex.  Similar to major 
U6, U6atac also has three highly conserved regions; AAGGAGA loop, AGC triad, U46 
(U80 in Major U6) and ISL structure, that have been shown to be important for the 
complex formation and the catalytic activity147. Also, it has been shown that RNA-RNA 
interactions at the catalytic core of the minor spliceosome are markedly similar to that of 
the U2/U6 complex228.  Similar to its counterpart, these conserved regions within the 
minor spliceosomal U6atac are important for the formation of the catalytic core, interact 
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with pre-mRNA and rearrange the active site facilitating the catalysis. Hence, obtaining 
information related to the orientation and interactions between U12/U6atac duplex and 
pre-mRNA, conformational dynamics within the complex upon activation can enlighten 
the overall picture of the assembly and machinery of the minor spliceosome, which has 
not been revealed yet. The single-molecule experiments with U6atac containing 
mutations at highly conserved regions (ACAGAGA loop and AGC triad) can be done to 
determine the effect of those regions on the formation of U12/U6atac complex, as well 
as in the catalysis. Similarly, singe-molecule experiments can be done to study the 
effect of U46, which is known to be important for the metal ion coordination as its major 
U6 snRNA counterpart, U80.  U6atac snRNA with mutated U46 to A, G or C or deleted 
U46 can be used in these assays to reveal the effect of these changes on the formation 
of the complex, similar to the study done with U80 in major U6185. The experiments with 
these mutations provide information about the importance and specificity of these 
regions in assembly and catalysis. Other than U6atac, U12 have also shown to contain 
some important regions. Previously a photochemical study has shown that an upstream 
5’ exon region is necessary for stabilizing the RNA-RNA interactions in the catalytic 
core257. Therefore, single-molecule experiments can be done to study the effect of these 
highly conserved regions on the U12/U6atac complex formation, simply by mutating 
those regions within U12258. Another important study that can be done is determine the 
conformation of pre-mRNA bound U12/U6atac complex and elucidate the 
conformational dynamics within the snRNA helices upon pre-mRNA binding. It has been 
shown that U6atac interacts with the 5’ SS in a same manner as U6 and the 5’ SS 
mutations can be rescued using some compensatory mutations in U6atac228. To obtain 
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this information, single-molecule experiments can be done in the presence of short RNA 
strand consisting 5’ and 3’ splice sites (resembling pre-mRNA), with and without 
mutations at 5’ SS and U6atac strand. These experiments will evaluate the effect of pre-
mRNA binding on the overall conformation of U12/U6atac complex. Altogether the 
results from these experiments will reveal more information related to the conformation 
of U12/U6atac complex, importance of the conserved regions within the two snRNAs on 
the active site formation and how U12/U6atac interacts with other components at the 
catalytic core, which eventually leads to understand how this structural information is 
related to its function. Other than the U12/U6atac complex, similar experiments can be 
done to study the structural information about other minor spliceosomal sub-complexes 
such as U4atac/U6atac di-snRNP. As a whole, these studies provide more information 
regarding minor spliceosome, which has not studies in extend, though it plays an 
important role in regulation of many important genes.    
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